Child Neurology
7th Edition

Chapter 18
Disorders of Mental Development
Marcel Kinsbourne
Frank B. Wood
A host of neurologic disorders with onset early in life compromise mental development. The cognitive impairment may be one among many neurologic abnormalities, or it may be the dominant feature. Even in the latter case, less prominent neurologic signs and symptoms are usually also to be found, and no clear neurobiologic distinction can be made between syndromes of mental dysfunctions and other brain disorders. This chapter treats in detail those disorders in which the mental development component is key. Where disordered mental development is one of many abnormalities, the mental component is briefly summarized, and the reader is referred to other chapters for more comprehensive discussion of the entity in question.
A developmental disability is an impairment in behavioral development due to abnormality of the central nervous system. Developmental disabilities manifest during the developmental period and result in lifelong impairment in any combination of physical, cognitive, sensory, speech and language, and neuropsychologic functions. Beginning with the formation of the neuroectoderm, the developmental period is in principle not complete until the end of myelinization during the decade of the twenties. In practical terms, however, the general category of developmental disorders reflects alterations in neural maturation that manifest most often and most prominently in the preschool and early grade school years. This chapter considers the nature, diagnosis, and management of those developmental disorders and disabilities that implicate higher cortical function—that is, cognition and attention.
NATURE OF DEVELOPMENTAL DISORDERS
Postnatal neurologic maturation underwrites the gradual acquisition of an extensive repertoire of cognitive skills. The newborn is devoid of cerebrally controlled behavioral patterns, so that in the first 6 weeks of life it is hard to distinguish the normal newborn’s behavior from that of an anencephalic infant. Different brain regions progressively assume control over specific functions in predictable sequence and timing—brainstem before cerebrum, sensorimotor projections before integrative cortex. Late-developing skills, typically subserved by late-maturing prefrontal cortex (1), develop over many years, at least until late adolescence, before the skill in question asymptotes to its ultimate adult level (2).
A developmental disorder typically becomes apparent when a specific ability fails to present within the normatively expected time frame. It induces an unexpected low point in the child’s cognitive profile, a selective deficit. In the general childhood population, there is a high correlation between an individual’s performance on a wide range of mental tests, a phenomenon that has given rise to the construct of g, or general intelligence. Some two-thirds of the interindividual variance in the overall intelligence quotient (IQ) of the general population reflects genetic diversity (3,4). Variations in the prenatal and postnatal environment account for the remainder. Even in the general population, aspects of brain structure correlate with IQ: Intracranial, cerebral, temporal lobe, hippocampal and cerebellar volume as well as gray matter volume account for between 12% and 31% of the variance in IQ (5). However, many adverse biologic, genetic, environmental, and gene-environment interactions can reduce the rate of intellectual development, either globally, causing mental retardation, or selectively, compromising some components of intelligence only. IQ tends to be higher in those who were heavier at birth or who grew taller in childhood and adolescence. In a study of normal nine-year-old children, IQ at age 9 rose by about two points for every standard deviation increase of head circumference at 9 months and by nearly three points for every standard deviation increase at 9 years. It appears that postnatal head growth, at asymptote between age 14 and 16, is more important than prenatal head growth in determining cognitive function. Postnatal head growth correlates positively with mothers’ height and weight, socioeconomic status (SES), and educational level (6).
Selective cognitive deficit results in “intertest scatter,” such that the child scores within the normal range on some tests, but disproportionately poorly on those that tap
P.1098

developmentally compromised cognitive processes. Such scatter between normally and slowly developing skills is typical of learning disabilities. Any cognitive skill may be selectively impaired, but it is the impairments that have social consequences that attract attention. Those selective cognitive deficits that result in delayed language development, abnormal play, and defective social skills commonly become apparent during the second and third years of life. Selective deficits in attention, concentration, and learning that leave a child lacking readiness for instruction in academic areas may not be recognized until the preschool or grade school period. Such disorders are usually diagnosed on functional and behavioral criteria, whether or not biologic validation of the diagnosis is feasible.
In some cognitive domains, normal development continues until late in adolescence. Examples of this include executive functions, such as the capacity of working memory and cognitive flexibility (7). A recent imaging finding that dorsolateral frontal activation continues to develop in adolescence (8) is provocative but may only show that adolescents tend to underutilize that cortex, rather than that they are as yet incapable of using it. Developmental delays usually reach an end-point of persisting cognitive deficits by late adolescence, within the same time frame as that in which normal development asymptotes. In general, gradual improvement is common, though some is due to statistical regression artifact. But some improvement reflects genuine progress as the child sorts out the most relevant and controlling stimuli of life, school, and work, thereby reserving the most effort at improvement for the areas that promise the most gain. A child’s brain may compensate, reorganize, and mature, and special education may offer systematic practice of impaired skills, combined with alternative training that circumvents the cognitive limitation (“bypass”). In other instances, cognitive abilities gradually deteriorate, as in increasingly intractable seizure disorder and secondary behavioral disorder. Or development may be predestined genetically to decelerate gradually, as in Down syndrome. However, usually the child makes gains over time but with a ranking relative to his typically functioning peers that does not appreciably change. Notwithstanding that, the gap in adolescence is usually rather more obvious than it is around school entry. Such a child’s level of functioning is quantitatively insufficient for his chronologic age and instead is as would have been expected in a younger child.
TABLE 18.1 Typical Cognitive and Language Developmental Milestones of Infancy and Childhood
Age Early Cognitive Milestones Early Language Milestones
From birth Interest in faces; begins to make eye contact Phonologic discrimination
Few mo A social smile should develop before 6 weeks of age
Laughing out loud is a reliable milestone that should occur around 4 months of age
Responsive vocalization, turn-taking, cooing (vowels)
6–8 mo Grabbing for objects, exploring surroundings Babbling consonants/vowels, syllables, dada, baba
10–12 mo Pointing to indicate wanted object; comprehension of words 2–3 words with meaning; imitation of animals
18–22 mo Should follow simple commands, indicate body parts, ask for objects by pointing, and imitate actions Vocabulary spurt; jargonizing develops interspersed with intelligent words; receptive language and understanding are more developed than speech
  Onlooker behavior, nonsocial activity, and solitary independent play By 2 years: word combinations/many single words; expansion of comprehension
Around 2 yr Limited social participation; parallel play 2-word utterances; mostly intelligible to family; comprehend many sentences
By 3 yr Beginning social play (the child talks about play, borrows/lends toys, controls who may play in the group) Speaks in grammatical sentences (with some errors); mostly intelligible to strangers (still makes phonologic errors)
Thereafter Cooperative play; acts out make-believe themes Phonology by school age; vocabulary increases lifelong
NEURODEVELOPMENTAL LAG
Normative cognitive and language developmental milestones are presented in Table 18.1. In neurodevelopmental lag, the effects of an early brain lesion or maldevelopment become increasingly apparent many months or years later as cognitive milestones are slow to be reached and immature patterns of sensorimotor control persist. The newborn has a limited repertoire of innate movement patterns. These synergisms subserve activities such as rooting, sucking, startle, and lateral orienting, which occur spontaneously or as reflexive responses to stimulation. Synergisms gradually disappear according to a well-delineated schedule in the course of infancy or childhood. The overall trend of motor development is toward increasingly precise control over an ever widening repertoire of discrete movement combinations (9); sensory development tends toward a finer, more exact differentiation between various stimuli (10).
P.1099

In neurodevelopmental lag, synergisms may persist, presenting as “soft signs” on the neurologic examination. Soft signs are signs that would have been normal had the child been younger. Motor soft signs are of two kinds: (a) unwanted movements (e.g., persistent asymmetrical tonic neck response, unwanted associated and mirror movements); and (b) imperfect execution, such as slowness in speeded sequential activities such as finger tapping or finger-thumb sequencing, or in alternating movements, such as pronation-supination of the forearm or flexion-extension at the ankle (dysdiadochokinesis). In the absence of long tract signs, dyspraxia, or clumsiness, is diagnostically nonspecific (see discussion of developmental coordination disorder below).
Delayed development proceeds through the same stages as normal development, although at a slower rate. Thus, with increasing age and neurologic maturation, scores on quantitative scales for soft signs decline, regardless of diagnosis (11). Considerable consistency in neuromotor developmental status has been demonstrated over periods as long as 10 years (12). Signs of sensorimotor immaturity are often lower-level analogues to later emerging cognitive immaturity, behavioral problems, and attention deficits. Early signs of developmental delay indicate a high risk of long-term functional developmental disabilities, depending on the distribution and severity of the underlying cause, but these associations do not provide an adequate basis for prognosis. For instance, an association exists between persisting mirror movements and aggressive psychopathology, perhaps because both are manifestations of disinhibition (13). Excessive, uncontrollable crying that persists beyond 3 months of age has been associated with a shortfall of some nine IQ points relative to controls with colic only in a prospective study (14).
Neurodevelopmental lags that involve both cognitive and sensorimotor control have been bracketed together as “minimal brain dysfunction” (MBD) (15). This construct was intended to indicate organicity, so as to counteract the now virtually extinct tendency to ascribe developmental delays to intrapsychic problems. A similar construct, intended to be descriptive rather than making hard-to-prove claims about the brain, has gained acceptance in Scandinavia. This is the collective labeling of children with childhood onset of deficits in attention, motor control, and perception with the acronym DAMP (16). These disparate neurocognitive immaturities may or may not affect specific academic skills. A clinical level of deficit is reached by 1.5% of the childhood population. The syndrome does not indicate any particular etiology (17), and its antecedents do not differ qualitatively from those of major brain dysfunctions such as cerebral palsy or mental retardation, which also are end results of a host of different neuropathologies. The extent to which development is impaired depends on the anatomical distribution and the severity of the insult, rather than its cause. Despite their substantial comorbidity (18), neuropsychologic testing does not reveal any functional overlap between the motor and the attentional components. The practical usefulness of the MBD/DAMP construct is limited by the fact that each component of the syndrome is managed in the same way when it coexists with the other ones, as when it is present in isolation.
CLASSIFICATION OF DEVELOPMENTAL DISORDERS AND DISABILITIES
Ideally, disorders of cognitive development are classified on both an etiologic and a descriptive and functional basis. However, many patients have developmental disorders “of uncertain etiology.” In the absence of a precise medical diagnosis, it is preferable to record the chief characteristics of the abnormal developmental process rather than to make inferences such as “cerebral dysfunction,” “organicity,” or “static encephalopathy.” The characteristics include qualitative and quantitative descriptions of the mental status, including use of language, play skills, visual and auditory recognition, reasoning, orientation to spatial relationships, impulse control, and the ability to sustain attention.
Most neurodevelopmental disorders that result in mild disability affect quality of life but do not curtail longevity. The children require no more than the customary standard of medical care throughout their lives. Any need for additional specific medical interventions for certain neurologic disorders (e.g., diets for metabolic disorders or epilepsy, pharmacologic treatment for severe behavioral problems), or for nonmedical therapy programs, should be re-evaluated periodically for evidence of cost-effectiveness on long-term outcome.
PRACTICAL APPROACHES TO NEURODEVELOPMENTAL DISORDERS
The medical model and the habilitation model (Fig. 18.1) are complementary, and both are fundamental to clinical practice. The habilitation model is particularly relevant when, as in disorders of mental development, there generally are few means of offering complete symptomatic relief and fewer still of outright cure. By federal law, the Individuals with Disabilities in Education Act (IDEA)—the habilitation/rehabilitation model for developmentally disabled children—is the programmatic and financial responsibility of local education authorities, assisted to a varying extent by federal funding.
Medical Diagnosis and Treatment
Developmental disorders have a wide variety of causes, and few have a specific, identifiable genetic or neurobiologic etiology. Different etiologies converge on identical
P.1100

behavioral phenotypes. The diagnostic yield is much greater if there is associated microcephaly, antenatal toxin exposure, or focal findings (19). In their absence, a thorough search for diagnostic clues includes family history with a three-generation pedigree and information from the prenatal, perinatal, and early postnatal periods. The development of motor skills; comprehension of speech; emergence of words and formed, intelligible sentences; and quality of social play skills are often relevant. The physical examination includes measuring head circumference as well as body size and growth; assessment of vision, hearing, and ocular funduscopy; searching for facial, skeletal, somatic, and dermatoglyphic anomalies and asymmetries; visceromegaly; neurocutaneous lesions and depigmentations; and other signs of chronic illness. Hand preference and pencil grip are noted as well as any abnormal postures and involuntary movements. Clinical clues in the evaluation of developmental disorders are presented in Table 18.2.
FIGURE 18.1. The practice of the medical model and the rehabilitation model should coincide.
TABLE 18.2 Clinical Clues in the Determination of Developmental Disorders and their Etiology
Clinical Clue Etiologic Category Examples
Family member with known condition, mental retardation, other developmental disabilities, multiple miscarriages Genetic Mendelian dominant, recessive, X-linked; some mitochondrial disorders; cytogenetic/chromosomal anomalies
Facial dysmorphism, severe central nervous system malformation Genetic or acquired during embryogenesis CHARGE syndrome, anencephaly, holoprosencephaly, septo-optic dysplasia
Evidence of neuroblast migrational disorder, hydrocephalus, congenital microcephaly Genetic or acquired during the fetal period Lissencephaly (Miller-Dieker syndrome), X-linked hydrocephalus
Born too soon, too small Prematurity Periventricular leukomalacia
Low Apgar scores, low cord pH, neonatal seizures Perinatal Hypoxic-ischemic encephalopathy
Acquired microcephaly, stagnation in developmental gain Postnatal Rett syndrome
Postnatal vomiting, failure to thrive, hypoglycemia Metabolic Phenylketonuria, urea cycle disorders, organic acidurias, other specific enzyme defects
Cerebral calcifications, congenital or acquired microcephaly Infectious Cytomegalovirus encephalopathy, toxoplasmosis, herpes simplex viruses, human immunodeficiency virus, bacterial meningitis
Hemorrhage, infarction, venous thrombosis Cerebrovascular Factor V Leiden deficiency, sickle cell disease
Failure to thrive Nutritional Prenatal and postnatal protein malnutrition, vitamin and essential element deficiency
Parental drug abuse, neonatal jaundice, acute encephalopathy Prenatal, perinatal, postnatal toxic exposure Fetal alcohol syndrome, neonatal hyperbilirubinemia, lead poisoning
Dry skin, hypotonia, hyporeflexia Endocrine Hypothyroidism
Extreme poverty, parental drug abuse, low parental educational level, severe plagiocephaly Sociocultural/environmental Nonaccidental head trauma, emotional deprivation, lack of infant stimulation
Nonspecific findings Unknown Up to one-half of all developmental disabilities
The mental status examination assesses the child’s orientation, relatedness to, and interest in the examiner, caregiver, siblings, peers, and other people in the child’s environment; the quality of reciprocal social exchange in verbal and nonverbal communication (e.g., eye contact, gestures, facial expression), ability to engage in reciprocal imaginative play with representational toys; presence of perseverative, stereotypic, and ritualistic behavior; and presence of problematic behaviors such as attention difficulties, overactivity, aggression, and self-injury.
The laboratory evaluation of choice for developmental disorders continues to evolve as increasingly detailed understanding of the human genome leads to improved delineation of syndromes and advances in cytogenetic,
P.1101

molecular, and neuroimaging techniques. Routine test batteries are not effective. The incidence of identifiable metabolic disorders in children with developmental delay is low, ranging from 0% to 5% (20,21). In addition, nonspecific, nondiagnostic, or false-positive “abnormalities” are common in routine nondirected laboratory testing. This can lead to further futile laboratory pursuits. Most infants and children with inborn errors of metabolism show signs or symptoms of their metabolic disorder such as hepatosplenomegaly, failure to thrive, intolerance of certain food groups, intermittent emesis, recurrent unexplained illnesses, seizures, intermittent somnolence, or fluctuating hypotonia. The relevant metabolic tests are reviewed in Chapter 1. In patients with developmental disorders who lack signs or symptoms of a metabolic disorder, metabolic screening should be deferred (22,23,24).
Many individuals with mental retardation have associated behavioral, emotional, and psychiatric disorders and nonneurologic congenital anomalies. A composite pattern recognition or cytogenetic testing may lead to a specific diagnosis (25). In these circumstances, the diagnostic label refers to the most salient aspect of the condition or is noted by an acronym, such as CHARGE association (of congenital anomalies) or eponym (e.g., Angelman syndrome), or by the underlying chromosomal abnormality, such as at chromosome 22q11.2. A specific molecular cytogenetic analysis, such as fluorescence in situ hybridization (FISH), may be indicated if the child has features of a known mental retardation syndrome (e.g., Williams or fragile X syndrome) or autism (e.g., chromosome 15q11 duplication) (see Chapter 4).
In most individuals with mild mental retardation, there are no specific neuropathologic correlates. Neuroimaging has a low diagnostic yield unless there are suspicious physical findings or localized neurologic deficits (26). Delayed myelination visualized on magnetic resonance imaging (MRI) is nonspecific in infants and children with neurodevelopmental delays (27). The diagnostic yield of neuroimaging increases considerably if the mental retardation is severe or complicated by microcephaly or macrocephaly, major motor abnormalities, features of a genetic syndrome, or seizures. MRI may reveal migrational disorders (e.g., lissencephaly), midline defects (e.g., holoprosencephaly or septo-optic dysplasia), or other brain malformations and disruptions (e.g., schizencephaly) (see Chapter 5). When the history suggests metabolic insult, vascular compromise, infection, or trauma, neuroimaging may reveal evidence of destructive central nervous system (CNS) changes.
There is no consensus on which children with developmental delay should be studied by imaging, and there are considerable variations in technique, methodology, demographics, and interpretation between the few available studies of computed tomography (CT) and MRI in children with mental retardation. Correspondingly, the reported frequency of abnormal neuroimaging findings in persons with mental retardation ranges from 9% to 80% (28,29,30,31). Positron emission tomography (PET), single photon emission CT (SPECT), functional MRI (fMRI) (32), and volumetric and morphometric MRI (33) provide insights into specific conditions but have limited overall application in the infant or child with a nonspecific developmental disorder. Formal audiologic testing is required to rule out hearing loss in all children who have language delay and may have isolated high-frequency hearing losses. Children with hearing impairment should be followed longitudinally for speech therapy and possible speech amplification.
Electroencephalography (EEG) is indicated if the history suggests seizures or regression or plateau in language acquisition (see Chapter 14). EEG can assist in the diagnosis of certain children with developmental disorders (34). Seizure disorders are often in their own right associated with diminishing IQ, as is their treatment with antiepileptic drugs (see Chapter 14). Memory may be deficient when the seizures are generalized. In complex partial seizure disorder, verbal and nonverbal memory may be impaired when there are left and right foci, respectively (35). Epileptic children as a group have inferior attention and general slowing of mental processes (36) as well as a varying degree of lag in language and reading ability (37). Children with frontal epileptic foci exhibited a relatively greater degree of impulsivity and disordered planning, verbal fluency, and motor coordination than generalized and temporal comparison groups (37). A comprehensive treatment of the neuropsychology of childhood epilepsy is available (38).
Habilitation and Rehabilitation
In habilitation, rehabilitation techniques are applied to individuals who, rather than having lost previously mastered skills, failed to master new skills at the expected age. This applies to children with developmental delay. For purposes of habilitation, the physician is less concerned about the level of function, and more with the implementation of evidence-based effective and enabling therapies, regardless of etiology. Schools are the primary venues of such therapies, and the consensus is swinging toward ever stricter demand for evidence-based justifications for such educational practices. For example, the Federal Department of Education maintains a “What Works Clearinghouse” that periodically reviews and reports educational efficacy evidence that meets high standards (39).
Children who are considered to have cognitive deficiency may come to attention because of poor academic achievement, abnormal behavior, or both. Is the lack of academic achievement due to limited cognitive ability, or does it represent underachievement relative to the child’s potential for other (e.g., psychosocial or emotional) reasons? If the child appears to be achieving at his or her
P.1102

maximum level, consistent with that child’s specific profile of cognitive or attentional strengths or weaknessess, then special needs are identified, and an individualized educational plan (IEP) is implemented. If the child is underachieving, the causes are sometimes found in the child’s school and social setting or emotional well-being. In only a few developmental syndromes, notably attention-deficit hyperactivity disorder (ADHD), can cognitive potential be enhanced by medical means. In particular, there is as yet no evidence that learning disabilities, distinct from any comorbid attentional disorder, are pharmacologically treatable.
Most disorders of mental development are long lasting, if not permanent. Whether the child’s condition declares itself at or before birth or during early childhood, the parents have to adjust their previous expectations of a perfectly healthy child to the current reality. This adjustment is traumatic, and not all parents navigate its difficulties with success. The problem is amplified if, as is commonly the case, a specific diagnosis as well as a specific prognosis cannot be formulated. Such opinions as “developmental disability” convey confusion and are no substitute for the clarity and credibility of a specific diagnosis. When the disability is chronic and not fully explained—for instance, as in mental retardation and in autism—the quality of the parent–child relationship may suffer for lack of clarity about what to expect in the future. The clinician cannot always persuade the parents of what appears to be the reality of the situation, or even of the diagnosis, when that can be ascertained. Continued uncertainty is detrimental to parent–child attachment as well as to the functioning of the family unit. Under such circumstances, encouragement to seek a second opinion can with advantage be accompanied by referral for psychological counseling.
Inclusion in Public Education
The Education for All Handicapped Children Act (EHA) was renamed the Individuals with Disabilities Education Act (IDEA) in 1990. This legislation requires schools to provide an appropriate individualized educational plan to students with disabilities, to be implemented in the “least restrictive environment.” The IDEA mandates a nondiscriminatory assessment, active involvement of parents in the educational process with due-process rights and hearing, and access to indicated ancillary services such as physical therapy, counseling, and transportation. The reauthorization of IDEA requires that students with disabilities be educated with their nondisabled peers to the extent possible, and that schools actively plan for student transitions (and that traumatic brain injury and autism be considered separate categories). The word handicapped in the original version of the law was replaced with the word disabled. Inclusion refers to the effort to include students with disabilities in general classrooms while providing special services outside the general classroom as needed. Currently, approximately 70% of all students with disabilities attend mainstream classes during part of the school day.
Quantitative Measurement of Cognition (Standardized Scales)
In infancy and early childhood, receptive and expressive language and play skills are the best indices of cognitive level. The prognostic reliability of cognitive testing improves when children reach an age at which some language competence is expected and a wider range of testing modalities becomes available. Language development up to age 3 years can initially be documented in the clinical setting with the Early Language Milestone Scale (40). Early cognitive and language developmental milestones in infancy and childhood are summarized in Table 18.1.
The diagnosis of a cognitive deficiency requires that a clinical impression be validated by standard psychometric assessment or referral report. The assessment that is appropriate for infants and children with developmental delays or disabilities depends on the child’s age, level of impairment, and the presence of additional sensory deficits. For clinical screening up to age 6 years, the Denver-II, formerly the Denver Developmental Screening Test–Revised (41), has been commonly used. The Denver-II draws on parent history, testing, and observation and takes approximately one-half hour to administer. However, for predictive value, the Battelle Developmental Inventory Screening Test (BDIST), which screens children up to age 8 years, is preferred (42) though it is not designed to identify specific learning disabilities. A trained infant psychometrist is likely to adminster the Bayley Scales of Infant Development II, which estimate the level of cognitive and motor deficits in infants (43). However, because infant cognition is limited, only sensorimotor functions can be evaluated accurately for normative purposes. These functions are nonspecifically correlated to an infant’s later emerging cognitive skills, the lack of which may result in a developmental disability in later years. More specific information about selective deficits in cognitive operations can be gleaned from the results of neuropsychologic testing. A cognitive profile is established for diagnoses and functional evaluation, the monitoring of further development, and rehabilitation planning. Some commonly used measures of cognitive and adaptive behavioral development are summarized in Table 18.3.
Administered with proper reservation, an IQ test is by far the most valid means toward establishing a child’s level of functioning—knowledge that has wide clinical application. Regardless of disagreements as to whether IQ is a valid measure of intellectual or educational potential (58), the IQ test result is unequivocably the best guide in estimating overall current levels of functioning. IQ within the normal range by definition eliminates mental retardation
P.1103

P.1104

as the reason for preschool or school achievement below the expected level. It does not exclude the possibility that specific learning disabilities are compromising the acquisition of some academic skills. Therefore, IQ has been withdrawn from the necessary definition of learning disability in the 2004 IDEA. Furthermore, no single IQ test measures all cognitive operations, and various subtests involve multiple cognitive processes. Therefore, a low score on a subtest would be unlikely to isolate the basic cognitive deficit that prevents the child from learning to read, write, or calculate.
TABLE 18.3 Common Measures of Cognitive and Adaptive Behavioral Development in Infancy and Childhood
Category of Test Test Name/Reference Ages Description
Screening Bayley Infant Neurodevelopment Screen (43) 3–24 mo Assesses neurodevelopmental skills such as object permanence, imitation, and language
Denver-II (41) 0–72 mo Screens for language, fine motor, adaptive personal/social, and gross motor skills
Intelligence measures Wechsler Preschool and Primary Scale of Intelligence, Revised (44) Preschoolers Measures verbal comprehension, perceptual organization, attention/concentration, and visual processing speed
Wechsler Intelligence Scale for Children-III (45) School-aged children Both the Wechsler Preschool and the Wechsler Intelligence Scale give a verbal, performance, and full-scale IQ
Stanford-Binet Intelligence Scale: Fourth Edition (46) Variable for each subtest Measures general intelligence, verbal reasoning, quantitative reasoning, abstract/visual reasoning, and short-term memory
Alternative cognitive measures Goodenough-Harris Drawing Test (Draw-A-Man) (47) 3–16 yr Easy to use as a screen of nonverbal intellectual abilities, especially useful for culturally diverse, low-functioning children
Kaufman Assessment Battery for Children (48) 2.5–12.5 yr Used to complement Stanford-Binet or Wechsler nonverbal estimates
McCarthy Scales of Children’s Abilities (McCarthy) (49) 2.5–8.5 yr Provides information on young children with suspected learning disabilities
Leiter International Performance Scale (50) 2 yr to adult Often used with autistic children as a measure of nonverbal intelligence
Behavior rating scales Achenbach Child Behavior Checklist (51) 2–3 yr Allows parents or caregivers to rate a young child’s social/emotional development
Conners’ Parent/Teacher Rating Scales (CPRS-48 and CPRS-28) (52) 3–17 yr The CPRS-48 has 48 items and CPRS-28 items that assess conduct problems, learning problems, impulsivity/hyperactivity, and attention
Adaptive behavioral scales Battelle Developmental Inventory (42) Newborn to 8 yr Assesses personal/social, adaptive, motor, communication, and cognition
Vineland Adaptive Behavioral Scales (53) Newborn to 18 yr Parent questionnaire that assesses communication, daily living skills, socialization, motor skills, adaptive behavior, and maldevelopment; useful in children with cognitive disabilities
Achievement Wide Range Achievement Test 3 (54) 5 yr to adult Screening test of basic academic skills, including reading, spelling, and arithmetic
Woodcock Johnson Psychoeducational Battery–Revised, Part II (55) 3 yr to adult Psychometric test of academic abilities with subtests in reading, mathematics, and written language
Language Early Language Milestone Scale (40) Newborn to 3 yr Examines listening, speaking, audition, and visual perception
Peabody Picture Vocabulary Test–Revised (56) 2–6 yr Vocabulary screening test for children with expressive language difficulties
Nonverbal Developmental Test of Visual-Motor Integration (57) 4–18 yr Tests child’s abilities to integrate visual perception and motor output by requiring the child to copy increasingly complex geometric forms
Some “scatter” between the levels of subscale or subtest scores on an intelligence scale is normal. Only when it is statistically excessive might it reflect a disparity in the level of development of different intellectual skills. Verbal-performance discrepancy scores are often reported. Children with mild mental retardation tend to score somewhat lower on the Wechsler verbal subscale than on the performance subscale. A much lower verbal than performance IQ accompanies selective language delay; the converse discrepancy is often found in association with developmental difficulties in spatial orientation and visuomotor control, and to some extent in Asperger disorder.
The Stanford-Binet scale (46) and the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) (44) are most commonly used for preschoolers. The Wechsler Intelligence Scale for Children (WISC-III) is available for school-aged children (45). These are well-standardized test batteries that call for the use of a range of different cognitive skills. For deaf children, the WISC-III performance scale and the Hiskey-Nebraska Test of Learning Aptitude have been specifically standardized (59). On such tests, deaf children without additional disabilities score close to the population average. The Perkins-Binet (60) and the Blind Learning Aptitude Test (61) are suitable for blind children. However, the most widely used psychometric instruments lack sensitivity in the mental retardation range. Even simple tests that use single words, such as the Peabody Picture Vocabulary Test (56), cannot be used if the patient is nonverbal. The Leiter International Performance Scale is useful for evaluating low functioning individuals (50). The interpretation of psychometric findings in mentally retarded subjects is complicated by uncertainties about the child’s test orientation and motivation. Because IQ levels in children younger than 3 years are unstable, the low-scoring child should receive a more definitive evaluation at a later date.
Considerations in the Assessment of Learning, Emotion, and Behavior
The developmental history and physical findings in early infancy are unreliable bases for prognosis as to developmental outcome. For example, Apgar scores of 0 to 3 at 15 and 20 minutes are predictive of high mortality and high probability of disability; however, many of these infants score normally in later developmental assessment (see Chapter 6). Intelligence tests in infancy yield a developmental quotient (DQ) that is necessarily heavily loaded with factors that relate to motor development. Within a normal population, the DQ is a poor predictor of individual differences in cognitive development. It has some success, however, in distinguishing a normally functioning from a mentally retarded population. Infant testing is highly specialized and also calls for the child’s cooperation. If this cannot be enlisted, the mother can be asked standard questions about her child’s social development (53).
Taken literally, the IQ scores can underestimate the child’s cognitive potential. Specific adaptive limitations often coexist with strengths in other adaptive skills or other personal capabilities. Limitations in adaptive skills may reflect the context of the child’s community. Motivation to perform during testing cannot be taken for granted, particularly when the child’s cultural or ethnic background has little understanding of and interest in cognitive testing and its uses. Anxiety can block the child’s reasoning processes, alienation and withdrawal can render the child unavailable for the task, thought disorders can intrude, and impulsive behavior can disrupt test performance. Lapses of attention owing to subclinical absence seizures can interrupt concentration, and psychotropic and antiepileptic medication may impair some cognitive processes. The limited attention span of patients with ADHD can degrade performance on tasks that demand sustained attention and cognitive effort. In young children, even gross impairment of vision, hearing, or touch can go unrecognized, and the child’s imperfect response to instruction or questions can be misattributed to defiance or cognitive deficiency. Other factors that complicate the interpretation of mental test performance are extremely low or high parental educational level, poor motivation with failure to expend mental effort on the test, depression, fatigue, and fear of failure with low self-esteem. Such potential sources of misinterpretation, which almost always lead to underestimation rather than overestimation, can never be fully ruled out, but conventional best practices expect the psychologist’s report, usually in writing, to provide an estimate of the reliability of the reported score, taking such factors into consideration.
MENTAL RETARDATION
Terminology and Definitions
The terminology that is used to characterize persons with cognitive and adaptive behavioral disabilities has evolved, in repeated efforts to minimize social stigma. Terms such
P.1105

as cognitive deficiency, intellectual disability, and learning disability have been suggested to replace mental retardation, a term that misleadingly implies delay and therefore the possibility that the child will catch up. A similar term is developmental delay, which is nonspecific and is more of a chief complaint or a symptom complex than a diagnosis (62). Whereas children with mental retardation may learn new skills as they mature and are taught, most functional neurologic impairments are associated with intractable deficits of intellectual capacity. Mental retardation is a compendium term that does not refer to particular groups of diseases, syndromes, or medical disorders. It is not applied to cognitive deficiency that is a result of neurodegenerative and progressive neurometabolic diseases, or is secondary to psychiatric disorders.
The World Health Organization (ICD-10) characterizes developmental disabilities as due to impairment of the central nervous system, causing a functional disability, which consequently handicaps the individual in activities of daily living (63). It characterizes mental retardation as “incomplete or insufficient general development of mental capacities.” Formal definitions of mental retardation that are currently recognized emphasize a descriptive diagnosis of persons with significant disability because of “subaverage intellectual functioning” and “concurrent deficits or impairments in present adaptive functioning [i.e., how effective persons are in meeting the standards expected for their age by their cultural group]” (64,65). In addition, the manifestation of brain dysfunction must originate during the developmental period of life. The three formal definitions differ slightly in their approach to the diagnosis because of differences in emphasis on adaptive skill symptom menus or underlying etiologic factors.
TABLE 18.4 Classification of Mental Retardation by Measure of IQ and Level of Adaptive Behavior
Severity (Older Terminology) Estimated IQ Category of Support Required Estimate of Cognitive/Academic Level Estimate of Adaptive Behavior as a Function of ADL
Borderline 70–85 Intermittent Adequate language ability, but often develops late
Variable learning disability
Independent in ADL
Employable
Mild 50/55–70 Intermittent Adequate language ability, but often develops late Most are independent in ADL
Severe learning disability
May develop minimal reading ability
Employable at simple jobs
Moderate 35/40–50/55 Limited Simple language, develops late
Most lack even minimal reading ability
Most are trainable in ADL (often need help)
May be employable in a sheltered environment
Severe 20/25–35/40 Extensive May speak some words or be nonverbal May be trainable in some basic ADL
Profound <20/25 Complete May speak a few words; most are nonverbal Dependent in all ADL
ADL, activities of daily living.
Because mental abilities are on a continuum, the quantitative definitions of mental retardation and its subdivisions based on the IQ are necessarily arbitrary cut-off points. The mental age (the age equivalent at which the child functions on the test) divided by the chronologic age is the IQ. The mean I.Q. for the general population is set at 100. Higher IQ predicts more academic success in such terms as higher grades, more years completed, and higher standardized test scores. It also predicts positive life outcomes, such as better mental health, lower divorce rate, lower level of criminality, and greater occupational success (66,67).
The standard deviation (SD) of a test refers to the distribution of scores around the mean. Mild, moderate, severe, and profound mental retardation have been traditionally associated with cutoff points in standard deviations below the mean of –2, –3, –4, and –5, respectively (68) (roughly corresponding to IQs of 70, 55, 40, and 25). IQ scores between 70 and 85 are sometimes referred to as borderline. But measured intelligence does not offer specific information about the individual’s adaptive skills (Table 18.4). There is ongoing controversy on whether to emphasize IQ level or adaptive behavioral deficits as the central defining characteristic of mental retardation (69). The extent to which persons with mental retardation succeed in life is determined by their level of adaptive skills rather than by their IQ. However, there is no single measure of
P.1106

adaptive behavior. Newer efforts to define mental retardation have emphasized the amount of support needed for an individual to succeed or maintain basic activities of daily living, instead of focusing on global degrees of impairment (70). Support intensities are subdivided into four levels: intermittent, limited, extensive, and pervasive. Support functions are classified into eight categories: teaching, befriending, financial planning, behavioral support, in-home living assistance, community and school access and use, and health assistance. This categorization acknowledges that the diagnosis of mental retardation is useful only as a pointer toward providing the individual with additional supports for activities of everyday living beyond those that are considered to be customary for the child’s age.
Further insight into the child’ strengths and weaknesses is afforded by neuropsychological testing, which attempts to tease out of the cognitive spectrum different domains of functioning that can be differentially affected by brain damage, depending on which areas have borne the brunt of the insult. These techniques are most frequently used with normal functioning children who have school problems but also can be applied to mildly mentally retarded children. The resulting information may be helpful with respect to diagnosis, prognosis, and educational and vocational planning (e.g., 71). IQ labeling should not replace repeated educational and achievement assessments. Not only is the IQ score unreliable below age 3 years, but also deficits in visual, spatial, and motor function, as well as expressive language, may influence early testing. Underprivileged and understimulated children may perform poorly on language-based tests for reasons that are sociocultural rather than neurobiological. Such a child’s level of functioning is better reflected in the results of nonverbal testing, as on the Culture-Fair Intelligence Test, Scale 2 (72), Raven’s Progressive Matrices (73), and the Universal Nonverbal Intelligence Test (74). The interpretation of IQ test results should take into account cultural and linguistic diversity, differences in communication ability, and attentional and behavioral factors.
Behavioral Phenotypes of Mental Retardation Syndromes
A syndrome is a recognizable and consistent pattern of multiple manifestations that are known to have a specific etiology (75). More than 1,000 defined syndromes involve multiple congenital abnormalities (76). Most feature some pattern of impaired mental development. The degree of mental retardation is quite variable in most of these syndromes and is not indicated by the severity of neurobiologic concomitants, such as degree of abnormality of brain structure as visualized on MRI. Also, the deficit is often compounded by social factors. Dysmorphic facial features may give a misleading impression of low intelligence, and severe neurologic handicap may limit the children’s ability to express their intellect. Striking instances are athetosis and Lesch-Nyhan syndrome. Teachers may underestimate the child’s learning potential and offer a restricted number of learning opportunities. Nonetheless, some syndromes are characterized by specific behavioral phenotypes—of cognition, personality, and psychopathology—over and above the generally diminished level of functioning and any negative effects of the child’s environment.
Behavioral phenotypes have been characterized as follows, “a number of conditions, recognizable by a common physical phenotype, single gene defect or chromosomal abnormality, seem also to have a constellation of behaviors or cognitive anomalies which are characteristic” (77). Although mentally retarded children are by definition impaired in all or most cognitive domains, certain mental retardation syndromes present striking cognitive and behavioral dissociations. Selective neuropsychological deficits can occur against a background of generally deficient intellect as well as in otherwise normally functioning children. The adverse influence, whether genetic or due to intercurrent insults, is widespread, but lowering the level of intelligence below normative expectations, is not homogeneous, perhaps reflecting unequal impact on areas of the brain that differ in functional specialization. Examples of dissociations follow.
Mentally retarded children with autism are disproportionately handicapped in the language and social domains, domains that are relatively spared in children with Williams syndrome (78 and see Chapter 4). Children with Williams syndrome speak with appropriate phonology and syntax, although their comprehension and pragmatics are weak (see Chapter 4). However, they are especially deficient in visual-spatial construction and number sense. Conversely, visuospatial skills are a strong point for children with Prader-Willi syndrome, who display a specific flair for jigsaw puzzles (79). Down syndrome children are particularly impaired in receptive and still more in expressive language, long-term memory (80,81), and gross and especially fine motor skills (82). Particularly with respect to language, these impairments become more obvious after the initial relatively rapid development of the first three years has decelerated. Some Down children become autistic, especially if there is an autistic spectrum disorder family history (83). Girls with Down syndrome as a group consistently perform better than boys (84). Children with hydrocephalus tend to be disproportionately strong in speech production, producing rapid uninformative “cocktail chatter,” though not in speech comprehension and pragmatics. They are weak in face recognition and social cognition (85). Among X-linked chromosomal aberrations, fragile X syndrome (85a) is particularly handicapping in language development and social skills (86). Speech development is delayed, perseverative, and echolalic, and the children are
P.1107

shy, anxious, and show many autistic features. There is fine and gross motor delay. The language and social domains also are problematic for children with XXX (87), whereas Turner syndrome (XO) is associated with visuospatial, arithmetic, and memory deficits (88) as well as deficient recognition of faces and facial expressions (89), while language is intact. XYY syndrome is characterized behaviorally by language disability, lack of sociability and aggressiveness, and Klinefelter syndrome (XXY) boys tend to exhibit low verbal abilities, clumsiness, and introversion (90). In Cornelia de Lange syndrome, nonverbal abilities may be selectively impaired (91). Untreated, phenylketonuria results in severe mental retardation. Even when effectively treated, children with phenylketonuria exhibit impaired performance on executive function tests (92), apparently implicating dopaminergic projections to dorsolateral prefrontal cortex (93). The characterization of the selective deficit as involving executive functions is disputed, however (94). Untreated children with congenital hypothyroidism are severely mentally retarded. After early treatment, deficits are confined to the domains of visuospatial skills, attention, and fine motor control (95). In galactosemia, language and executive impairments as well as fine motor deficits have been reported. Some of the children are mentally retarded (96).
It is apparent from the highly diverse listing presented above that deficits in cases of atypical development are not interpretable in terms of selective loss with respect to a single behavioral module or a single functional domain. Rather, there is a suite of more impaired domains, and a suite of better functioning domains, in every type of affected child. The cognitive phenotypes associated with a specific genetic abnormality also can be quite diverse, as for instance in Williams syndrome (97). Therefore, the phenotypes even of genetically determined syndromes appear to be multiply determined, with some effect of environment, in the broad sense that encompasses both prenatal and postnatal factors, interacting with the genetically determined susceptibility. Notably, language ability does not fall out or remain intact in one piece (98). The classical dispute about whether language skill is modular and unique among cognitive skills (99) is not resolved by the study of atypical development.
TABLE 18.5 Examples of Genetic Syndromes with Characteristic Behavioral Phenotypes
Syndrome Behavioral Phenotype References
Fragile X Poor eye contact, shy, withdrawn, hyperactive, self-injurious See Chapter 4, 85a, 86, 150
Lesch-Nyhan syndrome Self-injurious, especially compulsive lip and finger biting 111,112,126
Prader-Willi syndrome Food seeking, hyperphagic, implusive, obstinate 79,113,114
Rett syndrome Features of autism, stereotypical hand-wringing and hand-flapping, hyperventilation 115
Velocardiofacial syndrome Ultrarapid cycling bipolar disorder, schizophrenialike condition 116,117,123,124
Williams syndrome Superficial sociability, musically talented, shy, obsessive 78,118,119
Comorbid Psychiatric Disorders in Persons with Mental Retardation (Dual Diagnosis)
Persons with mental retardation are at increased risk for psychiatric disorders. Whereas the incidence of psychiatric disorders in the general childhood population is 7% to 10% (100), approximately one-third of all children with developmental disorders also have psychiatric disorders (100,101,102,103). In the severely retarded subpopulation, the frequency of psychiatric disorders is much higher and approaches two-thirds by adolescence (104). The broad spectrum of psychopathology includes affective disorders (105), anxiety disorders, autisticlike behaviors (106), conduct disorders (107), maladaptive behaviors (repetitive self-stimulation, self-injurious behavior, pica) (108,109), and psychosis. These emotional and behavioral disturbances are caused by multiple factors, both primary psychopathologies and neuropsychologic disorders and the secondary effects of illness, dependency, environmental deprivation, frustration, and low self-esteem (110).
The behavioral phenotypes of certain genetic syndromes are associated with typical personality characteristics and reproducible behavioral mannerisms (Table 18.5). Though otherwise often of even temperament, Down syndrome children may be irritable and inattentive because they are prone to obstructive sleep apnea (120), which in turn is a separate risk factor for neurocognitive (especially right hemisphere) deficits (121) and for depression (122). Specific personality differences also may occur in mental retardation syndromes, such as unusual sociability and distractibility in Williams syndrome and compulsivity, excessive talkativeness, impulsivity, and low activity level as well as compulsive eating and foraging for food in Prader-Willi syndrome (79).
Children with velocardiofacial syndrome have on average a borderline IQ, concrete thinking, bland affect, and little social interaction. They are highly susceptible to
P.1108

psychiatric disorders, particularly schizophrenia, with which they may have a frequently occurring deletion on chromosome 22 in common (123). Twenty-five percent of children with velocardiofacial syndrome present with schizophrenia by early adulthood. A higher proportion still presents with ADHD in childhood and responds favorably to stimulant therapy (124). Girls with Turner syndrome tend to be unassertive and compliant and maintain poor and sparse social relationships (125). Children with Lesch-Nyhan syndrome have a unique form of compulsive behavior, which is expressed by an apparently involuntary drive toward self-injury and aggression. The children apologize and ask to be restrained in the act of attacking others or themselves (126). Abnormal dopamine functioning during early development may be implicated (126).
Epidemiology and Prevalence
Since the frequency with which a disorder arises in a population during a stated period of time is its incidence, and since its prevalence describes the amount within a population at a given time, the prevalence of the condition is the product of its incidence and its duration. The prevalence of a developmental disorder, therefore, may change over the years because of prenatal diagnosis and more frequent termination of pregnancy, changes in the maternal population, and changes in health care. For example, the prevalence of Down syndrome increased from the 1920s through the 1960s, as persons with this condition began to live much longer because of improvements in medical care. However, since 1980, further increases have been slight (127,128).
The prevalence of mental retardation is 6 to 20 per 1,000 (129,130,131,132). The published estimates vary on account of regional differences, ascertainment biases, and variations in diagnostic criteria and study methodology. Mild mental retardation is 10 to 12 times more common than severe retardation. Mental retardation is more common among males because of X-linked syndromes involving mental retardation, especially fragile X syndrome. The male to female ratio ranges from 1.3:1 to 1.9:1 (133). Morbidity and mortality are greater in persons with severe mental retardation, not due to the mental retardation itself, but because of the severe cerebral palsy that is often associated with it. Total immobility and feeding by nasogastric tube are the features that are most predictive of curtailed life span (134,135).
Causes of Mental Retardation
Timing
Mental retardation can be caused by genetic, environmental, and ecogenetic factors. A specific diagnosis can be determined in most children with global developmental delay [see (136) for recommendations as to which tests should routinely be used]. The diagnostic process is aided considerably if one can determine when the developmental insult occurred. Prenatal causes of mental retardation, with genetic etiologies as the major subset, account for approximately 60% to 80% of all developmental disorders. Perinatal causes include asphyxia and birth trauma. Mental retardation secondary to perinatal causes is almost invariably accompanied by cerebral palsy and/or epilepsy and probably accounts for at least 8% to 12% of all cases (137). Postnatal causes, including meningitis, encephalitis, trauma, and malnutrition, may account for up to 10% of cases. Some individuals may have more than one etiologic cause of their developmental disability, and the interacting causes may have occurred at different periods of development. For example, a fetus with hypotonia secondary to genetic causes is predisposed to perinatal injury (138,139,140). When individuals thought to have perinatal causes of their disabilities are later found to have a genetic etiology, the latter causation is likely to have been interactive with the perinatal stressors (141).
Severity
The more severe the mental retardation, the more likely it is that a specific etiologic diagnosis can be made [and the more likely the child is to be nonrighthanded (142)]. An identifiable cause is found in 70% to 80% of severe cases but in less than 50% of individuals with mild mental retardation. By neuroimaging or at autopsy, the brains of most severely mentally retarded individuals are found to be grossly abnormal. Mild mental retardation for which no specific cause can be uncovered is usually ascribed to polygenic inheritance. Subnormal head circumference may be the only abnormal physical sign in mentally retarded children. In a review of referrals to a child development center, some 15% of children were microcephalic. One-half of these children were mentally retarded. Prematurity, perinatal asphyxia, intrauterine growth retardation, respiratory distress syndrome, and intracerebral hemorrhage were associates of microcephaly (143) (see Chapter 5).
Diagnostic Categories
Chromosomal and Genetic
Chromosomal aberrations have been reported in 4% to 28% of persons with moderate to severe mental retardation, craniofacial differences, and other congenital anomalies (Table 18.6;143, 144, 145, 146, 147, 148). The percentage of clinically relevant chromosomal abnormalities varies between studies because of differences in definitions, methodology, ascertainment (population-based versus institutional), and type of cytogenetic study. Down syndrome is by far the most common chromosomal disorder and accounts
P.1109

for 4% to 7% of all cases of mental retardation (148,149). The fragile X syndrome (FXS) is considered in Chapter 4. In FXS, developmental testing reveals delays by 9 to 12 months of age (150). Cognitive deficits are milder in females than in males and often implicate math learning disability and frontal lobe–related deficits. Chromosomal disorders, including the contiguous gene syndromes, are considered in Chapter 4.
TABLE 18.6 Cause of Mental Retardation by Diagnostic Category
  Percent
Chromosome abnormalities 4–28
Recognizable syndromes 3–9
Structural central nervous system malformations 3–17
Complications of prematurity 2–10
Perinatal conditions 8–13
Environmental/teratogenic causes 5–13
Cultural-familial mental retardation 3–12
Metabolic/endocrine causes 1–5
Unknown 30–50
Compiled references 22,25, and 143,144,145,146,147,148.
Primary malformations of the CNS result from multiple genetic and ecogenetic causes (see Chapter 5). Numerous major and minor developmental malformations result from disturbances in neuronal proliferation, migration, differentiation, axonal outgrowth, synapse formation, dendritic arborization, and process elimination, depending on the genetic condition or severity and timing of an environmental insult. In the prenatal period, it is often impossible to distinguish the extent to which an environmental insult causes vascular or parenchymal injury or disrupts gene and signaling molecule expression.
Prematurity and Cerebral Palsy
Technologic advances in neonatology have transformed survival rates and morbidity patterns. Outcomes differ notably between very-low-birth-weight infants (less than 1,500 g) and extremely low-birth-weight infants (less than 1,000 g). Outcomes in premature infants range from normal functioning to severe disability (151), lasting at least into the teenage years in the form of academic deficits (152). Cognitive deficits occur even if the neonatal course was uncomplicated. Difficulties in spatial memory, sustained attention, and visuospatial function were documented at 4 years of age in otherwise normal preterm children (153). A wide range of cognitive deficits as well as elevated scores on an ADHD rating scale were found in children aged 7 years who were born before 32 weeks of gestation and were being educated in mainstream schools (154). Very-low-birth-weight children do even worse if they also had bronchopulmonary dysplasia (BPD). At age 8 years, the presence of BPD and/or relatively long duration on oxygen were found to have predicted lower performance IQ, impaired perceptual organization, and motor and attentional skills as well as lower educational achievement, with more frequent special education placement (155). Twenty percent of BPD children had IQs below 70, in the mental retardation range, as compared with 11% of very-low-birth-weight children without BPD and 3% of term controls. However, even mild indications of risk for birth anoxia had significantly adverse effects on cognitive outcome (156). This result supports the view that the deficits following asphyxia at birth are a matter of degree, in proportion to the severity of the injury—“there is a continuum of brain injury in asphyxia” (157)—rather than supporting an all-or-none “threshold” model (158). Correspondingly, selective neuronal necrosis in asphyxiated sheep brain was directly proportional in its severity and extent to the duration/ischemic of the inflicted insult (159). Another recent study also found a continuum, such that the neuropsychologic outcome was inversely related to the birth weight among children born weighing less than 1,500 g (160). Verbal functions were relatively spared, whereas spatial recognition, working memory and attention shifting were most affected.
Bradycardia and apnea are postnatal causes of hypoxia. In one study, 256 preterm and term infants were monitored at home and then tested on an index of mental development 96 weeks after conception. Infants who had five or more episodes of apnea and/or bradycardia performed significantly worse than infants who did not meet that criterion (161). Furthermore, 5-year-old children with sleep-disordered breathing scored less well than controls on tests of overall intellectual ability as well as on attention, memory, and planning (162).
Nearly one-half of a group of premature children had ocular pathology associated with impaired acuity, stereopsis, contrast sensitivity, and color vision (163). Cognitive deficits may be associated with regional brain volume reductions revealed by neuroimaging. Episodic memory deficits were associated with diminution in hippocampal volume in otherwise normal very-low-birth-weight children (164). MRI studies of adolescents who were born after a gestation of 33 weeks or less reveal decreased brain volume and enlarged lateral ventricles (165). In premature infants scanned near term, regional volume reductions were documented. White matter volumes in the sensorimotor and midtemporal regions correlated strongly with neurodevelopmental outcome (166). Neurological complications of prematurity are reviewed in Chapter 6.
Those premature and term children who sustain damage that results in cerebral palsy frequently bear the additional burden of associated deficits in vision, hearing and the ability to learn. Independent of the frequently present mental retardation, children with bilateral spastic
P.1110

cerebral palsy were found to have selective difficulty on tasks that call for inhibitory control, and presumably rely on intact prefrontal function (167). More generally, cerebral palsied children have up to a 40% chance of learning disability or mental retardation. Most of this is accounted for by children with spastic quadriplegia. In hemiplegic cerebral palsy, early damage to either side has relatively more detrimental cognitive effects if it is complicated by seizure activity. The more severe deficits that accompany the seizure disorder group do not bear the usual qualitative relationship to the side of the lesion (168). Stroke before age 1 year has similar but greater effects on cognition than in adults (), calling into question the notion that children escape from the consequences of brain injury if it occurs very early (169). Both cerebral palsy (170) and childhood stroke (171) feature ADHD phenotypes among their sequelae. Methylphenidate is effective in treating the ADHD phenotype associated with cerebral palsy (172).
Toxins and Radiation
The long-term effects of exposure to alcohol, marijuana, cigarettes, cocaine, and other street drugs on cognition and behavior are difficult to determine separately because polydrug use is the rule. Also, the frequency, quantity, type of substance, and timing of exposure during pregnancy vary greatly. Moreover, drug habits are frequently associated with poor nutrition and lack of prenatal care. However, there are clear associations between maternal alcohol abuse and adverse effects on early brain development. Fetal alcohol syndrome (FAS) may be the most common among the identified causes of mental retardation in North America and Europe. Children with facial features of FAS and a history of maternal alcoholism during pregnancy have been described as inattentive and hyperactive, with disordered conduct and defective memory (173). Whether prenatal cocaine exposure has any adverse effect on long-term cognitive outcome is questionable (174). Any low functioning is more likely to be due to adverse conditions in the postnatal caretaking environment (175). Some children with fetal valproic acid syndrome have been reported to be autistic (176). Fetal alcohol syndrome and the effects of cocaine and opiates are discussed in Chapter 10.
Acute severe lead poisoning may cause mental retardation as a sequelae of an acute encephalopathy. Chronic subclinical lead poisoning is associated with an increased risk of antisocial and delinquent behavior as well as disorders of cognition and learning (177), but these outcomes are confounded by the effects of low socioeconomic status and stimulation level in the home environment (178) (see Chapter 10). The HOME questionnaire measures the stimulation a child receives at home. This type of variable is a crucial covariate in any population study on cognitive effects of potential toxins. When relevant covariates were held constant in a meta-analysis, the apparent detrimental effects of subclinical lead dwindled into insignificance (179). Maximum controversy centers on the clinical significance of the 10 to 19 ug/dL blood lead dose level, the Centers for Disease Control’s (CDC) lowest “level of concern” (180,181). An attempt to show that lead levels below 10 ug/dL cause deficits in cognitive and academic skills (182,183) is controversial (184) and suffers from methodological shortcomings (185). The neurobiology of lead poisoning is discussed in Chapter 10.
Mercury nitrate is the toxin that caused “Mad Hatter’s” disease (186). Children who were given a “teething” powder that contained mercury fell victim to acrodynia (pink disease), which in addition to physical signs caused severe irritability, anorexia, photophobia, and sleeplessness (187). A comprehensive resource for information about the toxic effects of methylmercury is available (188). Widely differing sensitivities to comparable levels of exposure draw attention to host factors in clinical susceptibility to mercury poisoning. Mercury is found in dangerous amounts in fish in certain geographic locations. When consumed in large amounts by pregnant women, it has led to cerebral palsy and mental retardation in their children (189). Symptoms of less severe exposure included muscle stiffness, dysesthesia, hand tremor, dizziness, loss of pain sensation, muscle cramps, arthralgia, chest pain, palpitations, fatigue, visual dimness, and staggering (190). Muscular atrophy was observed. Methylmercury is taken up by multiple organs. In the brain, it is gradually broken down to metallic mercury, which cannot be cleared. Over time, cerebral atrophy results. Other sources of intense mercury poisoning include skin whiteners and processing of mined gold. The recently withdrawn ethylmercury-containing vaccine preservative thimerosal was administered by routine vaccination (DPT, Hepatitis B, HiB) to infants in cumulative amounts well above the Environmental Protection Agency’s (EPA) maximum sanctioned (benchmark) dose. Low-level prenatal exposure to methylmercury from maternal consumption of seafood poses a less severe but still increased neurodevelopmental risk (191,192,193). Neuropsychologic testing has implicated language, reading, attention, memory, and visuomotor function (194). The younger the child, the greater the risk. Susceptibility to low-grade poisoning also varies tremendously between individuals due to as yet unidentified host factors. Signs of mercury poisoning may present, weeks, months, or even years after exposure (195).
Prenatal polychlorinated biphenyls (PCB) and dioxin exposure have an apparent detrimental effect on children’s mental development, which for reasons that are not clear spared children who were raised in optimal environments or breast-fed (196,197). Organophosphate pesticides also are under suspicion (198).
Pelvic nuclear (199) and x-irradiation (200) can lead to mental retardation of offspring, especially if applied between the seventh and fifteenth weeks of gestation. The
P.1111

degree of mental retardation is proportional to the amount of irradiation. The incidence of Down syndrome and other chromosomal abnormalities is greater among offspring of those women in their late reproductive years who were irradiated during pregnancy (201).
Poverty and Other Familial Factors
There is a complex relationship between genetics, nutrition, social environment, and learning (202). The adverse effects of psychosocial deprivation on socialization and motivation may impair performance even if the child has normal cognitive abilities. One American child in five lives in a family with income below the poverty threshold (203). The risk of mental retardation and inferior academic performance increases with decreasing socioeconomic status (204,205,206). However, on a population basis, the factors that mediate the effects of poverty on child health and development are uncertain (207). Parental nurturing, sociocultural influences, and educational environments are determinants of developmental outcome and ultimate adaptation to society (208). Less positive parenting contributes to adverse outcomes (208a). Some children are resilient and function better than one would expect based on their socioeconomic status. Resilience is partly heritable and partly mediated by maternal warmth and stimulating activities (209). In contrast, infants and children who are deprived of maternal attention and are institutionalized in a hospital or an orphanage often become depressed, and their cognitive skills decline or fail to advance (210,211,212). Children adopted from Romanian orphanages exhibited anomalies of attachment and personality (213). A positron emission tomography study of such adoptees revealed reduced brain activation in orbitofrontal, inferolimbic, and medial temporal cortex, including amygdala, structures involved both in cognition and emotion regulation (214). EEGs of Romanian adoptees showed diminished power in high frequency bands at frontal and temporal electrode sites and increased power in low-frequency bands posteriorly (215). These EEG abnormalities indicate cortical hypoarousal and/or delayed cerebral maturation. Adverse cognitive and academic consequences are to be expected in such children, but the outcome is never certain, let alone irremediable, in the individual case.
Hormones and Infections
Maternal hypothyroidism results in lowered IQ of the offspring (216). Congenital hypothyroidism causes mental retardation only in children who are left untreated after birth. Insulin-dependent diabetes mellitus is associated with declining verbal test scores (217). The neurologic complications of thyroid deficiency and diabetes are presented in Chapter 17. Nutritional disorders are discussed in Chapter 10.
CNS infection early in life is a major cause of mental retardation, especially in developing countries. Prenatal infections such as toxoplasmosis, syphilis, rubella, cytomegalovirus, herpes, and varicella are associated with microcephaly, intracranial calcifications, cataracts, growth retardation, sensorineural hearing loss, and seizures. Such infections may cause mild, moderate, or severe mental retardation. Bacterial, viral, and fungal meningitis and encephalitis—in particular, neonatal and childhood herpes simplex encephalitis—are perinatal and postnatal causes of mental retardation (see Chapter 7). Hookworm infection can contribute to iron deficiency, which is associated with decreased cognitive abilities (218) whether anemia is present or not (219).
Management
Medical
Stimulant medications, such as methylphenidate, may be beneficial for some mildly mentally retarded children who are hyperactive (220). Numerous other older and newer medications have been used with variable success to ameliorate adverse behaviors such as aggression, self-injury, and severe hyperactivity in persons with mental retardation. Neuroleptics, such as thioridazine in low doses, may have a calming effect in some children and when given at bedtime may assist sleep. Carbamazepine and propranolol can be beneficial for rage and episodic loss of control. Antidepressants, such as clomipramine and fluvoxamine, are often helpful in decreasing compulsive behaviors and stereotypies. Opioid antagonists, such as naltrexone, are occasionally successful in decreasing self-injurious behaviors (221,222). On withdrawal, some medications can give rise to tardive dyskinesias because of dopamine hypersensitivity (223). This tendency can be counteracted by GABAergic antiepileptic agents (224). Pharmacologic treatment of behavioral disorders in children with mental retardation should be coordinated with behavioral modification programs.
Nonmedical
Management includes family support and education, and the provision of early intervention and special education programs. There are no specific methods for improving the overall intelligence of most mentally retarded people, although improvement in some skill deficiencies is a feasible educational goal. There is disagreement about how the largest group, the mildly mentally retarded, should be taught, and even about whether that should be any different from how learning disabled children are taught. The efficacy of early intervention programs in enhancing mental development has not been validated (225). The primary goals are to provide a “least restricted environment,” a placement that safeguards the child and at the
P.1112

same time permits the child to function at maximum potential. The child’s temperament and level of socialization are important modifying factors that can differ widely among individuals at a given IQ level. A regular preschool with language therapy may be appropriate for mildly disabled preschool children with adequate comprehension and without behavioral problems. For children whose attention and concentration are limited, special education teachers use attention-focusing techniques to optimize learning. Best results are obtained in structured rather than flexible settings because individuals with mental retardation are usually deficient in judgment and problem-solving strategies. A child with mild mental retardation who is taught at an appropriate rate in suitably structured settings can become self-reliant in a considerable variety of work competencies, not strictly limited to manual and domestic occupations or routine industrial tasks such as assembly and production-line operations.
Children with mental retardation who in addition have significant language and social dysfunction often do not succeed in the typical classroom settings that are appropriate for students with specific learning disabilities. Self-contained classrooms usually provide a better environment for children with severe mental retardation and severe communication disorders or autistic behaviors. These classrooms ideally have a low teacher to student ratio with special education teachers who are familiar with interventions for students with nonverbal learning disabilities and social communication deficits. Some children with severe mental retardation require placements that offer behavioral modification programs and school time geared toward life skills such as basic hygiene and self-care. Public laws mandate that individual educational programs (IEP) be regularly reassessed.
Management involves many nonmedical disciplines. Caregivers may need to be trained in how to handle, feed, and toilet their child. Effective case management comprises health care planning that includes comprehensive diagnostic evaluation, an assessment of disabilities, and individualized treatment plans for educational, behavioral, pharmacologic, and medical interventions.
Declining Intellectual Function in Adolescence or Preadolescence
Infrequently, children are referred by psychologists, social workers, educators, or rarely, parents, based on the impression—with or without psychometric documentation—of declining intellect or IQ. Test-retest reliabilities on IQ tests are well established, and the findings must be taken seriously, especially when the psychologist’s report rules out the usual motivational or sociocultural reasons for an occasional aberrantly low score. A progressive neurological disorder also must be ruled out. More commonly, drug abuse is responsible and should be investigated by serum drug screening, cocaine being the substance of greatest interest. Alternatively, prodromal changes heralding schizophrenia should be considered. By standard definition, schizophrenia involves declining function over a 6-month period, and declining IQ may be a warning sign. Particularly for a child with a history of schizophrenia spectrum disorder in the extended family, the appropriate syndromally based diagnostic interview is called for (over and beyond any global impression or score on a single scale). An outcome that falls short of being diagnostic of schizophrenia may still offer warning signs of an impending diagnosis if the decline persists. Prompt treatment may then forestall the more serious outcome.
Epilepsy
The mental functioning of children with epilepsy is at risk of impairment by the underlying brain malfunctions, the seizures themselves and the side effects of antiepileptic agents. Most children with epilepsy score within normal limits on IQ tests such as the WISC-R, but the distribution of IQs is skewed toward the lower end of the range. Lower IQ scores reflect the detrimental effects of the total number of seizures, which is compounded of age of onset and frequency of the seizures (226). Among seizure subtypes, minor motor and atypical seizure states are associated with lower mean IQs than other seizure types. Even in children with an IQ in the normal range, neuropsychological testing can pinpoint cognitive domains that present individual difficulty. Examples are the verbal learning and memory difficulty associated with complex partial seizures that arise from left-sided foci and the visuospatial learning and memory deficits that accompany right focal discharges. Left focal temporal discharges also may underlie dysnomia and circumlocution in speaking (227). A study of children with complex partial seizures found cognitive and linguistic deficits that were predicted by the duration and frequency of seizures and by the number of antiepileptic drugs that were used (228). Petit mal implicates sustained attention only. The more severe manifestations of epilepsy are often also associated with dysarthria, general inattentiveness, and slowing of responding. Seizures and antiepileptic drug treatments are discussed in Chapter 14.
AUTISTIC SPECTRUM DISORDERS
Autistic spectrum disorders (ASD) are a behaviorally defined set of developmental disorders that result from diverse biologic, genetic, and ecogenetic factors (229). Although the broad spectrum of cognitive and behavioral impairments defies a concise definition, clinicians tend to agree on its predominant features (230,231). Research into the neurobiology of ASDs is complicated by their broad heterogeneity in clinical and biological characteristics (see examples in Table 18.7; 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304).
TABLE 18.7 Some Neurobiologic Clues to the Etiology of Idiopathic Autism
Etiologic Clue Description of Findings in Studies of Autism References
Environmental Increased complications of pregnancy, labor, and delivery; perinatal problems/illness in some studies but not others 232,233,234,235,236
Genetic Higher concordance for autism in monozygotic twin pairs
Marked increase in prevalence of autism in siblings of children with autism
Increased frequency of cognitive and learning disabilities in siblings of children with autism
Increased frequency of mental health disorders in siblings and parents of children with autism
Studies of potential susceptibility genes, such as genes within the 15q11–13 region, are ongoing
232,237,238,239,240,241,242,243,244,245
   Chromosomal/monogenetic Numerous case reports and small series of patients with certain single-gene disorders and chromosomal anomalies are reported; these may account for 5% to 14% of all children with features of autism 246,247
   Contiguous genes Features of autism in some children with recognizable conditions such as Williams syndrome or Angelman syndrome; the most common cytogenetic finding in autism to date is the duplication of maternally derived chromosome 15q11–13 248,249,250,251,252
   Mitochondrial Possible effects of abnormal energy metabolism on central nervous system 253,254,255
   DNA expansion Features of autism in some children with fragile-X syndrome 256
Immunology Abnormal immune function or presence or autoimmune antibodies in some studies of children with autism
Reported improvement in some persons following nonspecific immunosuppressive or immunomodulating therapies
257,258,259
Infection Features of autism in some children with congenital rubella and cytomegalovirus infections, among others; inflammatory bowel disease with intracellular measles virus genomic material in some autistic children 260,261,262,400
Metabolism Features of autism in some children with phenylketonuria and other metabolic disorders 263,264,265,266,267
Abnormal intestinal permeability 268
Neuroanatomy
   Cerebellum Selective hypoplasia of the neocerebellar vermis (especially lobules VI and VII) in some autopsy and magnetic resonance imaging studies
Developmental cellular abnormalities in the posterior inferior cerebellar hemispheres
269,270,271,272,273,274,275
   Cerebrum Associated abnormal neuronal migration, cortical cytoarchitecture in septum, hippocampi, amygdala, entorhinal cortex, and mamillary bodies
Nonspecific differences in positron emission tomography and P nuclear magnetic resonance spectroscopic studies
Variable morphologic differences in some magnetic resonance imaging studies
Suppressed voluntary oculomotor responses attributed to prefrontal dysfunction
276,277,278,279,280,281,282,283,284
   Electroenceph-alographic findings Depending on associated brain dysfunction, seizures occur in 6% to 35%, and electroencephalographic abnormalities are reported in 35% to 65% of children with autism 285,286
   Brainstem Associated smaller pons in some studies 287,288,289
Neurochemistry
   Serotonin Increased blood concentrations of serotonin in some children with autism
Asymmetric serotonin metabolism by positron emission tomographic studies
290,291,292,293
   Dopamine Dopamine agonists worsen behavior, and dopamine antagonists improve behavior in some children with autism
Increased CSF homovanillic in some studies
294,295,296
   Norepinephrine Increased plasma norepinephrine in some studies, but in others, normal plasma, urine, and CSF catecholamine metabolites are reported 296,297,298,299
   Endorphin neuropeptides Analogy to “insensitivity to pain” in those children with autism who show self-injurious behavior
Increased CSF endorphin concentrations in some studies
300,301,302,303,304
P.1113

P.1114

When Kanner described and named autism in 1943 (305), he noted the following five characteristics in the 11 children he described: inability to relate to people, absent or abnormal and noncommunicative speech, obsessive desire to maintain sameness, but good cognitive potential and normal physical status. Autism was initially ascribed to dynamic causes, in line with the theoretical orientation of the times (cf. DSM I, DSM II). Reflecting the rise of biologic psychiatry, in 1980, the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III), abandoned the psychodynamic approach for the medical model and adopted an atheoretical nomenclature. The current criteria for autistic disorder in the DSM-IV include qualitative impairment in social interaction; qualitative impairment in communication; and restricted, repetitive, and stereotyped patterns of behavior, interest, and activities (48). By definition, onset is before 3 years of age. The World Health Organization’s International Classification Diseases (ICD-10) invokes similar criteria (63). Rett syndrome, discussed in Chapter 3, and childhood disintegrative disorder (CDD) are separately classified. Autistic disorder, Asperger syndrome, Rett syndrome, and childhood disintegrative disorder are subsumed under the category of pervasive developmental disorders (PDD) in the DSM-IV (65).
The distinctions between the diagnostic categories are arbitrary and probably reflect differences in degree rather than kind (306). In family studies, different PDD subtypes cluster within the same pedigree, indicating that they share common causes. In the family of a proband with PDD, there is a 3% chance that another offspring has autistic disorder and a further 3% chance of an offspring with PDD or Asperger’s disorder (307). Concordance between monozygotic twins is about 70% as opposed to 5% for dizygotic twins (308).
Approximately one-third of children appear to develop normally until the second year of life, at which time they gradually regress into autism (309,310), often in the context of seizures (312). Subtly abnormal signs may precede the overt regression (313). Some of these children may have become autistic after sustaining brain damage postnatally (314).
Clinical Characteristics
As a psychopathology, autism is profoundly internalizing. The children are deeply preoccupied with their internal states of mind and feeling and only minimally engage the outside world for purposes of activities of daily living. The majority of children with autism are to a varying degree atypical even at an early age, moving and crying little, averse to being held, and content to be alone. Scales that assist earlier diagnosis are available, and home videos reviewed retrospectively can reveal a previously unsuspected onset during infancy (315,316). The children may reject solid foods, and toys elicit little interest or are held onto with unusual obstinacy. Their motor development is usually normal, but minor physical anomalies are more frequently found in autistic children than in controls (317). During the second year of life, children with autism are typically unusually sensitive to auditory, visual, tactile, and movement stimulation, and repetitive mannerisms or gestures begin to appear. The older child with autism has restricted and stereotyped behaviors and activities and markedly impaired creativity, social relations, language, and perception. Disturbances in social relations are manifested by poor or absent eye contact and a lack of interest in people, whom the child uses instrumentally rather than interactively. Toys are handled bizarrely or are dropped when handed to the child. Mannerisms include repetitive, stereotyped movements, such as hand flapping, ear flicking, or head banging (318). Toe walking, whirling, and rocking also are common. These movements, often complex, increase when the child is anxious or is confronted with a novel situation (319).
Language disturbances can consist of complete lack of speech, failure to communicate by pointing, failure to imitate (320), perseveration, echolalia (repeating words or phrases out of communicative context), and lack of reciprocity in dialogue (321). If speech does develop, its prosody is often monotonal, pronouns are used poorly, and humor is not understood. Speech in children with autism differs qualitatively from the speech of children with mild mental retardation. Within the limits of a restricted vocabulary, children with mild mental retardation typically speak normally, whereas children with autism use abnormal prosody, syntax, semantics, and pragmatics (322). In some children, termed hyperlexic, mechanical reading skills develop out of proportion to spontaneous verbal expression or reading comprehension (323,324).
Children with autism may be oversensitive to stimuli, notably self-created sounds or spinning objects (325). This oversensitivity can alternate with periods of nonresponsiveness to speech, objects, or pain. Affected children frequently ignore sounds and are “aloof,” provoking testing for possible hearing loss. Some have prolonged attention spans during self-initiated activity (326). Observational studies demonstrate hyperselectivity of attention in children with autism (319). They focus exclusively on a single distinctive aspect of a display, while ignoring its other features. They are impaired in broadening the spatial spread of visual attention (326a). Conversely, the excel as compaud to their typical peers on tests that calls for local perceptual processing, in which context has got to be discounted. An example is the Embedded Figures Task (326b). The propensity of some people with autism to achieve savant status on very narrowly defined skells (326c) also reflects their narrow focus. Children with autism also have been shown to be impaired in perceiving faces, but not objects (327). People’s clothing was more salient to autistic children then their emotional expressions (328). They fail as compaud to age-matched peers in infering other
P.1115

people’s perspectives and mental states, focusing narrowly on their own (326d).
Some children exhibit transitional or milder degrees of autistic behavior, within the PDD spectrum. After age 5 to 6 years, such behaviors may merge with those observed in mental retardation. Others deviate into childhood disintegrative disorder (329) or Asperger disorder (330). The natural history and outcome of autism is variable. Some 80% manifest a pronounced impairment in intelligence. Approximately one-third of children with autism do not develop communicative speech. Others develop rudimentary language, although their communication remains literal and concrete and their affect flat. In yet other affected children, characteristics of organic brain disease become apparent over subsequent years, including auditory or visuoperceptual impairment. A small subset of children with autism develops bizarre thoughts and even delusions. About 75% of children who fail to show language skills by age 5 years fail to adjust personally or socially. Other children with autism make a fairly adequate social adjustment but retain certain peculiarities of personality, lack of humor, and unawareness of social nuances (331). Neuropsychologic testing reveals deficits on problem-solving tasks (332). Standard diagnostic instruments include the ADI (332a) and the ADOS (332b). Early diagnosis is facilitated by the use of standard instruments such as the Checklist for Autism in Toddlers (CHAT) (333). It consists of nine questions asked of the parents, and five items that call for observation by the clinician. The latter include pointing and looking to where a parent is pointing and pretend play, activities that are available to a normal 18 month old. Approximately one-half of the population with autism have an IQ above 50, and one-fourth to one-third have an IQ above 70. Children who regressed into autism after initially developing normally generally are ultimately more impaired cognitively (312,334). Even when they are enrolled in treatment programs, only some children with ASD improve significantly. If children improve, they usually do so during the second half of their first decade.
Prevalence
Based on twin studies, autism is thought to have the heaviest genetic loading of the chief developmental disorders, with more than 50% hereditability for the narrowly defined autistic disorder (335), and as much as 90% for the wider range of ASD (336). Moreover, autistic individuals rarely reproduce (337). Autism would therefore be expected to have a stable incidence. On the contrary, its prevalence across the ASD spectrum has risen from 2 to 4 in 10,000 children in the 1970s to 60 in 10,000 children in recent years, that is, 0.6% of the population (338,339,340,341,342,343,344,345). The rate of increase in autism is highest in developed countries, in the United States among children of American rather than immigrant mothers, and for autistic children who are high-functioning (346). It has been argued that the rise in prevalence is due to relaxation in diagnostic criteria, diagnostic substitution [e.g., ASD diagnosis substituted for Developmental Language Disorder (DLD) diagnosis—(346)], changes in and increasing availability of special education services, mandatory notification of ASD diagnoses, and increasing awareness and earlier recognition of ASD. However, the rise in incidence is so worldwide that it cannot be attributed to regulatory changes in just one country. Potential alternative causes and a true rise in incidence are not mutually exclusive, and the explanatory power of the alternative factors is open to challenge (347,348). No published research has managed to determine how much of the variance in the spectacular increase in ASD diagnoses is attributable to each of the various factors that have been suggested. Pending such information, it is unwarranted to assume that the true incidence of ASD is not increasing.
Causes of Autism and Its Neurobiologic Basis
Pathogenesis
Autism clearly has genetic factors in its origins. Previous theories that certain family dynamics promote autism (349) have been refuted (238). However, autistic offspring are more frequent among mothers of relatively high intelligence (346) and perhaps social class (350). The importance of genetics in autism is illustrated by the four to one higher incidence of autism in males (336), a recurrence risk of up to 9% in families with one affected child (351), a high concordance of autism among monozygotic twins (336,352), an increased incidence of developmental and affective disorder in first-degree relatives (350), and the association of some disorders of known genetic etiology with autism. Susceptibility loci have been identified on distal 7q and 15q11–13 (353).
Increased head and brain size in autism contrasts with the frequent microcephaly of mentally retarded children (354). However, there is also an excess of microcephaly among autistic children who are mentally retarded and have diagnosable medical diseases. Autistic macrocephaly indicates an enlarged brain, according to measures of brain volume by MRI. The bulk of the increase is in cerebral and cerebellar white matter. It is not evident at birth, but develops throughout the first year of life (354a), and mostly consists of increased volume of the peripheral (radiate) cerebral white matter (355). It is perhaps the most consistently replicated neurobiologic feature of ASD (356). There is no consensus on the neural pathophysiology of autism (357). Structural abnormalities in various brain regions of autistic children may reflect etiologic heterogeneity. They include widespread abnormalities in the frontal and temporal cortices, cerebellar hemispheres, and vermis (358,358,359,360,361,362). An overview of neuropathologic findings (363) highlights the limbic system (increased cell packing density and smaller neurons in 9 of 14 cases), the
P.1116

cerebellum (21 of 29 had a decreased number of Purkinje cells), and cerebral cortex (more than half had dysgenesis). Purkinje cell loss in the cerebellum is the most consistent microscopic neurological abnormality found in autism. The high energy demands of these large neurons makes them vulnerable to damage following a variety of insults (364), and the associated presence of gliosis (362) opens up the possibility of damage rather than dysgenesis. The neural substrate of autistic disorders has typically been thought to be the medial temporal lobe and limbic structures (365,366). Bilateral excisions of amygdala and hippocampus of monkeys resulted in impairment of social interaction (367). The hypothesis that autistic behaviors are attempts to compensate for frequent phasic overarousal (368) has found support in recent neuroanatomic (369) and physiologic (370) findings that suggest that the cortical network is underconnected and therefore insufficiently inhibited (371).
Etiology
Many genetic syndromes feature autistic behavior, notably Rett syndrome (372), fragile X syndrome (373), and occasionally Down syndrome (see Chapters 3 and 4). An intriguing instance is Timothy syndrome, a rare multisystem disorder that features cardiac arrhythmias and both cognitive and physical deficits. It is caused by a mutation in the CaV1.2 calcium channel (374) that incurs the risk of excessive entry of calcium into the cell. That some children become autistic, and that others with the same mutation do not, suggests that the autistic phenotype requires some additional epigenetic or environmental factor. The raised incidence of autism in thalidomide (375) and valproic acid (176,398) embryopathies indicates that an abnormal event such as a poisoning can trigger autism as early as 20 to 24 days after conception (376). Children with autism often have recurrent seizures (377) and EEG abnormalities usually with onset in the first year of life (378). The neurological symptoms of tuberous sclerosis become apparent only after the onset of seizures. Seizures that interact with pre-existing temporal lobe abnormalities may result in manifestations of autism. Tuberous sclerosis is discussed in Chapter 12. Perinatal injuries (232,233,234,235,236,379) and prematurity (380) are associated with autism with greater than chance frequency. However, the evidence more usually indicates prenatal maldevelopment even early in the first trimester (376). Rarely, an autistic syndrome arises during encephalitis (381), even at as late an age as 31 years (382). Therefore, autism is not always a developmental disorder.
Neurotransmitter levels have been extensively studied, with serotonin at the center of interest (290,291,292,293). Whole blood serotonin is elevated in more than 30% of patients with autism as well as in their first-degree relatives. Low binding site affinity of the 5-HT transporter may be related to distractibility (383). Serotonin synthesis also has been found to be abnormal in its distribution in the thalamus, cerebellum, and frontal cortex. Other research has implicated increased levels of norepinephrine, increases in opioid peptides, and decreased levels of oxytocin (383a), a substance shown to influence social behavior in animal studies. Neurotransmitter findings in autism were recently reviewed (384).
Abnormalities of immune response appear to be disproportionately frequent both in children with autism (259,384,385,386,387,388) and in their first-order relatives (385,389). In one study, 46% of families with autistic children had two or more family members with autoimmune disorders. The children of mothers with autoimmune disorders had the highest risk for developing autism. Autoantibodies to various components of the nervous system have been repeatedly demonstrated in a subset of autistic children participating in controlled studies (384,390). Recently, a sample of autistic children showed related elevations in the levels of antibodies against gliadin and cerebellar peptides, raising the possibility of immune-mediated attack against the brain and lending biologic plausibility to the anecdotal success of gluten-free dieting in minimizing symptoms of autism (391). A recent study of autopsied brains of autistic individuals revealed active inflammation in the cerebrum and cerebellum, with microglial and neuroglial activation but no adaptive immune response (392). In the same study, cerebrospinal fluid acquired from living autistic children contained markers of a neuroimmune reaction. This suggests that autism can be an active disorder over many years, rather than the static aftermath of prenatal dysgenesis, as is usually assumed. Table 18.7 presents genetic, immunologic, metabolic, neuroanatomic, and neurochemical findings associated with autism. Across varying diagnostic criteria and varying extent of medical evaluation, the specific etiology remains unknown in 70% to 90% of cases of autism (393). The etiology of autism in the diagnosable minority has recently been reviewed (394). Table 18.8 presents syndromes and other disorders that may be associated with autism.
External causes of autism subdivide into toxic [e.g., alcohol (395), cocaine (396), thalidomide (397)]; in utero exposure to valproate (398); stress-related (399); and infectious [e.g., cytomegalovirus (400), herpes simplex (401,402,403), rubella embryopathy (404)]. Viral infections are thought to contribute to the pathogenesis of neurodevelopmental disorders, including autism (405,405a), and maternal viral infection has been cited as the “principal non-genetic cause of autism” (406). A mouse model of maternal influenza infection gives rise to macrocephalic offspring with abnormal cerebrum and hippocampus and atrophy of pyramidal cells (407) that are deficient in exploration and social interaction—perhaps a model for human autism (408).
There are many examples of gastrointestinal involvement in neurologic diseases (409). Many autistic children have gastrointestinal symptoms (410), and colitis and lymphoid nodular hyperplasia in the ileal region (ILNH) have been reported (260,411). Immunohistochemical
P.1117

studies of biopsy material from children with ILNH have revealed the hallmarks of dysregulated mucosal immunity (412). The enterocolitis has been attributed to infections with measles, mumps, or other paramyxoviruses (413). Despite apparent links between measles, mumps, and rubella (MMR) immunizations and autism (260), which have been vehemently disputed (414,415,416), the definitive epidemiologic study that would distinguish causation from chance association has not been performed. Measles vaccine virus genomic material has been reported in the gut mucosa of children with ILNH (417), as well as in blood and cerebrospinal fluid (418), consistent with a possible causal relationship of the MMR vaccine and late-presenting (“regressive”) autism.
TABLE 18.8 Conditions Associated with Autism
Genetic
Fragile X
Rett syndrome
Tuberous sclerosis
Neurofibromatosis
Hypomelanosis of Ito
Phenylketonuria
Joubert syndrome
Prader-Willi syndrome
Angelman syndrome
Goldenhaar syndrome
Moebius syndrome
Cornelia de Lange syndrome
Lujan-Fryns syndrome
Sotos syndrome
Marker chromosome syndrome
Timothy syndrome
Metabolic and other
Landau-Kleffner
Tourette syndrome
Williams syndrome
Duchenne myopathy
Hypoythyroidism
Lactic acidosis
Mucopolysaccharidoses
Free fatty acid abnormalities
Autoimmune lymphoproliferative syndrome
Viral
Rubella embryopathy
Herpes simplex encephalitis
Cytomegalovirus
Toxic
Thalidomide
Valproic acid
Alcohol
Cocaine
Differential Diagnosis
Classical autistic disorder is one of the five subtypes of pervasive developmental disorders listed in the DSM-IV. The four other subtypes are Rett syndrome (see Chapter 3), Asperger syndrome, childhood disintegrative disorder, and pervasive developmental disorder not otherwise specified (PDD-NOS). However, these subgroups may be better conceived as arranged along a spectrum of severity of autistic disorders (419).
Asperger Disorder
Possibly distinct from relatively high functioning autism but nonetheless highly similar to and possibly on a continuum with autism are individuals first described by Asperger (330) with flat affect, insensitivity to social cues, and obsessively indulged special interests. Their language skills develop normally, but their use of language and other means to communicate is aberrant. Their speech is formal, pedantic, and is uttered in a peculiar voice and with deviant prosody. Their gestures also are deviant, stiff, limited, inexpressive, and stilted. Their visuomotor development may be delayed, and they are clumsy and walk with a stiff gait. They are severely impaired in reciprocal social interaction, for which they have little enthusiasm. Their interests are quite circumscribed, and they impose many routines and rituals on themselves. Like autistic children, children with Asperger disorder seek sameness. They exhibit mannerisms such as hand or finger flapping or twisting. Children with this syndrome are of normal or near normal intelligence, and their self-help and adaptive behavioral skills are age appropriate. The prevalence of Asperger disorder in boys has recently risen to about one in five hundred. The male to female ratio is 4:1.
Childhood Disintegrative Disorder
First described by Heller (420) and alternatively known as Heller’s disease, CDD appears after a child has developed normally for at least 2 to 3 years. The child regresses profoundly over weeks or months in at least two of the following domains: language, motor skills, play, and social or adaptive skills, including bowel and bladder control, to an autistic endpoint (330). CDD is rare. Averaged across four surveys, the prevalence of CDD was 1.7 per 100,000 (421).
Pervasive Developmental Disorder Not Otherwise Specified
PDD-NOS differs from autism in its later age of onset and in the subthreshold or atypical severity of communication, behavioral, and social impairment. Like Asperger syndrome, it may be on a continuum of social and cognitive impairment with autism (419).
Other Conditions with Autistic Features
Other conditions presenting with behavioral phenotypes that overlap those of autism include childhood schizophrenia, elective mutism, developmental language disorders, severe mental retardation, complex motor tics, and
P.1118

obsessive-compulsive disorder. Originally classified together with autism under the heading of childhood psychoses, childhood schizophrenia is now recognized to be quite distinct from the autistic spectrum disorders. Unlike autism, it is rare in the first decade (422). It is characterized by thought disorder, delusions, or hallucinations. The onset is gradual, initially presenting as shy, odd, and awkward behavior and social isolation (423). Once the psychotic symptoms emerge, the condition can be diagnosed by the same criteria as schizophrenia in adults (424). Children of schizophrenic mothers, who are at high risk to develop schizophrenia, tend to exhibit slow motor development and achieve poorly in school. They are described as being anxious in social situations and preferring solitary play (425). In early life, preschizophrenic children could be reliably retrospectively differentiated from healthy siblings based on home video recordings, mostly by their abnormal movements and reduced facial expressions (426). Prospective studies of “high risk” children (with a schizophrenic parent) consistently reveal deficits in attention, memory, and social skills (426a). Before schizophrenia becomes clinically obvious, the children increasingly manifest social withdrawal, anxiety, academic difficulties, and thought problems each year between the ages of 12 and 18 (427). Children with elective mutism, though generally mute, do by definition speak normally in some situations or to some people, typically a parent, and engage normally in play and nonverbal social interactions (428). Developmental language disorder is not associated with impaired social interaction and behavior. A few children with severe language disorders exhibit some aspects of autistic behavior but relate well, using gestures to communicate (429). Children with congenital ocular or cerebral visual impairment, such as retrolental fibroplasia and septo-optic dysplasia, respectively, may show stereotypic or self-injurious behavior. Autistic behavior is commonly seen in children with congenital deafness and with mental retardation. Milder cases described only as having some “autistic-like” features but exhibiting relatively normal intellectual functioning overlap the broad category of attention disorders (326 and see below).
Diagnostic Evaluation
High-resolution chromosome analysis leads to a diagnosis in approximately 5% of children with autistic traits. Brain imaging studies are indicated only if there are indications of progressive loss of function, localized neurologic deficits, or persistent focal seizures. An EEG is indicated if there is a suggestion of seizures. A spinal tap can assist in the differential diagnosis of new onset seizures or autistic regression. Approximately one-third of patients with autism experience one or more epileptic attacks during the first two decades of life. Various seizure types have been described. Of these, the most common are complex partial seizures (312). The question of subclinical seizures is frequently raised in the autistic subtype in which an acquired loss of receptive and communicative abilities occurs, as in Landau-Kleffner syndrome (see below and Chapter 14). For this reason, sleep electroencephalography has been advocated for children whose autistic symptoms develop after 2 to 3 years of age, in the hopes that antiepileptic drug therapy might improve their language and social skills (430,431). Magnetoencephalography appears to be more successful than electroencephalography in revealing the subclinical epileptiform discharges (432).
Metabolic studies, including serum copper and ceruloplasmin levels, are indicated if autistic symptoms develop in late childhood or are progressive. Cognitive, language, educational, and behavioral assessments establish the level of severity of the child’s impairments and serve as a baseline for IEPs and additional therapies.
Prognosis
Outcomes are most favorable in the least severely affected children, who have normal or near normal intelligence and speak before they are 5 years old (433). There is a strong impression among clinicians that applied behavior analyses (ABA), has improved the chances of children with autistic spectrum disorder to function independently in the mainstream school and society. Whether such outcomes draw upon brain plasticity, or are strictly due to improved behavioral strategies, is unknown. In their adult years, high functioning autistic or Asperger patients usually achieve normal understanding of speech. However, their semantic and pragmatic deficits are lifelong and make it hard for them to converse normally while letting the listener take his turn or introduce a new topic (434).
Autistic Language Compared with Developmental Language Disorder
Autistic spectrum disorder and developmental language disorder are classified as distinct and separate entities. However, deficient or absent language skills are a major characteristic of ASD. Is autistic language similar to or distinct from language in DLD?
Until recently, autistic language has been assumed to be different from language in DLD. Whereas DLD is characterized by impairment in understanding and producing phonology (speech sounds) and syntax (grammar), the language deficit in autism was thought to be at the “pragmatic” level, at which one understands what is said and uses language communicatively (e.g., DSM-IV). However, a majority of ASD and DLD children exhibit both receptive and expressive language difficulties. Some children with ASD even exhibit these difficulties in their extreme form, verbal auditory agnosia (VAA) (433,434,435). Those whose language problems are limited to pragmatics are actually in the minority. DLD children do not have pragmatic disorder, whereas ASD children do not have expressive speech problems in isolation. Thus, most ASD children have a language
P.1119

impairment that is comparable to the receptive/expressive language impairment that stands alone in DLD.
The similarity in pattern of language deficit is accompanied by a similarity in the size and shape of the various parts of the cerebral hemisphere. Previously only seen at autopsy, these parameters can now be measured by structural MRI. On average, both ASD and DLD children have larger than expected brains in childhood, excess of cerebral white matter, and anomalous asymmetries between the right and left hemispheres. The volumetrics of ASD and DLD resemble each other more than either resembles the normal control state (436,437). So, the macroscopic structure of the brain in ASD and in DLD is quite similar.
The close relationship between DLD and ASD originates from closely associated abnormalities in the genome. Susceptibility loci on distal chromosome 7q are associated both with ASD and specific language impairment (SLI). When there are abnormalities in this chromosomal region, individuals with ASD, SLI, or both are characteristically found in the same extended family tree (438,439,440,441,442). Therefore, individuals with an abnormality on distal 7q have a genetic predisposition to both ASD and SLI and may express either one. The as yet unknown intervening variables that transform a risk into the reality of a language disorder might also be able to transform an ASD risk into overt ASD.
Management Strategies
Medical
Autism may be the most difficult developmental disability to manage. Impairments in cognition, communication, socialization, and behavior often result in lifelong disability and frustration. Fifty years of behavioral and pharmacologic treatment efforts for autism (433) have shown that none is potentially curative or even treats the core features of autism. Agents that modulate monoamine systems have had some success in ameliorating associated symptoms such as impulsivity, poor concentration, obsessive and compulsive actions, rituals and stereotypies, anxiety, depression, aggression, disordered sleep, and self-injury. These agents include serotonin reuptake inhibitors such as fluoxetine (443), dopamine and serotonin receptor antagonists such as risperidone (444,445), atypical antipsychotics (445a) tricyclic drugs such as clomipramine, antihypertensives such as propranolol and clonidine (446), and antiepileptic agents such as valproic acid (430). Dopamine antagonists such as haloperidol are used to reduce stereotypic behavior (447), whereas dopamine agonists such as stimulant drugs may reduce hyperactive behavior, though they increase stereotypies and mannerisms (448). The short- and long-term risks and benefits of corticosteroid regimens (431) await further investigation.
Little evidence exists that children with autism have nutritional deficiencies (449), but various dietary supplements, such as magnesium and pyridoxine, are commonly used (450). Gluten-free/casein-free diets (451,452) have gained wide public acceptance when, as is very common, autistic children have associated gastrointestinal symptoms, notably constipation with overflow, although evidence from controlled studies is still awaited. Those who believe that ethylmercury, which constitutes 49% of thimerosal, a now discontinued vaccine preservative, caused their child’s autism, have used chelation in an attempt to reduce the body’s mercury burden. The therapeutic use of secretin has been assessed in an open-label study, with negative outcome (453). On the theory that intestinal flora, notably Clostridia, can exacerbate autistic symptoms, oral vancomycin has been given to children whose late-onset autism was preceded by diarrhea, with apparent short-term success (454).
Nonmedical
Social skill training encounters unusual difficulty with autistic children, in that one cannot assume the usual infrastructure of social experiences and spontaneous learning (455). Autistic people create their own environment, comprised more of things than of people. Even if they master the principles of socialization in the abstract, they still may lack social pragmatics—the ability to recognize the situations in which the principles should be applied (456). The major intervention programs offer intensive training and often involve parents to the point of making them cotherapists. Five prominent programs are representative of the ongoing effort to ameliorate this allegedly untreatable condition with comprehensive behavior and educational treatment programs, ideally initiated in the preschool years. They are the UCLA Young Autism Project (YAP) (457), the Program for the Treatment and Education of Autistic and Related Communication Handicapped Children (TEACCH) (458,459,460), Learning Experiences … an Alternative Program (LEAP) (461), Applied Behavior Analysis (ABA) (462), and the Denver Health Sciences Program (DHSP) (463). YAP operates most intensively, on a 40-hour-per-week basis, and follows the lines of operant conditioning (454). TEACCH offers parents the opportunity of acting as cotherapists. All five programs report significant gains in measured IQ and in social skills, but none of these claims has been evaluated by rigorously designed research designs and methodologies. In particular, random assignment of subjects, verification of training at home, and long-term outcome assessment by independent observers are lacking. It is not clear whether less intensive programs are less effective. Demonstrations are lacking both of internal validity, that the methodology exerts its effects by actually ameliorating the autistic disorder rather than through other means, and external validity, that the gains achieved in the training program generalize to diverse real-world settings (464). Subject to this caution, clinicians and teachers increasingly prefer applied behavioral analysis. Education within the mainstream, so often encouraged for
P.1120

P.1121

children with disabilities on account of their social deficits, offers little obvious benefit to most children with autism. It is not clear that they would learn by example in the mainstream classroom.
TABLE 18.9 Conventional Strategies for Children with Autism
Therapy/Intervention Method Rationale/Benefits References
Alleviate family distress Provide diagnostic information
Counseling (e.g., social worker)
Helps families deal with guilt and frustration
Increases understanding of the cause and possible prognosis
465
Behavioral modification Modify environmental factors
Redirect maladaptive behaviors
Engage children with solitary play
Deter tantrums, aggression
Restrain injurious behavior
Stereotypies, maladaptive and injurious behaviors occur less frequently in structured and stimulating environments 319,466
Communication therapy Direct speech training
Sign language
Augmented communication
Increase all forms of communication, not just speech 467,468
Individual education program Structured teaching to promote communication, cognitive and social learning
Limits overstimulation
Direct social skills training
Self-help, life skills training
Promotes directed cognitive, language, and social learning
To help adaptation to new situations
319,458,459,460
Pharmacologic trials Individual medication trials should be symptom oriented, time-limited, beginning with low doses and gradual increases until the true benefits of the therapy are determined May improve attention, impulsivity
May decrease agitation, aggression, anxiety
May enhance sleep
Stops seizures
469
TABLE 18.10 Unproved Intervention Programs for Children with Autistic Spectrum Disorder
Therapy/Intervention Method Rationale/Benefits/Outcomes References
Auditory integration training Use filters to remove frequencies to which the individual is sensitive Decrease sound sensitivity and hence behavioral disturbances
Studies have not shown effectiveness of training
470,471
Cranial osteopathy Gentle manipulation of cranial bones No adequate outcome studies exist  
Facilitated communication An augmented communication technique that requires a facilitator to provide physical assistance for writing or keyboarding Leads to independent communication in few persons, communication is influenced by the facilitator 472,473
Nutritional restrictions or supplements Includes numerous restriction diets (e.g., gluten casein) or supplements (e.g., vitamin B6, magnesium, secretin) Benefits remain unproven, side effects include sensory neuropathy and photosensitivity 450,451,474
Patterning exercises Daily, extensive controlled stimulation of muscle activity Claims to repair nonfunctional neural networks
Little or no benefit from the treatment has been shown, places enormous demands on families
475
Sensory integration therapy Attempts to improve sensory processing through exposure to auditory, olfactory, visual, and tactile stimuli Unproven and probably ineffective treatment, but its current use is widespread 476,477
Spurious impressions of improvement abound with respect to all types of children with chronic developmental handicap, regardless of the specific therapy that has been applied. However, they seem to be particularly widespread in the case of the autistic spectrum disorders. This may be because of autistic children’s perplexing variability in performance, which can give the impression that hidden skills are waiting to be released into activities of daily living. Be that as it may, efforts to identify the optimal education and behavior programs must rely on controlled long-term outcome studies.
Publicly funded special education programs and financial aid programs such as social security income (SSI) offer support, and developmental disability services provide funding for respite care. Family support groups, such as the National Society of Autism, offer additional information and family self-help services. The typical community-based support services, including education and communication (e.g., sign language, augmented communication) therapies, and behavioral modification programs are summarized alphabetically in Table 18.9 (319). Some unconventional and unproved interventions are summarized alphabetically in Table 18.10 (450,451,457).
SPEECH AND LANGUAGE DISORDERS
Prevalence
At least 5% to 7% of the school-aged children in the United States (aged 5 to 21 years) have serious deficits of speech or deficits of hearing, with which a speech disorder is associated. An additional 5% have relatively minor speech impairments (478,479). Approximately twice as many boys as girls are affected. Speech and language disorders overlap with academic underachievement and behavior problems in school-aged children (480,481).
Language Development
Precursors
Neonates can discriminate virtually all the speech contrasts that are used in natural languages. By the end of the first year, they begin to understand meaningful speech and then to produce it. At about the same time, they lose the ability to discriminate contrasts that do not occur in their own language (482).
Even in the first 6 weeks of life, infants vocalize when they orient by turning their head and gaze to a target and by hand pointing (asymmetrical tonic neck reflex), in response to a novel stimulus. Babbling begins between 2 and 6 months of age and soon includes all the phonemes in human languages. Babbling is both spontaneous and imitative of the speech of others. Although some severely mentally retarded children are late to begin babbling, the characteristics of babbling, when it occurs, cannot be used to predict the quality of the language that will follow. The act of babbling is not causally involved in the child’s use of language. For instance, when babbling is prevented by long-term tracheotomy, this does not retard the development of speech once the aperture is closed. Babbling does not initially depend on auditory feedback; even profoundly deaf children babble (483). Toward the end of the first year, however, the deaf child babbles less and then falls silent.
Early Language
At around 11 to 13 months of age, children begin to utter single words, of which mama and dada are often, but unreliably, reported first by parents. They look and point with the right hand at the objects they are naming, and about two months later, they also monitor the listener’s reaction (484). According to parental report, children produce approximately 4 words at 10 months, 12 words at 1 year, and 80 words at 16 months (485). When children acquire a vocabulary between 50 and 100 words, they begin to utter words in combination. There is a burst of vocabulary development toward the end of the second year (approximately 150 to 300 words by age 2 years) and of syntactic development in the third year (486). Girls show the language spurt earlier than boys. Simple sentences emerge at around 3 years and agreement between subject and verb toward the end of the fourth year. At all stages, children can understand more words and phrases than they can utter, and even children who cannot vocalize develop substantial comprehension of spoken speech. However, there is great variability; first words are aquired anywhere between 6 to 30 months and phrases between 10 to 44 months. Late talkers have a good prognosis as long as their receptive vocabularies are in the normal range (487).
Ontogenesis of Cerebral Dominance for Language
Lesion, stimulation, and metabolic activation effects show that in almost all right-handed individuals, the left hemisphere is primarily concerned with the neural process underlying language as well as the decoding of symbols and the programming of motor sequences. Some deficits in tasks that are not overtly verbal have been reported in children with language delay, notably discriminating the order of presentation of rapidly successive stimuli in various modalities (488). With respect to other nonverbal functions, such as spatial orientation and spatial organization of nonverbal patterns, there is a less striking but definite asymmetry in favor of the right hemisphere. As the child matures and new skills emerge, the laterality conforms to that of the child’s precursor skills.
Left-handers are either genetic or pathologic (488a) in origin. The latter are thought to have incurred mild
P.1122

prenatal left hemisphere injury, not sufficient to result in an overt neurologic injury, but enough to impair right-hand dexterity sufficiently for preference to shift to the left hand. Conversely, those who incurred early right brain damage became unusually right-handed. Regardless of whether they are genetic or pathologic left-handers, about one-half are left lateralized for language, a third bilateralized, and a sixth right lateralized. A person’s hand preference, right, left, or mixed, has little or no predictive value for cognitive development.
Although a newborn’s cerebrum is barely functional, most newborns more often spontaneously turn their heads and eyes to the right rather than to the left, a tendency that subsequently comes under control of the left hemisphere. Congenital left hemispheric maldevelopment and injury in the first year do not invariably lead to the expected gross language disorder or delay (489a); the right hemisphere assumes language representation (489b). Preschoolers show transitory language deficits after left hemisphere injury, but usually only after the first decade does the language disorder assume the characteristic severity and persistence of adult aphasia (490). In very early lateralized lesions of either hemisphere, there is often contralateral compensation, but age, lesion site, lesion size, presence of seizures, and use of antiepileptic drugs or hemispherectomy contribute to variable outcomes (491,492).
Language lateralization was believed to be progressive, from bihemispheric origins toward the end-point of fully established left hemispheric dominance for language, only near the end of childhood. The weight of evidence is against this theory, however. Instead, it now appears that language processes and their antecedents are lateralized from the beginning, in conformity with how they will be lateralized in their mature adult state (491,493). This inference was directly validated when the location and extent of the language areas in young children were probed by intracranial electrical stimulation and found to be much like those of adults (494). Children are credited with more plasticity of the nervous systems than adults, in which their higher levels of brain glucose metabolism (495) and ongoing synaptic pruning (496) may be involved. Specifically with respect to language (497,498,499), young children show more recovery than older children and adults after unilateral brain damage. At any age, recovery after unilateral hemisphere injury can rely on adjoining ipsilateral areas (500), or homologous contralateral areas (501), to take over the compromised function (see also section on Acquired Childhood Aphasia, below).
The nonexistence of progressive lateralization invalidates a host of theories offered over the years that attribute a variety of language disabilities to delay in the “lateralization process.” Because no such process exists, therapy programs that purport to jump-start or accelerate it by manipulating the side of entry of stimulation, the child’s positioning, and which hand and eye the child is permitted to use (e.g., 475), are irrational.
Left hemispheric control of language involves inhibition of the potential language capability of the right hemisphere. Massive left hemispheric lesions release this inhibition. Disconnection of the hemispheres by section of the corpus callosum reveals that the right hemisphere can decode at least simple speech messages. The right hemisphere’s ability to comprehend speech also emerges when the left hemisphere is temporarily anesthetized by intracarotid injection of amobarbital (502). The patient remains responsive to verbal commands, as indicated by left facial and left hand movements. This residual ability to comprehend and respond perhaps explains why permanent total receptive aphasia is so rare and hardly ever seen in children. Right hemisphere compensation for language disorder is more complete for language decoding than encoding (503). When the right hemisphere is involved in language from the start, rather than because the left hemisphere was malfunctioning, as happens in pathologic non–right-handers, language nonetheless develops in the normal manner. There is no basis for attributing language deficits, as in Down syndrome, to right-sided language lateralization per se. Agenesis of the corpus callosum yields few of the signs of hemispheric disconnection exhibited by patients who have undergone callosal section. Whether compensation for a prenatal injury involves brainstem commissures, redundant functional specialization in each cerebral hemisphere, or both, is not clear (504). Early right hemisphere damage, like later damage, results in sensory inattentiveness and motor impersistence, as well as negative affect, consonant with the early right-sided specialization for negative emotion (505).
Recent evidence also has implicated the cerebellum, and specifically its posterior lateral area, in developing language. A cerebellar cognitive affective syndrome has been proposed (506) and related to early language development by studies of the aftermath of cerebellar excisions during childhood (507). Transitory mutism is replaced by dysarthria and impaired spontaneity of speech. Neuropsychological deficits, including impaired executive functioning, are more severe with right-sided cerebellar involvement, perhaps reflecting the crossed organization of cerebral-cerebellar connections (508). In contrast, damage to the vermis is credited with causing disordered behaviors ranging from irritability to withdrawal (509). Congenital cerebellar hypoplasia may result in a similar profile of deficits, but obscured by the profound mental retardation that typically characterizes these children (510). The pattern of cognitive and emotional impairment described in children was previously established in adult postoperative cerebellar patients.
Disorders of Pronunciation and Stuttering
The prevalence of speech disorders is closely related to age. Speech disorders occur most commonly in young children
P.1123

and reach an incidence of 15% in kindergartners (511). Approximately 90% of children younger than 8 years of age outgrow their speech disorders, but those who still have a speech impairment by 14 years of age can expect improvement only with speech therapy.
The frequency of production of sounds normally increases up to 2.5 years of age, at which time the speech sound pattern closely resembles that of the adult. Children’s phrases average 1.5 words at 18 months, 1.8 words at 2 years, 3.1 words at 2.5 years, and 4.1 words at 3 years. Ninety percent of children can correctly articulate all vowel sounds by 3 years of age. For boys, a 90% success rate for consonant sounds comes later; by age 3 years, they can pronounce p, b, m, h, w, d, n, t, and k; by age 4 years, ng; by age 5 years, y; by age 5 to 6 years, j; by age 6 years, zh and wh; and by age 7 years, f, l, r, sh, ch, s, z, th, and v. Girls achieve some of these sounds slightly sooner. Speech sounds are more accurately spoken when they are in the initial rather than a middle position. They are least well articulated at the end of the word. Impaired intelligibility is prognostically less ominous than depressed level of language use, and referral to speech therapy on its account can be delayed until 4 years of age. If speech also is sparse, however, as in the 2 year old who does not yet utter two-word phrases, earlier referral is justified. Even so, progress is slow, and a special effort by the parents is needed to offer the child experience by talking to him or her more than is usual.
Whereas immature central control of articulation is by far the most common cause of speech disorders in children, definable neurologic deficits contribute in some cases. Quadriplegia or double hemiplegia associated with suprabulbar palsy causes speech to be slurred, and athetosis renders it jerky, explosive, and indistinct. Congenital suprabulbar palsy is a major impediment of speech. A hyperactive jaw reflex distinguishes congenital suprabulbar palsy from acquired nuclear and infranuclear paralysis of muscles of articulation. Buccolingual apraxia affects voluntary tongue, lip, and palate movements but spares automatic movements (512).
Stuttering presents between the ages of 2 and 4 years, with maximal incidence at age 3 years. Many children stutter only transiently, but in some, the stutter persists. The underlying cause of stuttering in childhood is unknown. Rarely, it appears secondary to organic brain disease, such as focal dystonia. When stuttering is a symptom of an extrapyramidal disease, the patient is more likely to repeat an entire word, rather than a single sound (palilalia). Relatively more boys and left-handed persons stutter. The notion that stuttering is the result of left hemispheric dysfunction is supported by positron emission tomographic studies (513,514). Language representation may be bilateral in children who stutter, with rivalry between the hemispheres for control over speech (515). Stuttering cannot be a disorder of auditory feedback because speech, like any highly practiced and automatized process, is not under continual feedback control. However, stutterers do find it difficult to disengage their attention from their own speech, which then cannot be automatic. Stuttering is relieved by noise that is sufficiently loud to mask speech sounds, and it is rare among deaf persons.
The child who stutters has difficulty in passing smoothly from phoneme to phoneme, especially at the beginning of sentences, and with words of more than five letters. The child who stutters explosively reiterates a single sound or blocks speech completely. Moments of self-consciousness and embarrassment yield maximal dysfluency, whereas distraction can result in temporarily normal speech. Singing is spared. Speech therapies include awareness training, regulated breathing, and social support. Treatment outcomes are variable (516).
Distinct from stuttering is cluttering, in which speech is fast, slurred, and dysrhythmic, with omission, reduplication, and transposition of speech sounds and words. Like stuttering, it can rarely result from brain lesions (517).
Secondary Language Disorders
The DSM-IV differentiates developmental language disorders from those secondary etiologies such as epilepsy, mental retardation, autism, and severe brain injury that have other prognosis and treatment implications (48). Secondary language disorders may be associated with risk factors such as low socioeconomic status and other family and environmental adversities or with learning disabilities (518).
Twins who share a secret language, that sounds coherent though incomprehensible, rapidly transfer to normal language when they are separated. Blind children of normal intelligence tend to be slow to begin to learn to speak and often pass through an echolalic phase. Subsequently, their vocabulary grows at a normal rate, but they lack imitative gestures. Some “electively mute” children withhold speech, either totally or only outside the home (428), but comprehend well and otherwise act normally. Although some of them may be emotionally disturbed, the problem may be quite superficial, and the seriousness of the prognosis should not be overestimated. In autism, speech is not only limited but is pervaded by echolalia, stereotypic utterances, and avoidance of the personal pronoun I. Children with autism have less difficulty with articulation and more with comprehension than do children with DLD who are matched for nonverbal intelligence. Bilingual children, who have difficulty in acquiring the second language, are ones whose ability with the first language also is limited. A bilingual environment may explain some idiosyncratic uses modeled on the first language, but it does not explain delayed language development (519).
The language of culturally deprived children reflects local speaking patterns that are better described as different than impaired. On formal tests, such children score poorly relative to mainstream norms. The normally functioning
P.1124

child who has been totally deprived of language experience does not speak but rapidly learns once the opportunity is offered (unless the child is secondarily emotionally disturbed). Extreme instances of children isolated from language, such as “wolf children” (520), have been reported, but even 6 years of total deprivation can supposedly be overcome (521), although a striking counterexample exists (522). Evidence for a critical period for first language development is fragmentary. It is argued that second language learning results in lower ultimate competence the later it is begun, up to age 16 years. Beyond this age, there is no further relationship between age and ultimate level of proficiency in the second language (523). It also has been argued that children generally recover faster than adults from brain injury, including injury that causes aphasia, presumably because the brain is more “plastic” and better able to reorganize before maturity (524, but see 169).
Language in the Deaf
Three million American children have hearing deficits; 0.1% of the school population is deaf and 1.5% hard of hearing. Of cases of hearing deficits, the majority are congenital sensorineural, and related to genetic susceptibility factors. Children who are born with hearing loss in excess of 70 dB (severe) or even 90 dB (profound) cannot hear conversational speech and therefore do not learn to talk unassisted. Ostensibly, conflicting approaches to early intervention are the auditory-verbal and the bilingual-bicultural philosophies. When young deaf children are taught by the oral method, acquisition proceeds through the expected stages but falls far short of the expected eventual level of proficiency (525). In contrast, young children learn American Sign Language (ASL) spontaneously when exposed to it by their deaf parents. Their ultimate proficiency is an inverse function of the age at which learning began (526). Thus, it is essential to begin early. Consistent with the status of ASL as a natural language, its use depends on left hemisphere function, even though in execution it is visuospatial (527). However, ASL may not be particularly well suited to learning to read, since its gestures largely represent whole words, with less emphasis on individual phonemes. So-called “cued speech,” wherein the individual gestures often represent individual parts of words, seems to provide more support for learning the underlying structure of the language, thereby facilitating learning to read. “Total communication” aims use both oral and sign approaches flexibly, depending on the needs of the child (528). It has become the most commonly used teaching method for deaf children (529).
Deafness often goes unnoticed, even by observant parents, particularly when a bright child uses contextual cues to compensate for not hearing words. It can be suspected, however, as early as 4.5 to 6 months of age, if a child fails to look toward a sound source beyond his or her visual field. In young children, free-field audiometry is used for definitive diagnosis. This study should take place as early as possible so that the child does not go without appropriate language training (after the fitting of a hearing aid, if it is shown to help) and does not acquire the habit of ignoring auditory stimuli. Rarely, the auditory processing disorder is central, calling for tests of auditory attention and discrimination of speech modified in various ways. Performance on central auditory processing tests also is impaired in children with ADHD and improves after stimulant therapy (530). Children with recurrent otitis media can be at risk for language delays (531).
Congenitally deaf children with the usual high-frequency deafness adopt a harsh “deaf tone.” When children become deaf abruptly (usually owing to meningitis), the effect depends on the stage of their language development. Children who become deaf when younger than 5 years gradually lose their ability to control articulation and voice production, sounding increasingly like congenitally deaf persons. Children with as little as 1 year of language experience are substantially easier to train in language skills than the congenitally deaf, whereas children who become deaf before age 2 years become indistinguishable from the congenitally deaf. The early provision of hearing aids and training for all deaf children improves their language progress. The language skills and educational achievements of prelingually profoundly deaf children approximated the hearing population norms after cochlear implants (532).
Developmental Language Disorder
In the 3–10% (532a) of children who have developmental language disorder (DLD), alternatively named specific language impairment (SLI) (533), language develops abnormally slowly. The selective language delay results in speech that notably develops late, but also is semantically and syntactically impoverished. The diagnosis of developmental language disorder excludes secondary causes, unless the coexisting condition is unable to account for the severity of the language problem. Thus, an individual with mild mental retardation who is disproportionately impaired in verbal abilities can be considered to have developmental language disorder as well. However, the language impairment must not be explicable by other deficits, physical abnormalities, or disease processes, or by social or emotional deprivation. It is therefore a diagnosis of exclusion. Nonetheless, children with DLD exhibit subtle associated deficits in cognition, emotion, and motor performance (534).
The language of 2% to 3% of 3-year-old children is deficient in expression, reception, or both. Unlike speech in mental retardation, speech in DLD also is characterized by several articulatory disorders. These conditions differ from speech or articulation disorders such as stuttering, cluttering, lisping, and cleft palate nasality in that they are more severe, affect a wider range of phonemes, and involve a far
P.1125

greater difficulty in making the transition from phoneme to phoneme than in pronouncing the phonemes individually. This difficulty results in grossly curtailed word formation. Short binding words (“function” rather than “content” words) are frequently omitted.
In contrast to the relatively fixed deficits of speech disorder, delayed language is sensitive to context, and sound combinations that can be uttered at one time are unavailable at another. Greater mental effort often results in worse rather than better performance. The disorder is not limited to the spoken language; it affects writing, and even lip reading, manual alphabet, sign language, and Braille. Language delay invariably involves expressive speech. Verbal memory is impaired as well. In one subtype, speech comprehension can be relatively spared, although affected children have difficulty in discriminating speech sounds. In a less common subtype, semantic as well as syntactic comprehension is severely deficient. Rapin (535) distinguishes five subtypes:
  • Phonologic production and speech planning disorder: These are largely speech problems with other associated motor deficits. Utterances are sparse or fluent but contaminated by sequencing errors.
  • Lexical-syntactic deficit: Speech is sparse, though intelligible; word finding and paraphasic errors abound; and syntax is immature.
  • Phonologic-syntactic syndrome: Both speech sound formation and syntax are compromised and repetition is difficult. Speech is “telegraphic.”
  • Verbal-auditory agnosia: Language expression and reception are generally disordered. The child cannot derive meaning from spoken language.
  • Semantic-pragmatic disorder: The child is fluent and talkative, and syntax is preserved, but comprehension and verbal reasoning are deficient. Language onset is delayed, and utterances are stereotyped and tangential. Speech is accompanied by echolalia, jargon, and auditory inattention.
When comprehension is severely affected, the problem is often initially mistaken for peripheral deafness. The impression that auditory acuity fluctuates, which leads parents to doubt that the learning disorder is genuine, is borne out by audiometry. Stable hearing thresholds are hard to obtain, and repeated testing is apt to lead to radically different audiometric profiles. Recording psychogalvanic skin responses to sound is informative. These instabilities are caused by inconstant focusing of attention on sound, a function that normally depends on the integrity of auditory cortex.
The claim has been made that a defect in auditory perception exists in some developmental language disorders, specifically, a difficulty in discriminating the patterns of transition from speech sound to speech sound (536). This problem is most common in verbal auditory agnosia as well as when phonology is permanently impaired. Affected persons may have variable degrees of difficulty in auditory, visual, and linguistic processing. Alternative mechanisms for the underlying nature of DLD remain controversial, however (537).
The neuropathology of developmental language disorder is poorly understood but it has been associated with a mild neuronal migrational disorder in left inferior frontal cortex (538). Children with semantic-pragmatic disorder sometimes exhibit autistic features that meet PDD criteria (429) and, like autistic children, perform poorly on tests of social cognition (539). Semantic-pragmatic disorder and autistic disorder also share neuropsychological features of right hemisphere dysfunction (540). The language characteristics of children with hydrocephalus and of children with Williams syndrome often fall into the semantic-pragmatic category.
A genetic susceptibility to language disorders is indicated by the aggregation of cases within extended families (541) and their co-occurrence in monozygotic twins (542). A common genetic basis for motor immaturity and DLD has been suggested (543). An abnormal gene, FOXP2 on chromosome 7q31, is associated with dyspraxic speech and FOXP2 may be fundamental to human expressive language ability (543a).
Developmental language disorder is associated with a substantially increased incidence of behavioral disorders (544,545). The psychiatric symptoms may occur secondary to social isolation. This isolation may be compounded by relative lack of early experience of language, when parents become discouraged and relinquish their attempts to converse with the child. In other cases, the language and behavioral disorders may arise in parallel from the same neurodevelopmental deficiency.
Acquired Childhood Aphasia
Aphasia is considered to be “acquired” when it results from a condition that occurs after language development has begun, generally after age 2 years (546). Whereas bacterial infections causing encephalopathy used to be the most common causes of acquired aphasia in children, traumatic lesions currently predominate (490). Stroke in childhood is another cause of acquired aphasia, when the dominant hemisphere is affected (547).
Acquired aphasia is almost always nonfluent, especially in the youngest children, and loss of spontaneous speech or even mutism occurs more commonly than in adults. Other syndromes analogous to those in adults also have been described in children, and with analogous lesion location. Right hemisphere lesions cause aphasia in children no more frequently than they do in adults (1% to 4%). When they precede the onset of language, lesions of either hemisphere can temporarily retard both language and spatial development (548). Of 10 children with extensive early left hemisphere insults, five showed bilateral or right language reorganization, whereas the other five compensated
P.1126

within the damaged hemisphere. All but two of the children were left-handed, indicating more frequent transfer of hand preference to the lift than of language to the right brain (549).
Unless the lesion is bilateral, recovery of fluent speech is more likely in children with acquired aphasia than in adults, and disorders of comprehension occur less commonly. Residual minor language deficits and consequent school problems are common, however (550,551).
A rare type of acquired aphasia in children, acquired epileptic aphasia (AEA), otherwise known as Landau-Kleffner syndrome (LKS) (552) in addition to the seizure, is discussed in Chapter 14, under the heading of nonconvulsive status epilepticus. There is a severe comprehension deficit as well as an agnosia for environmental sounds. Oral expression is poorer than written, although both are impaired. Nonverbal intelligence is normal. Children with AEA typically develop normally until they are about 4 to 8 years old, when they fairly rapidly and quite unexpectedly cease to understand what is said to them and soon also lose the ability to express themselves in words. At its onset, the language regression is associated with some seizures and temporal lobe spiking on the EEG, but epilepsy rarely becomes severe in AEA. The language deterioration is often accompanied by the development of an autistic syndrome, perhaps in relation to abnormal temporal lobe metabolism (553). Perhaps temporal lobe dysfunction is why DLD and ASD are frequently associated in AEA.
Seventy percent of children with AEA have an associated severe behavioral disorder, featuring hyperactivity, impulsivity, and oppositional behavior. The severity of disturbed behavior follows fluctuations in the severity of the language disorder (554). Long-term outcome is poor despite attempts at cure by antiepileptic therapy and intravenous immunoglobulin (IVIG).
Diagnosis of Speech and Language Disorders
Normal intellect in domains separate from language is assumed in speech and language disorders. However, it is sometimes difficult to demonstrate, on account of the great contribution of language to overall intellectual performance. Tests that are verbally based, such as the WISC verbal subscale and the Stanford-Binet, cannot be used to estimate the intellect of children with speech and language disorders. Nonverbal alternatives include Ravens Colored Progressive Matrices for Children (73), the Leiter International Performance Scale (34), the Test of Nonverbal-Intelligence (TONI), and the Hiskey-Nebraska Test of Learning Aptitude (46). While discrepancy between a child’s language and nonverbal developmental levels is integral to the developmental language disorder diagnosis, there is no consensus on how great a differential is critical and how it might vary with age (555). Audiometry excludes cases secondary to high-frequency deafness, and it can reveal the fluctuating impairments of pure tone sensory threshold that are typical of cortical deafness. The language behavior itself is evaluated by one of the standard language test batteries, such as the Clinical Evaluation of Language Fundamentals (CELF). Physical examination reveals any mechanical or motor deficits of the vocal apparatus. In the rare instances in which receptive aphasia and deafness resist clinical differentiation, the ability to elicit auditory-evoked potentials confirms that the auditory projections to the auditory cortex are intact.
Electroencephalography and neuroimaging are often used to seek structural intracranial abnormalities but as a rule yield little information of practical use. Rarely, subclinical seizures thought to disrupt cognitive processes can be detected by EEG (556). In such cases, effective anticonvulsant management, and less often excision of circumscribed foci defined by electrocorticography, can improve cognition. Brain imaging techniques such as PET and functional MRI that index regional metabolic activity yield insights in language dysfunction (557,558), but their routine clinical value is still to be clarified. Molecular cytogenetic analysis can explain the susceptibility to developmental language disorders in a small minority of affected children (559,560).
Treatment of Speech and Language Disorders
Language delay with an organic basis resists remediation. Treating the commonly associated impairments of dexterity, attention, and impulse control has little effect on the language problems (561,562). Speech therapy is at its most effective in improving a child’s articulatory skills, although such skills also are apt to improve spontaneously in most children with increasing age. However, the central problem of impoverished vocabulary and syntax and the resulting difficulty in thinking in words is harder to address, and the so-called enrichment techniques are at best marginal or inconsistent in the improvement they can provide. Syndrome-specific remediation may be more effective (563,564). A meta-analysis revealed that speech and language therapy is effective for children with phonologic and expressive language difficulties, mixed in outcome when there are expressive syntactic problems and ineffective for receptive language disorders (564). The parents’ expectations need to be reconciled with the realities of what is often an enduring problem, and the children’s education should be organized to enable them to learn optimally at their admittedly limited rate. Individual instruction is usually required as well as family therapy and behavioral modification on account of secondary emotional disorder, which involves the whole family.
When language skills remain inadequate, augmentation and alternative communication methods (AAC) may
P.1127

succeed (565). Beyond manual signing as used by the deaf, these methods are applied to children with disordered oral and verbal development caused by cerebral palsy, bulbar palsy, and dysarthria; developmental language disorder; autism; and mental retardation. The need first to verify that intensive speech training does not succeed is balanced against the advantage of starting AAC training early (566), keeping in mind that AAC training may even facilitate verbal production rather than merely replace it. AAC subdivides into unaided (manual signing, finger spelling) and aided (communication board displaying pictures, symbols, or words). Depending on the child’s motor capabilities, the child responds with finger, head, or eye indicating; yes and no indicating; or through electronic devices. A frequently used symbol system is Blissymbolics (567). The additional placement of another’s hand on the child’s hand or arm, combined with an expectation of sophisticated latent communication skills, characterizes the method of facilitated communication (568). This treatment lacks both scientific basis and empirical validity (467,569).
LEARNING DISABILITIES
Definitions
Parents often seek clinical assessment when their child’s performance in school is unexpectedly poor, based on the prevalent but inaccurate assumption that a child who deals intelligently with some topics also should be able to do so with others. Some children do not benefit as much as expected from conventional methods of education in specific subject areas. This failure of response to instruction (RTI) has now itself become one of the allowable defining criteria of learning disability in the 2004 IDEA.
The term learning disability conventionally refers to a developmentally determined impairment in acquisition of certain mental skills that are necessary for academic learning in the early grades. Historically, it was assumed that such skill deficits should be defined by reference to a significant discrepancy between observed low performance on an academic achievement test and significantly higher intellectual level, as estimated by the child’s age or IQ (570,570a). An increasingly influential alternative formulation invokes depressed reading level alone, regardless of IQ (571,572,573,574). The educational prognosis and response to instruction is poorly, if at all, predicted from IQ. Therefore, the requirement for IQ to be significantly higher than achievement has not been empirically supported. In the 2004 reauthorization of IDEA, the federal policy has responded by permitting schools to disregard discrepancy from IQ in their definition of learning disability. Descriptors variously imply a neurologic basis (minimal cerebral dysfunction), a perceptual deficit (word blindness), or the isolated character of the disorder (selective reading disability or dyslexia). However, while a central nervous system role in the expression of the symptoms of dyslexia is certain, a preoccupation with the brain as the basis of the difficulty can lead to investigations that do not help in planning for the child’s future. The isolated character of the deficit implied by the terms selective, specific, or pure also can be misleading, if it precludes a rational search for exactly what each affected child finds particularly difficult. Most dyslexic children have a scattering of other, nonreading disorders—often including ADHD—that are part of the overall constellation of academic difficulties. In particular, ADHD occurs along with dyslexia far more often than expected by chance alone (561,576), and it can have a significant independent role in diminishing long-term school achievement. Selective arithmetic disability, absent a coexisting reading (577) or attentional problem, is uncommon. Selective drawing disabilities, sometimes overinterpreted as “constructional apraxia,” are more common but are much less frequently brought to clinical attention, unless the drawing disability includes poor handwriting and misshaping of letters.
Because social pressure is concentrated on reading, and schools use printed texts as vehicles for all forms of learning, especially as the child grows older, an early reading disability that is left uncorrected can broaden out into a general school and vocational failure. This is further aggravated by coexisting socioeconomic disadvantage. Such generalized failure retains its more specific etiology (see the genetic review below) and must therefore be distinguished from the consequences of global mental retardation, attentional problems, and severe hearing impairment causing severe delays in both reading and math achievement even for those who are skilled users of American Sign Language (578,579).
In addition to ADHD, other psychopathologies, including internalizing ones, are prominent and sometimes serious comorbid accompaniments of dyslexia and related learning disabilities (575). Anxiety is common (580,581,582,583), including phobic reactions. Depression, including suicidality, is the more serious and equally common comorbidity (584,585,586,587,588,589,590), and it is poorly recognized by parents and by teachers (585,591). For that reason, it behooves clinicians to monitor their dyslexic patients, from as early as age 8 or 9, for hitherto unexpressed or unrecognized symptoms of emerging depression. Children are often surprisingly frank to acknowledge depressive feelings to outsiders. Such feelings, coinciding with progressive withdrawal from school or life activities, as well as classic vegetative symptoms such as altered sleep and appetite, warn of potentially significant but treatable depression.
Prevalence
Approximately 11% of school-aged children (aged 6 to 21 years) in the United States are classified as disabled, and
P.1128

52% (2.4 million) of these students have learning disabilities (592). Another 10% to 20% of all students have learning or behavioral problems that are not severe enough to be classified as disabilities. Other studies estimate that 7% to 8% of early grade-school students have reading disabilities (593).
Selective Reading Disability (Developmental Dyslexia)
Models of reading have progressed from the theoretical to the empirical, which has produced a recent consensus account—the National Reading Panel (594). Word decoding ability accounts for much variance in reading skills at all levels (596,597). Reading difficulties are not confined to any particular orthographic system; they are approximately equally prevalent among readers on all continents (598). Although selective reading disability was originally thought to be more frequent in males (599), current evidence favors little or no gender difference in prevalence. However, it remains controversial whether to regard children with reading disability as simply on the low end of a normally distributed function (593) rather than a distinctive group within the childhood population.
More advanced reading also requires fluent successive visual fixation and appropriate direction of eye movement as well as knowledge, explicit or implicit, of the phonologic structure of the language and the ability to construct meaning from the words in their context. Thus, a deficit that limits beginning readers, once overcome, does not prevent further acquisition of reading skill in a normal manner, whereas a deficit that limits advanced reading might not be foreshadowed in the early stages. Failing readers in early and later stages can show different patterns of cognitive deficit. Phonologic and fluency tests particularly describe the earliest stage (kindergarten through second grade); vocabulary increases in importance until the third grade, when it assumes a major role. In some cases, difficulty is limited to spelling (600).
Numerous cognitive components, acting together, represent the larger domain of reading and writing. Each component process is potentially subject to developmental immaturity. Thus, while phonologic, fluency, and vocabulary deficits remain central to dyslexia, slow readers are routinely reported to have numerous limitations. None is necessary or sufficient for dyslexia itself, but rather the overall academic difficulties are compounded. These implicate visual and auditory memory, the ability to store memories in terms of speech sounds and their linkage to visual information, left and right discrimination, auditory synthesis, analysis of words into speech sounds, rhyming judgments, temporal order judgment, fast sequential processing, and nonword reading (601,602,603,604,605). In the long-term, most individuals with reading disabilities face persistent global deficits in academics, underemployment, and problems with behavior, social skills, and emotional adjustment (606).
Many minor neurologic abnormalities have been uncovered in children with learning disabilities, but these seem haphazard in their occurrence. Soft signs of neuromotor immaturity are frequent in these children but do not predict problems in any particular cognitive or academic domain (607). Soft signs are less prevalent after puberty but remain in excess of those found in normally developed adults. MRI indicates a tendency toward decreased volume of the left posterior perisylvian region in children with learning disabilities. Topographic mapping of EEG activity has demonstrated differences between dyslexic and normal boys. These differences are localized not only to the cortical speech areas, but also in both supplementary motor areas (608). Regional cerebral blood flow is reportedly decreased in both parietal lobes (609). Additionally, multiple foci of microdysgenesis of cortical and thalamic architecture have been documented in the brains of dyslexic individuals (610). Widespread in the left hemisphere, they also extend into the right frontal territory. In contrast, CT scans are rarely revealing, even if there are abnormalities on neurologic examination (611). Structural imaging reveals a scattering of abnormalities, consistent for inferior parietal lobule, inferior frontal gyrus and cerebellum, but varying in degree (611a). In short, at none of the three levels of analysis (behavioral, physiologic, and anatomical) is the notion of “pure” dyslexia validated. Rather, a more widespread abnormality is indicated, particularly in dyslexic adults (612) and can be demonstrated by neuropsychologic studies of adult dyslexics (613) as well as by studies that document the various comorbid deficits that rather randomly accompany dyslexia (614). Still, even when adults are defined as selectively reading disabled by their childhood psychometric records, a notable degree of residual specific reading-related deficit is still observable.
Functional neuroimaging has proven unenlightening about the etiology of dyslexia and has yet to be related to the genetic evidence. Nonetheless, the studies are revealing with respect to how the disorder works: for example, by underactivity of the visual-verbal crossmodal association areas, particularly Brodmann’s Area 37 in the vicinity of the left occipitotemporo incisura, and neighboring regions including anterior Area 19 on the ventral cerebrum near the fusiform gyrus (615). More superiorly on the lateral cortex, the angular gyrus has been implicated, sometimes as an abnormality of excess (616), sometimes as one of deficiency (617; see also 618,619,620,621,622). The abnormality of excess may reflect higher level cognitively or semantically based crossmodal associative processes that are being deployed to compensate for lower level perceptual deficits. Conversely, when the function being imaged calls for a higher level of semantic crossmodal processing, the angular gyrus may be underactive. Since the extant functional imaging studies describe a neurological
P.1129

accompaniment to the behavioral deficit, functional imaging studies also might reflect the improved functioning that results from successful remediation. In a study on adults with psychometrically documented childhood dyslexia, remediation as well as deficit was imaged.
Investigation of Failure in School
Ultimately dyslexia is an educational, not a medical, problem. Because the diagnosis of a learning disability is predicated on some specificity of deficit (thereby differing from global mild mental retardation), an array of psychometric tests is given to document the preserved and impaired functions. When these tests establish disproportionate difficulty in real word reading (both by phonologic decoding (sounding out) or sight word recognition, reading disability is appropriately diagnosed, either by the psychologist reporting the testing or by the responsible school committee. Since the highest correlations between IQ and reading achievement tests tend to range between 0.5 and 0.75, whereas the correlations between specific reading risk batteries and achievement can range above 0.8, specific skill-related testing is the sine qua non of reading disability diagnosis. Estimates of reading skill so derived are conventionally reported in standardized scores and in percentile ranks. It is when the percentile ranks range downward from about the 15th percentile, and especially when they descend below the tenth, that true disability is commonly diagnosed. However, many authorities recommend a threshold of educational concern at the 30th percentile, reflecting the fact that even children in this range have skill inefficiencies that, unless remediated, could substantially impair their future academic progress (624). If the child’s motivation is inadequate, the reason may be a behavior deviancy that often involves the whole family, an impulsive or hurried approach to the task (as in ADHD), or a cultural alienation from middle-class educational aspirations. The lack of motivation also can derive from poor self-image and a sense of hopelessness secondary to cumulative failure. Psychologic or neuropsychologic assessment is expected to differentiate the motivational or attentional factors from those involving cognitive skill deficit, even when both are present, but the distinction can never be completely assured. Caution in the diagnosis of reading disability is always appropriate, particularly since the vast majority of children with reading disability, especially in the earliest grades, improve with proper remediation (624,625).
Genetics of Reading Disability
For over a century (626), reading disability has been known to be familial, at the least; and explicit models of genetic transmission extend back a full half-century (627). A large number of genetic studies have since confirmed a genetic transmission of risk, and clinicians can be entirely confident that a child has substantially heightened risk for dyslexia if a parent is affected (629,630)—especially so if both parents are affected. Mostly within the last decade and a half, a considerable range of specific genetic linkage and association studies have been done, suggesting multiple genes conferring risk for dyslexia. The best current evidence implicates loci on chromosomes 1, 2, 3, 6, 15, 18, and 21 (631,632,633,634,635). There is no consistent evidence for sex-linked transmission, and correspondingly, population-based studies (636) tend not to show a disproportionate gender prevalence in reading disability. In the genetic as well as the epidemiologic studies, phonologic decoding and its underlying skill of phonemic awareness are routinely implicated. However, the loci on chromosome 6 and 15 may implicate a risk profile that extends to include or even to emphasize fluency or single word reading, respectively (637). Fluency deficit alone is not usually considered an identifiable subtype of reading disability, but when reading problems coexist with fluency deficit, the prognosis is particularly guarded. Fluency is the single best predictor of later outcome for poor readers (615). Single word reading by definition includes some nonphonologic (sight word) skills, so it is possible that there are phenotypic differences across the various genetic loci that have been implicated. The distinctiveness of the phenotype is most prominent in the chromosome 2 studies, which appear to implicate a relatively uncommon but quite significant language disorder syndrome that includes reading disability in its phenotypic presentation (638).
Selective verbal or performance impairments on the Wechsler scales, for example, are neither necessary nor sufficient conditions for reading problems. In children with DLD, the impact on reading—once general language skill is accounted for—is somewhat unpredictable (638a). Children with nonverbal Wechsler deficit are especially unpredictable as to their reading skills. It has been proposed that a nonverbal learning disability explains a variety of symptoms ranging from arithmetic problems to social skills deficit (639). Arithmetic problems commonly occur with reading problems, and clinical experience suggests that their occurrence in isolation is often due only to attention problems. But specific arithmetic disability, apart from ADHD, is well known, with its own subtypes (640; see below). The assumed visuospatial component of some arithmetic disability may be plausibly related to social skills deficit, since social information processing particularly requires global integrative perception, often considered a particularly right hemisphere–related function.
Historically, visuospatial subtypes of reading disability were recognized (641), but these are confounded with comorbid ADHD and are not generally diagnosed in current practice. However, a specific version of this proposal is the subject of intense current research (642,643). Surprisingly, the dorsal stream of visual information, which is
P.1130

usually associated with visuospatial rather than with linguistic functioning, may be implicated in some aspects of reading disorder. This is perhaps because of the disproportionate involvement of the magnocellular visual system (644,645), or because this pathway specializes in visual “look ahead” anticipatory processing, hence fluency. The evidence does not implicate deficits in this pathway as sufficient to explain the reading disorder however, and is controversial (645a,645b).
The decoding needs not only to be accurate, it needs to be fluent. The ability to automatize retrieval of names is quantitated by the Rapid Naming test (RAN). There is a correlation of about 0.6 between RAN performance and reading rate (646,647). Scores in this test have substantial predictive value for poor readers (648).
Rare in the United States, a presumably left hemisphere–related disorder that implicates arithmetic is the developmental version of the Gerstmann syndrome, in which children make errors in manipulations (such as subtraction) that involve the relative position of digits, and in spelling that involve mistakes of letter sequence rather than letter choice (649). Failure on tests of “finger order sense” is similarly accounted for by difficulty in making use of information about relative position (650). Right-left discrimination difficulties may occur in severe cases, since typically developing children can distinguish between their right and left sides by about 7 years of age.
Another pattern is that of the child, often left-handed, who has a normal psychometric profile, but who occasionally reads or writes from right to left. Although these directional mistakes attract much attention, they are transient and of little consequence. Mirror-image reversals of letters are made by typical children who are not yet ready to learn to read.
As a group, slow readers have frequently been reported to show an excess of left-handedness, mixed-handedness, and inconsistency of side of preference for hand, foot, and eye. Some large series have shown no such relationship, however. In general, samples that yield a high proportion of left-handed subjects come from clinical sources, whereas samples that do not are drawn from the general school population (651). Samples from clinical sources are more likely to include children who have suffered early brain damage, which leads to pathologic left-handedness (489). The association between left-handedness and dyslexia also can encompass a vulnerability to autoimmune disease (652), and poor readers are more likely to have mothers with immune dysfunction (653), but current evidence distinguishes separable genetic bases for dyslexia and immune dysfunction (654). Eye preference, usually inferred from sighting dominance (655), bears no close relationship to hemisphere dominance. It is influenced by minor disparities of visual acuity between the eyes that are not neurologically significant. Anomalous lateral preference is too inconstant to be useful in diagnosis, and there is certainly no rationale for trying to correct a learning disability by interfering with a child’s established limb preference or by guiding a younger child toward right-handedness. The evidence for the relationship between laterality and learning disability is tenuous (656).
Investigating reading disability with structural imaging such as MRI rarely yields useful information. The EEG is helpful only when absence seizures momentarily interrupt the child’s attention often enough to interfere with the child’s ability to follow trains of thought in class. On average, trains of generalized 3 per second spike-wave discharges that last 5.5 seconds or more can interfere with mental activity (see Chapter 14). Brain electrical activity mapping (608), using average evoked potentials, or mapping of brain activity using MEG (magnetoencephalography) reveal interesting group differences but are not suitable for individual diagnosis. This is partly because of the heightened sensitivity of these techniques to a wide variety of other variables that affect the evoked response but are less clearly related to the clinical syndromes themselves. Structural imaging reveals reversed hemisphere asymmetry no more frequently than in controls (657; but see reference 658).
Certain obvious genetic disorders impact reading other than by causing dyslexia. For example, children with Klinefelter syndrome have a language-based learning disability as well as executive dysfunction (659). Children with Duchenne muscular dystrophy have impaired verbal memory spans, which are detrimental to classroom learning (660). More broadly, gross deficits of hearing and vision must be ruled out as contributing to the problem; however, reading is only impaired when visual acuity is substantially reduced. Orthoptic investigation may reveal poor vergence control and stereoacuity, especially in children who report that the text is subjectively unstable (661). Six months of monocular occlusion reportedly results in better reading (662). Vestibular dysfunction is no more common among children with learning disabilities than in a control population (663).
Treatment
Treatment is at present altogether nonmedical. In order, it focuses first on phonemic awareness, then on matching phonemes to visual letters for decoding of words, then on sight words, and then on semantic aspects of the reading process. For early reading, the combination of phonemic awareness training (664) and direct instruction in alphabetic coding is the most effective and well-documented. Fluency training (665) is gaining a research base as well; vocabulary and comprehension training are earlier in development.
Ineffectual treatments for reading disability include optometric exercises (666), improvement of neuromuscular control (e.g., sensory integration therapy) (667,668),
P.1131

labyrinthine stimulation, attempts to change peripheral or central laterality (669), psychoactive drug treatment (670), and anti–motion sickness medication (671,672).
Physical training with a view to improving spatial orientation and body image has been claimed to improve mental performance. However, these techniques involve teaching the child accomplishments far removed from the area of the child’s difficulty and giving him or her unaccustomed attention. This encouraging experience could improve self-concept and motivation, without specifically improving reading (673,674). Efforts to change hand preference do not address the basic deficits in learning disability and are ineffective. Eye-movement training ignores the fact that, except in rare cases of conjugate gaze palsies, rate of eye movement shift from fixation to fixation is not a limiting factor in reading skill. Visuomotor training is based on the view that early motor ability influences and predicts later intelligence. No evidence supports the claim that either visual training or perceptual training can improve the academic outcome of children with reading disabilities (675). A motor program based on “patterning” of locomotion (676) is not only ineffective but may be harmful and cause unnecessary expenses, delay in appropriate educational intervention, and engender a false sense of security. In general, the notion that cognitive deficits can be remediated by training ontogenetically earlier perceptuomotor skills has been abandoned.
Noneducational remedial methods have not been shown to have specific benefits for reading readiness. A systematic, analytic approach to reading itself is preferable, in which the information is presented stepwise, while distractions are minimized. Usually, this can only be achieved by individual instruction, to conform to the individual learning requirements of the child. “Language experience” approaches are generally unsuccessful.
To meet these requirements, some educators “teach to weakness” in the hopes of improving the efficiency of the process responsible for reading deficiency; others regard it as more realistic to circumvent (“bypass”) the deficiency by teaching to residual strengths. In fact, neither position is supportable in isolation. Initial attempts must be to teach to weakness, since all but a very few children can and do learn the skills of reading if given the appropriate additional instruction and practice in the very things (phoneme-grapheme correspondence, for example) they initially find difficult. In this regard, the formal randomized prospective trials (677,678,679) are unambiguous, and there is therefore no rationale for withholding such instruction and practice from children who need it. Such instruction can, however, take time that in severe cases is measured in years, and the goal of education during this period must also be to develop the child’s strengths. It is only rarely necessary or even helpful to remove the child totally from the regular classroom, though in severe cases such placements in “self-contained classrooms” of children with similar levels of need do maximize the instructional opportunity and can promote peer relationships with other similarly struggling students. There is the countervailing risk of negative self attributions by the child, who may complain that he or she has been put in the “dummy class.” When otherwise indicated by the educators on the scene (who routinely avoid these placements when they can for cost reasons), children can usually be counseled and helped to focus on the prospect of improved reading and learning skills—which they will often value above the discomfort of the placement. Such counsel, of course, implies that the clinician also will follow the child’s progress and expect evidence of improved learning from the schools, thereby to encourage the child and facilitate re-placement in a regular classroom when appropriate. In this context, the rare child who needs continued placement in a special class will become obvious to all parties. The more common case is that of a child needing individual or small-group services from specialist staff at the school, outside the main classroom. Sometimes termed pull out services, these occasions usually total at most a few hours a week. At times, children object to the adverse inference that they believe is implied by such services, but the prospect of improving their reading skills will override their social reservations.
Beyond identifying the child who needs individualized reading instruction, some educators attempt to subtype the reading disability and deploy special treatments for special needs ranging from visual recognition problems to auditory discrimination problems. If the diagnoses are about different degrees of phonologic, fluency, vocabulary, and sight word and text comprehension skills, then they can be useful in guiding efficiently individualized instruction in small groups and sometimes individually. However, suitably controlled randomized prospective efficacy evidence is not available to support allegedly specific but theoretically imprecise forms of sensory training for conditions such as “visual learner,” “left hemisphere learner,” or even “auditory discrimination deficit” (unless it involves actual deafness that prevents hearing of normal spoken discourse). The teaching of reading, like that of any other skill, has no shortcuts: The relevant underlying processes (phonemic awareness, phonologic letter-sound coding including spelling, fluent letter-sound-word associations, vocabulary, and text comprehension strategies) cannot be avoided and must not be replaced by expensive and unproven quick remedies. The state of the art in education now mirrors that in medicine: proper prospective randomized controlled studies of efficacy are required before new treatments can be endorsed. A recent review of the extant evidence is provided by the National Reading Panel Report (594).
Finally, lexical knowledge does not guarantee fluency. The child who has mastered phonics may nonetheless emerge as a halting, dysfunctional reader. Fluency training
P.1132

is a necessary sequel. Different children are led through these stages at different rates, encountering different problems on the way. This exacting, long-term effort is not substantially facilitated by any form of diagnostic testing at the time of the original assessment.
Prediction
Socioeconomic circumstances ultimately exert the most influence on success in learning to read (595). Holding these constant, preschool prediction of reading failure remains difficult, though less so by the second half of kindergarten (596). The predictive success of reading readiness tests naturally increases as early reading achievement itself—for example, knowledge of the alphabet—develops. Predictions from first grade forward therefore tend to be stronger than those predicted from kindergarten. Readiness testing is best performed by entry to first grade, soon enough to enable any necessary modifications in the classroom. Longitudinal studies indicate that learning disability persists into adulthood and even broadens into vocational and personal problems, and occasionally delinquency and depression, more often than generally realized.
NONVERBAL LEARNING DISABILITIES
Some children have selective difficulties that impede school performance in spite of satisfactory spoken and written language skills. In the long run, such nonverbal learning disabilities, NVLD (639) can be more handicapping for employment prospects than selective reading disability. They include children with developmental dyscalculia whose difficulty in mathematics is not explained by concurrent verbal difficulties, but instead is associated with visuospatial impairment (680,681,682). Some children with attention disorders have difficulty in achieving fluency in knowledge of arithmetic facts, such as tables (683). Children with dyscalculia also are described as experiencing difficulty in tactile discrimination, concept formation, fine motor coordination, and dysgraphia (684). Dyscalculia is as prevalent as dyslexia (685) but attracts little attention, perhaps because a fourth-grade arithmetic achievement level suffices for everyday activities (686). Four subtypes of mathematical disability have been suggested, corresponding to weakness in semantic memory, knowledge of mathematical procedures, visual and spatial processing, and working memory (687).
One formulation relates NVLD to hypothesized inadequacy of the right hemisphere (688) and invokes impaired social skills as yet another component. Shyness and social isolation are accompanied by lack of eye contact and impaired use of gestures with speech in flat intonation. Of the main groups of learning-disabled children, those with nonverbal learning disabilities experienced depression twice as often as children with reading disabilities (689). When soft neurological signs are present, they tend to be left-sided. An electrophysiological study reports diminished activity in the 36- to 44-Hz band over the right hemisphere during a face recognition task in dyscalculics (690). A group of children being treated for phenylketonuria conformed to such a neuropsychological pattern (691). Children with Turner’s syndrome have impaired visuospatial, memory, and attentional skills (692). The behavioral phenotype of children with velocardio facial syndrome also suggests NVLD syndrome. Nonverbal learning disability is common in female carriers of fragile X (694). It is the most common type of learning disability in epilepsy (695). Some 50% of children with neurofibromatosis type 1 (NF1) have learning disabilities (696) that are described as being specifically visuospatial and visuomotor deficits and reading disabilities (697). However, a recent study has found the cognitive deficits in NF1 to be less specific and associated with low IQ and behavioral disorders (698). MRI studies that show basal ganglia and cerebellar lesions implicate subcortical structures in the etiology of NF1 (699,700,701).
Children with learning disabilities have low social status among their peers (702). This low status could result both from their associated social obliviousness, and from the school failure that children with learning disabilities experience, resulting in low self-concept and negative perception by others.
Social learning disability (703) comprises skill deficits, both in perception (of others’ nonverbal communications) and performance (in the manner of outward behavior toward others). “Deficit” applies when the socially relevant skills or behaviors are not in the child’s repertoire. Motivational failure is applicable when the skills are in the repertoire but not used (704). They might not be used because the child avoids interactions for reasons of fear or hostility or lacks adequate impulse control. In the rare cases, where the social deficit turns to aggressive expressions, the implication of dangerousness to others must be cautiously, but carefully, considered.
Developmental Coordination Disorder
Children who are so clumsy that they have difficulty coping with the demands of everyday tasks (such as dressing, feeding, writing, gym and playground activities) have been variously characterized as being physically awkward, developmentally dyspraxic, or subject to sensory integrative or perceptual motor dysfunction—the clumsy child syndrome (705). Named developmental coordination disorder (DCD) both in the DSM-IV and ICD-10, it was defined as existing when the child lacks the motor coordination necessary to perform age appropriate tasks, although intellectually normal and otherwise neurologically intact.
P.1133

Previously believed to represent a temporary immaturity or lag that resolves with increasing age, it is now thought to persist at least into adulthood and probably to be lifelong, bringing in its wake health and fitness problems, disordered behavior, low self-esteem, and deficient social interactions (706). DCD is thought to be present in 5% to 6% of schoolchildren (707).
Movements are generally slow; DCD may involve timing difficulties related to dysfunction of the cerebellum. The child finds it particularly hard to inhibit moving toward salient external stimuli (708). Visuospatial deficits have been documented even in the absence of movement. When it is found in combination with ADHD, DCD persists into the adult years (709). The coordination deficits in ADHD children could not be attributed only to inattention (710). The poorly legible writing and copying of text found in writing disorder that is due to DCD differs from that in dysgraphia based on linguistic problems, in which spelling is poor but copying is preserved (711). When diverse physical interventions to remediate DCD are critically evaluated, it appears that any gains are slight and more probably accounted for by increased self-confidence than improvement in motor control (712).
ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Characteristics
Attention-deficit hyperactivity disorder (ADHD) refers to the covariation of inattention, hyperactivity, and impulsivity. The DSM-IV describes three ADHD subtypes: (a) inattention alone, (b) hyperactivity-impulsivity alone, and (c) a combined type with significant inattention, hyperactivity, and impulsivity. Some 80% have the combined type, 15% the inattentive, and 5% hyperactivity and impulsivity only. Children may be restless during one stage of development but not subsequently. This two-factor model is a departure from the previous unidimensional model, and though it is far from validated, it does have some empirical basis (713). Correspondingly, hyperactivity/impulsivity is associated with externalizing psychopathology (e.g., conduct disorder, oppositional defiant disorder) and the inattentive subtype with internalizing psychopathology (e.g., anxiety, depression) (714). The DSM-IV does not include developmental qualifiers among its criteria for ADHD, but the listed behaviors, and particularly hyperactivity, typically decrease as the child grows older. This does not imply that the disorder grows milder with increasing age, but that its form of presentation changes during development. A synopsis of the current state of ADHD diagnosis and treatment is available (715).
According to the DSM-IV-TR (text revision), the major clinical manifestations of ADHD—namely developmentally maladaptive attention, activity, and impulse control—must be sufficient to cause impairment in social, academic, or occupational functioning (48). Signs of ADHD generally begin before age 7 years and should persist for at least 6 months in two or more settings (e.g., home, school, or play) before the diagnosis is made. However, some children may have a later onset of the signs of ADHD (716).
There is consensus on the behavioral characteristics of ADHD that are listed in DSM-IV criteria. The most frequently reported primary manifestations of ADHD include cognitive disorganization, distractibility, inattention, impulsivity, and hyperactivity. The most commonly reported secondary manifestations include disruptive behaviors, poor social skills, emotional immaturity, fidgeting, poor academic performance, and excessive talking.
The relationship between the level of motor activity in infants and subsequent hyperactivity is unknown. Mothers often observe in retrospect that their child with hyperactivity was unusually active from birth. Feeding difficulty and sleep disturbances in infancy and the preschool period are commonly reported precursors (717,718). A prospective study found the second year of life to be the earliest in which ADHD symptoms could be detected and age 3 to 5 years to be the peak time of onset (719). Young children with hyperactivity explore their environment with unusual persistence, which accounts for the increased frequency of accidental poisonings (720) and traumatic brain injury (721) in ADHD. In older children, gross motor exuberance can give way to a less flagrant but continual wriggling restlessness. More troublesome is the child’s impulsive, distractible, and often antisocial behavior. The hyperactivity becomes less a source of adults’ irritation at home and more an occasion for disapproval from teachers at times when schoolchildren are expected to sit still and pay attention. This disapproval may be partly responsible for the high stealing and truancy rates among hyperactive children. Girls and boys with ADHD are similar in their impulsivity, academic performance, social functioning, fine motor skills, parental education, and parental depression (722). Girls tend to be less hyperactive and externalizing, but more inattentive and cognitively impaired and more subject to rejection by peers (722,723).
Gross body movements are not uniformly more frequent in children with hyperactivity. In unstructured situations, many typical children are just as active, and children with hyperactivity do not stand out. In structured situations, differences appear both in the amount and the relevance of the activity. In a 24-hour study, an ADHD group did exhibit more overall activity than controls during the night and throughout the day (724). Recorded over as long as 1 week, boys with ADHD were significantly more restless than controls at ages 6 to 11 years, but rarely so at older ages. Some children manage to continue to be attentive (e.g., to a television program) while moving around a room. Mostly, however, each movement signals a more
P.1134

comprehensive reorientation of mental set. In infancy, and until the child walks, this continual reorientation appears not to cause concern. Subsequently, complaints gather as the child disrupts the orderly home or classroom while failing to pay the expected degree of attention to the teacher, the instructional materials, and homework assignments.
Young children with ADHD initially show no signs of distress, but negative reactions from adults and peers gradually engender feelings of inadequacy, and this can lead to withdrawal or aggression. Hyperactive children are seen as quarrelsome, irritable, defiant, untruthful, and destructive by their classmates as well as by adults (725). The discipline imposed by the school and the need to repeat grades further contribute to learning failure and social maladjustment. Nonhyperactive children with attention deficit are misperceived as undermotivated or lazy, and the diagnosis is often missed.
Schoolwork demands increasing effort and organization as of fourth grade (726), and the intermittency of attention interferes more with learning and becomes more troublesome to teachers. Some 10% to 50% of children with ADHD underachieve in reading (727,728). Whether this is due to the attention deficit, which can impair word attack (729), or to comorbid dyslexia is hard to determine in the individual case (730). Children with ADHD are not lower in IQ than attentionally normal children.
Neither restlessness nor inattention is the core of the ADHD syndrome. That ADHD is primarily a disinhibitory disorder (731) is questionable (732). A recent study failed to confirm a selective executive/inhibitory deficit in ADHD boys (733). There is experimental evidence that ADHD behavior is more variable than that of normal children and of children under stimulant control (734,735). Hyperactive children attend as efficiently as normal children to tasks that they find intrinsically interesting or rewarding. It is when the task is tedious and the incentive for doing it is remote in the future that their inattention is maximal. The hyperactive child understands consequences and professes the usual concern about them. However, the consequences make little impression on the child’s behavior. But if the task is attractive or of interest to the child (i.e., intrinsically motivating), then the ADHD child performs as well as a child who is attentionally normal (736).
Diagnosis of Attention-Deficit Hyperactivity Disorder
There are no definitive diagnostic tests for ADHD. Rather, the diagnosis depends on determining (a) that the child is inattentive and/or impulsive and hyperactive to a degree that is excessive for the child’s age and expected level of developmental maturity, and (b) that there is consequent impairment in social and school functioning. Corroborating information can be obtained through child, parental, and teacher interviews; standardized rating scales (737); direct observation; behavioral laboratory tests; and formal psychologic and educational evaluations. The child’s history, physical, and neurologic examination should be complete enough to rule out any identifiable genetic or medical conditions that might simulate ADHD. Absent such conditions, and although it may uncover nonspecific soft signs, the neurological examination rarely contributes to the diagnosis. Neither physiological nor biochemical measures reliably identify ADHD children (738). Psychiatric consultation is indicated in children with more complex behavioral problems or who have comorbid depression or thought disorders. It is not known whether the three phenotypes presented in the DSM-IV-TR have different neurobiologic bases or are variants of the same underlying pathophysiology.
Prevalence
ADHD is the most common chronic behavioral disorder in children, with a prevalence that ranges between 3% and 5% of school-aged children worldwide (739). It is reported to be highest in inner city populations (740,741). It occurs far more frequently in boys than girls in clinic samples (742) as well as in approximately 3 to 1 ratio in population studies (722). Through the evolution of the diagnostic criteria and changes in the public’s attitude toward the disorder, the prevalence of ADHD has gradually increased, particularly in girls, as has the use of stimulant therapy (743). In a more recent study, primary care providers identified behavioral problems in approximately one in five children, and attentional/hyperactivity problems in 9.2% of the entire study sample, but the diagnosis was commonly made solely by parental interview and without the benefit of standardized questionnaires (742).
Although it is most frequently diagnosed in North America, crosscultural studies have shown comparable levels of prevalence in all countries studied, even in the Third World (739), not only of ADHD, but also of internalizing and externalizing psychopathology in general (744). In Britain, the diagnostic label hyperkinetic disorder (745) is reserved for the most severe cases. Other children who would have been considered to have ADHD in the United States are termed conduct disordered in the United Kingdom (746). This difference is not only semantic. It reflects a difference in management, being that stimulant therapy is used sparingly in the United Kingdom. Whether ADHD and conduct disorder are truly separable is questionable (747). Those who use aggressive conduct disorder as a primary diagnosis find a majority of their patients to be hyperactive as well (747). Comorbidities affect both prognosis and treatment (748,749). In particular, aggressiveness in early childhood is a negative prognostic sign. The home environment plays a role. Aggressive children as a group tend to be ones reared by depressed mothers who offer less positive caregiving. Family income is lower than for unaggressive
P.1135

children, and harsh parenting is more likely. Aggressive children continue to have more academic and social difficulty, and are seen as being angry, hostile, antisocial, and oppositional (750).
Neurobiologic Basis and Genetics
There is no single underlying cause of ADHD. It occurs both in the absence of any identifiable risk factors, and in association with numerous other childhood conditions such as motor dyspraxia, tics, learning problems, speech and language disorders, sleep disorders, oppositional behavior, enuresis, and encopresis. In addition, overactive and socially disruptive behavior is common in children who have evidence of injury from infections, head trauma (751), toxic exposures (752), and extreme prematurity (753,754). Minor physical anomalies are frequent (755).
In most cases, hyperactivity is already evident in infancy, although it is not necessarily recognized as such, and it frequently persists into adult life in the form of attentional and social problems (756). Thus, it has the characteristics of a stable personality trait or temperament, and for which there is a genetic link in most cases. Families of ADHD/conduct-disordered children are notable for the high incidence of sociopathy and alcoholism (757,758). ADHD is highly heritable, probably based on multiple genes, each with small effect size. Parents of children with ADHD have elevated ratings of ADHD symptoms (759). Compared with the general population, first-degree relatives are at a 4.6- to 7.6-fold risk of developing the disorder (760). Second-degree relatives also are at increased risk (761). Several linkage studies implicate a 7-repeat polymorphism of the dopamine receptor D4 (DRD4) gene, mapped to chromosome 11p 15.5 (762), and also a polymorphism of a dopamine transporter (DAT1) (763). The transporter is a target of many of the drugs used to treat ADHD (764). The density of dopamine transporters in the striatum is markedly increased, as measured by single photon emission computed tomography (SPECT) using labeled altropane, a specific ligand for dopamine transporter (765). This disorder in dopaminergic function results in a disinhibited sensation-seeking behavioral style (766).
Right frontostriatal circuitry has been invoked with respect to defective response inhibition. The right frontal lobe is reportedly smaller than normal in ADHD structural imaging (767), and the striatum has abnormal morphology (768,769,770). The cerebellar, temporal gray matter and total cerebral volume are smaller in ADHD individuals than attentionally normal controls, and these size variables correlate significantly with ratings of severity of ADHD behaviors (771). Corpus callosum size is reduced (772,773) as well as the inferior cerebellar vermis, posterior lobe (773a). Regional cerebral blood flow is diminished in striatum and frontal lobes in ADHD, a deficiency that is partly reversible by methylphenidate (774, but see 775). Power spectrum analysis indicates prefrontal underactivation (776) and cerebral glucose metabolism is diminished generally, but most notably, in the prefrontal cortex (777). Some neuropsychologic deficits are consistent with prefrontal underactivity. The quantified EEG in ADHD has abnormal features Lazzaro and colleagues, 1998. Event-related potential (ERP) studies suggest the presence of abnormalities in the right frontal (779) and parietal (780) regions. Some neurobiological clues to the etiology of ADHD are summarized in Table 18.11.
Differential Diagnosis
Restlessness and short attention span can be features of mental retardation and may conform to the child’s developmental quotient. The presence of mental retardation can itself be hard to verify. If the validity of the intelligence testing is uncertain, the educational psychologist may qualify the IQ score with a warning that it could under-represent the child’s cognitive potential, particularly for measures that require sustained attention rather than merely a quick response. Retesting after initiation of stimulant therapy can yield a more realistic estimate. Improvement can be conveniently documented by teachers and parents by means of the Conners rating scales (781). However, even correcting the attentional problem can leave the educational difficulty unresolved, given the 30% to 40% overlap between ADHD and learning disabilities (782).
When cognitive deficits do not explain the attentional problem, an alternative possibility is overanxious disorder. The anxious child is most restless under emotional stress, as in the classroom and consulting room, and least restless when unstressed, as on weekends or on vacation. The child is visibly unhappy, either characterologically or because of some maladjustment within the family. The hyperactive child, on the other hand, is typically in good spirits until he or she comes up against frustration and adverse attitudes from others. Whereas the time of onset of anxiety can usually be specified, hyperactivity often dates from early infancy. A favorable response to a stimulant supports the diagnosis of ADHD as opposed to anxiety. Anxiety is comorbid with ADHD in about one-third of cases. Its presence did not impair stimulant response in a large-scale study (783). Favorable response can be documented in the laboratory on a time-response and dose-response basis by use of a paired-associated learning task (784). The findings contribute to the design of an appropriate drug regimen for the child who responds favorably. Other tasks that can be used in a similar way are the Continuous Performance Test (CPT) (785) and the Test of Variables of Attention (TOVA) (786). CPT performance variables are significantly related to ADHD symptoms (787).
Overfocusing (326) is sometimes comorbid with ADHD and sometimes distinct. Children with overfocusing have difficulty in shifting mental set associated with perseveration and isolating tendencies. In addition to the social
P.1136

withdrawal that is often manifest, overfocusing classically includes aversion to novelty, complexity, and time pressure. It bears some resemblance to high-level autistic behavior, though it is milder (787a). A contrasting temperament of uncertain relation to overfocusing is exhibited by the behaviorally inhibited child (788). Irritable in infancy; shy and fearful as a toddler; and cautious, quiet, and introverted in grade school, these children are thought to have increased limbic-sympathetic tone and to be anxiety prone. Disordered sleep, especially caused by obstructive sleep apnea, can render a child inattentive and restless. Attention deficits are often found among children of schizophrenic parents, who are themselves at high risk for developing schizophrenia. They perform poorly on vigilance tasks but are not impulsive (789). Another potentially overlooked differential diagnosis of ADHD is occult mood disorder, notably bipolar disorder, particularly when it presents in adolescents with chronic rather than episodic symptomatology. The combination of dysphoric and irritable mood with aggressive conduct that is resistant to stimulant therapy as well as subjective report of elation, grandiosity, racing thoughts, flight of ideas, and decreased need for sleep (790) should prompt an examination of the family for bipolar disorder (791). However, a broad phenotype also is recognized: Children exhibit chronic nonepisodic disregulation, with severe irritability, hyperarousal, and increased reactivity to negative emotional stimuli (792). In one study of juvenile bipolar disorder, comorbidity with ADHD was 87% (793). Episodic loss of control is attributed to dysfunction in the limbic cortex (794). Whereas impulsive acts of aggression are common in ADHD, episodic explosive behavior is not. The restless movements of Sydenhams chorea are associated with ADHD in one-third of cases and are often accompanied by emotional lability and
P.1137

obsessive-compulsive symptoms (795). In addition to multiple motor and vocal tics, children with Tourette syndrome (TS) often exhibit symptoms that are diagnostic of ADHD. However, these symptoms represent comorbidity and are not inherent in TS. Learning disabilities and neuropsychologic deficits (796) have been reported in children with TS. With respect to executive functions, children with TS but without comorbid ADHD were impaired only in tests that call for response inhibition (797). The neurology of TS is considered in Chapter 3.
TABLE 18.11 Neurobiologic Clues to the Etiology of Attention-Deficit-Hyperactivity Disorder (ADHD)
Etiologic Clue Description of Findings in Studies of ADHD References
Environmental Increased incidence of behavioral disorders, sociopathy, and alcoholism in families of children with ADHD 757
Endocrine Increased frequency of ADHD in patients with resistance to thyroid hormone in some studies  
Genetic Increased concordance for hyperactivity/inattentiveness in monozygotic twins (59% to 81%) compared with dizygotic twins (approximately one-third).
Increased incidence of ADHD in first-degree (up to 25%) and second-degree relatives of children with ADHD
758,759,761
Neuroanatomy
   Cerebrum Some limited magnetic resonance imaging brain morphology and neuropsychologic studies suggest that children with ADHD have a smaller or functionally abnormal right frontal lobe; other studies show variable asymmetries and volumetric differences in the basal ganglia, corpus callosum, ventricular systems, and subcortical white matter 33,772,773
   Electroencephalographic findings Increased anterior absolute theta and decreased posterior relative beta activity in quantified electroencephalographic analysis suggests reduced cortical arousal in adolescents with ADHD 778
   Brainstem Prolonged latencies of waves III and V, and longer brainstem transmission of waves I–III and I–V in brainstem auditory-evoked potentials of children with ADHD suggest brainstem dysfunction in these children
Activation of reticular midbrain formation and thalamic intralaminar nuclei increases on attention-demanding tasks in a positron emission tomographic study; executive functioning associated with greater subcortical activation in ADHD subjects
 
Neurochemistry
   Dopaminergic and noradrenergic systems Pharmacologic agents that are effective in ADHD (e.g., stimulants and tricyclic antidepressants) increase central nervous system dopamine and norepinephrine transmission
Dopamine deficiency is postulated to account for lack of impulse control in ADHD; studies that measure catecholamines and their metabolites in blood, urine, and CSF in individuals with ADHD are inconclusive; regional dopamine inhibitory autoreceptors may play a role in central nervous system catecholamine metabolism
Functional neuroimaging studies support the hypothesis that attention is regulated at multiple levels, especially frontal, parietal, or temporal cortex as well as subcortical structures within the basal ganglia and thalamus
762,763,764,765
TABLE 18.12 Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder
Medication Dose Ranges (mg/kg per day) Maximum Dose (mg per day) Formulations Common Adverse Effects
Stimulants
D-amphetamine (Dexedrine) 0.1–0.5 40 5-mg tablets; 5-10-, 15-mg spansules Insomnia, poor appetite, stomachache, tics
D-amphetamine/L-amphetamine mixture (Adderall) 0.1–0.5 40 5-, 10-, 20-mg tablets Insomnia, poor appetite, stomachache, tics
Methylphenidate (Ritalin) 0.5–1.0 60 5-, 10-, 20-mg tablets; 20-mg sustained release Insomnia, poor appetite, stomachache, tics
Methylphenidate extended release (Concerta) 18 to 54 mg per day, given once a day in a.m. 54 18, 27, 36, 54 mg tablets Headaches, abdominal pain, decreased appetite, sleeplessness
Pemoline (Cylert) 0.5–3.0 112.5 18.75-, 37.5-, 75-mg tablets Insomnia, tics, stomachache, movement disorder; rarely: hypersensitivity and hepatic dysfunction
Others
Clonidine (Catapres) 0.001–0.005 0.3–0.4 0.1-, 0.2-, 0.3-mg tablets
0.1-, 0.2-, 0.3-mg transdermal patch
Somnolence, fatigue, hypotension, bradycardia, headache, dry mouth, constipation
Desipramine (Norpramin) 1–3 100 10-, 75-, 100-mg tablets Tachycardia, hypertension, arrhythmias; monitor electrocardiogram
Rare, unexplained sudden death
Guanfacine (Tenex) 0.5–2 mg/d; 12 yr and older 2 1-, 2-mg tablets Sedation, fatigue, headaches, insomnia, stomachache, decreased appetite
Imipramine (Tofranil) 0.5–3 100 10-, 25-, 50-mg tablets Fatigue, dry mouth, blurred vision
Rare, cardiac conduction block
Atomoxetine (Strattera) a selective norepinephrine reuptake inhibitor 0.5 to 12 mg as single dose in a.m. or divided doses in a.m. and after school 1.4 mg/kg or 100 mg per day, whichever is less 10, 18, 25, 40, and 60 mg capsules Upset stomach, nausea, vomiting, dizziness, mood swings, rare liver failure
Management Strategies
Medical
Although behavioral modification may be a sufficient first-line therapy in mild cases of ADHD, it is advisable to consider a pharmacologic intervention trial before instituting extensive behavioral management therapies, home interventions, or changes in the educational program or curriculum (798). In fact, a large-scale cooperative study found that stimulant therapy was as effective alone as when combined with behavior modification (799). Doses and common adverse effects of medications used in the treatment of ADHD are listed in Table 18.12.
The most effective pharmaceutical agents for symptomatic control of hyperactivity are the stimulant medications. Therapy with stimulants leads to significant improvement in at least 70% to 80% of children with ADHD (800). At the effective dose, stimulants modify the child’s activity, improve behavioral control, and permit a more adaptive disposition of attention in relation to the demands of the moment (801,802). A meta-analysis of effect size finds twice as much improvement of behavior as of classroom achievement (803). Stimulants also enhance performance in otherwise normal, healthy individuals when performance is impaired by disinterest, fatigue, or sleep deprivation. Methylphenidate may increase task salience, rendering it more motivating (804).
P.1138

There is no empirical justification for the practice of prescribing stimulants according to the child’s weight—for instance, at a dose of 0.3 mg/kg. Stimulant drugs have a strong affinity for the brain, which approximates its ultimate adult size by age 6 years, and the optimal dosage does not increase with increasing age or severity and is not a function of body weight (805).
Stimulant therapy usually remains useful for many years, if not indefinitely. Even after long periods of administration, discontinuing the drug leads to notable relapse within a day or less. Because most stimulants are short-acting, their effectiveness can be evaluated on a daily basis by comparing behavior on and off medication, without need for drug holidays.
Approximately 20% of children diagnosed with ADHD fail to respond to stimulants or respond adversely (806). In acute overdose, stimulants cause tics, which cease when the medication is stopped. The possibility that stimulant therapy can on rare occasions precipitate Tourette syndrome has been debated (807). If tics appear when stimulant therapy is begun, or if an existing tic disorder is aggravated by it, the medication should be discontinued. Approximately 50% of children with Tourette syndrome meet ADHD criteria, and one-third feel compulsions to perform risky acts (808,809). In up to one-half of these children, stimulant therapy exacerbates the tics (810). Desipramine or Risperidone are effective alternative treatments of symptoms in children with both ADHD and Tourette syndrome (811).
Dexedrine is preferred to the equally effective racemic amphetamine because it produces fewer side effects. The standard tablet is effective for 4 hours, but therapeutic effects can be distributed more evenly over time by using the longer-acting dextroamphetamine (Dexedrine Spansules). Any adverse effects are apparent within 3 days, and if these are worrisome, the dosage should be decreased or discontinued. If no change occurs at the initial dosage, an increase of 2.5 mg is introduced every 3 days until a favorable result occurs or until adverse effects supervene. Adverse effects are usually transient. Insomnia can be due to recurrence of hyperactivity after the stimulant has worn off or an effect of the stimulant itself. It can be controlled by adjusting dosage and timing. No long-term adverse effects have been substantiated. Stimulants may interfere with cartilage metabolism by inhibiting somatomedin-stimulated sulfate uptake by tissues (812). Nonetheless, the possibility that high dosages of stimulants retard growth (813) has not been confirmed (814,815, but see 816). The risk for substance abuse diminishes by as much as 50% in ADHD children who are receiving methylphenidate or amphetamine (817).
Methylphenidate probably inhibits receptor uptake of dopamine by blocking the dopamine transporter (DAT1) (818). A consensus group recommended that it be the first medication to use when treating ADHD (819). Optimal doses range between 10 and 50 mg per day (820). Methylphenidate is far more commonly used than dextroamphetamine. Both are effective, but are not necessarily effective in the same patients. The regimen is similar, but 5-mg doses are given in increments. Ideally, the drug is administered 30 minutes before meals because intestinal alkalinity is thought to degrade the product. The side effects are similar to, but less frequent than, those with dextroamphetamine. The long-acting methylphenidate preparation (Ritalin sustained release) is effective for approximately 6 hours. Other recently introduced long-acting methylphenidate preparations are trademarked as Concerta, Ritalin-LA, and Metadate CD. Their duration of action is in the 8 to 12 hour range, thereby reducing the variability of the stimulant effect and minimizing noncompliance. Scores on standardized IQ performance subscales may improve in some children who respond to methylphenidate, but stimulants do not treat comorbid learning disabilities. The drug assists performance by helping sustained attention, diminishing impulsiveness, and improving inhibition of hasty incorrect responses. Facility in creative thinking is unaffected (821). In some children, the medication improves motor control and handwriting. Methylphenidate can be used in ADHD children with seizure disorders. Double-blind medication and placebo crossover found that children whose seizure disorders had been well controlled on monotherapy did not relapse on methylphenidate, and their EEG tracings remained unchanged (822,823). The same applies for children with seizures and more severe underlying encephalopathy (824). A long-acting mixture of four amphetamine-based salts also is effective (825). Methylphenidate is also effective in adult ADHD, although brain activity remains abnormal (866).
The stimulant pemoline has a similar duration of action, similar beneficial effects on classroom behavior (826), and the additional advantage of lacking abuse potential. (Children with ADHD have not been reported to abuse their own prescribed stimulant medication.) Serum liver enzyme (aspartate aminotransferase/alanine aminotransferase) concentrations can be elevated during pemoline therapy (827). A few cases of liver failure attributed to pemoline have been reported (827,828).
Clonidine and guanfacine, α2-adrenergic receptor agonists and antihypertensives, are alternative medications that ameliorate ADHD symptoms—in particular, the frequently associated aggression (829,830). Clonidine can cause cardiovascular complications, especially when combined with methylphenidate (831). Guanfacine appears to be less sedating and less apt to cause hypotension than clonidine, and it has a longer half-life (832). More recently, a norepinephrine reuptake inhibitor, atomoxetine, with a usual half-life of 5 hours, was found to ameliorate ADHD behavior (833,834). In preliminary studies, the benefits of atomoxetine and methylphenidate have been comparable (835), but a definitive comparative study has yet to appear. Theoretically, atomoxetine incurs less risk of
P.1139

leading to drug abuse, but this has not been demonstrated empirically. Atomoxetine may be beneficial in the treatment of nonresponders with the use of stimulants. Side effects such as anorexia and weight loss occur at frequencies comparable to methylphenidate. Acute liver failure is a rare complication.
Tricyclic antidepressants (836) or selective serotonin reuptake inhibitors (such as fluoxetine, sertraline, and paroxetine) (837) may assist in hyperactivity management, particularly in the presence of depressed affect (838). Barbiturates, used for antiepileptic therapy, have a sedative effect and aggravate hyperactivity (839). When this occurs, nonbarbiturate antiepileptic drugs should gradually be substituted. Methylxanthines such as caffeine and theophylline do not appear to have adverse behavioral effects in children. They may even have a mild positive effect on some externalizing behaviors (840).
Nonmedical Biological
Suggestions abound as to factors that might precipitate hyperactive behavior. These include fluorescent lighting; heavy metals; certain natural foods, notably sugar; and certain food additives, especially dyes. The most recent inconclusive claim is for attention problems due to prolonged television viewing (841). Food additives have been the most vigorously propagandized and therefore have been the most systematically studied (842).
Additive-free diets show little benefit in open clinical trials and even less in controlled studies. Although there is reliable evidence that an additive challenge in high dosage can impair learning in hyperactive children (843), an overview of available information suggests that restriction of additives is far less effective and less widely applicable than stimulant therapy. Nevertheless, it is occasionally worth trying. The most vigorous elimination diets appear to be the most successful (844,845), and desensitization to specific food substances also has been reported to be effective (846). An effect of sugar in rendering children irritable and restless has been reported anecdotally and in open trials but resists validation in controlled studies (847). A meta-analysis of 16 studies did not reveal any effect of sugar on children’s behavior or cognition (848). The effects of sugar on brain function are complex and interact with whether a protein or carbohydrate meal preceded the challenge (849). A balance between factors promoting and opposing the availability of tryptophan as a serotonin substrate, carbohydrates versus amino acids, should be maintained. In contrast, megavitamin treatment and trace element replacement therapy are not supported by any acceptable evidence. There is no evidence that artificial sweeteners, such as aspartame, aggravate ADHD (850).
Nonmedical Behavioral
Short courses of supportive psychotherapy are often necessary for both the child and the child’s family and can help to reduce intrafamily tensions that aggravate, or sometimes even precipitate, restless and impulsive behavior. A multimodality regime including intensive psychotherapy reduced the incidence of antisocial behavior in an ADHD cohort (851). However, in ADHD children without conduct disorder, adding multimodal psychosocial intervention did not further enhance the benefits of methylphenidate therapy (852). A recent study that compared ADHD children on stimulant therapy alone with children also afforded help through academic assistance, parent training, counseling, social skills training, and psychotherapy showed that a comprehensive outpatient treatment program for ADHD children is feasible and beneficial (853). For a detailed review of behavioral interventions, see Barkley (854).
Whereas underfocused, classically ADHD children benefit from the stimulative properties of many behavioral management techniques; the overfocused children do not. While the same structure and predictability that benefits ADHD children also benefits them, overfocused children do need less intrusive and confrontational approaches, the better to minimize their already excessive limbic arousal.
Rational management of children who are not relieved of their disability by medication rests on individual attention, frequent and consistent reward of socially acceptable behavior, consistent limit setting, and the gradual phasing in of material to be learned. Although it is possible to extinguish hyperactive behavior by operant conditioning, there is no evidence that this effect is lasting, that it generalizes, or that it is practicable to offer this labor-intensive individual management option to all but a few of the large number of ADHD children. In general, behavioral therapy should be an adjunct to effective stimulant therapy rather than the only treatment (855). Cognitive-behavioral therapy of ADHD is controversial (856,857), but parent training and school-based interventions may be effective (858,859). Children whose attentional, behavioral, or comorbid needs are not fully met by existing therapies are eligible for benefits under the Americans with Disabilities Act (860).
Prognosis
Whereas the overt restlessness of hyperactive children diminishes in adolescence, their impulsiveness and emotional lability usually persist, with a correspondingly mixed prognosis for long-term adaptive outcome. Long-term follow-up of children with ADHD shows an unfavorable outcome in many but not all. Adults who had ADHD in childhood often continue to show functional impairment (861). When aggressiveness is a feature, it particularly tends to persist (862) and appears to bear some association with early onset alcoholism (863). Impulsive aggressiveness is associated with low concentration of the serotonin metabolite 5-HIAA in cerebrospinal fluid (864). Thus, the ADHD prognosis is intermediate between that
P.1140

of control patients and the graver outlook for children with frank psychiatric disorder in childhood. Schizophrenia is not a major ADHD outcome. However, children of schizophrenic mothers, at high risk for adult schizophrenia, have been found to be prone to attentional dysfunction and poor social competence (789,865).
Attempts to relate the long-term prognosis of ADHD to psychoactive drug therapy have been so poorly controlled as to be uninterpretable. In the medium term, stimulant therapy is clearly beneficial for educational progress.
REFERENCES
1. Giedd JN, Blumenthal J, Jeffries NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 1999;2:861–863.
2. Luna B, Garver KE, Urban TA, et al. Maturation of cognitive processes from late childhood to adulthood. Child Dev 2004;75:1357–1372.
3. Bouchard TJ, Lykken DT, McGue M, et al. Sources of human psychological differences: the Minnesota study of twins reared apart. Science 1990;250:223–228.
4. Dickens WT, Flynn JR. Heritability estimates versus large environmental effects: the IQ paradox resolved. Psychol Rev 2001;108:346–369.
5. Andreasen NC, Flaum M, Swayze V 2nd, et al. Intelligence and brain structure in normal individuals. Am J Psychiatry 1993;150:130–134.
6. Gale CR, O’Callaghan FJ, Godfrey KM, et al. Critical periods of brain growth and cognitive function in children. Brain 2004;127:321–329.
7. Welsh MC, Pennington BF, Groisser DB. A normative-developmental study of executive function: a window on prefrontal function in children. Dev Neuropsychology 1991;7:131–149.
8. Bjork JM, Knutson B, Fong GW, et al. Incentive-elicited brain activation in adolescents: similarities and differences from young adults. J Neurosci 2004;24:1793–1802.
9. Denckla MB. Development of motor coordination in normal children. Dev Med Child Neurol 1974;16:729–741.
10. Kinsbourne M. Development of attention and metacognition. In: Rapin I, Segalowitz S, eds. Handbook of Neuropsychology. Amsterdam: Elsevier Science, 1993:261–278.
11. Mikkelsen EJ, Brown GL, Minichiello MD, et al. Neurological status in hyperactive, enuretic, encopretic, and normal boys. J Am Acad Child Psychiatry 1982;21:75–81.
12. Shaffer SQ, Stockman CJ, Shaffer D. Ten-year consistency in neurological test performance of children without focal neurological deficits. Dev Med Child Neurol 1986;28:417–427.
13. Woods BT, Eby MD. Excessive mirror movements and aggression. Biol Psychiatry 1982;17:23–32.
14. Rao MR, Brenner RA, Schisterman EF, et al. Long-term cognitive development in children with prolonged crying. Arch Dis Childhood 2004;89:989–992.
15. Rutter M. Syndromes attributed to “minimal brain dysfunction” in childhood. Am J Psychiatry 1982;139:21–33.
16. Gillberg C. Deficits in attention, motor control and perception: a brief review. Arch Dis Child 2003;88:904–910.
17. Gillberg C, Rasmussen P. Perceptual, motor and attentional deficits in seven-year-old children. Background factors. Dev Med Child Neurol 1982;24:752–770.
18. Piek JP, Dyek MJ, Nieman A, et al. The relationship between motor coordination, executive functioning and attention in school-aged children. Arch Clin Neuropsychol 2004;19:1063–1076.
19. Shevell MI, Majnemer A, Rosenbaum P, et al. Etiological determination of childhood developmental delay. Brain Dev 2001;23:228–235.
20. Wuu KD, Chin PC, Li SY. Chromosomal and biochemical screening of mentally retarded school children in Taiwan. Japan J Hum Genet 1991;36:267–274.
21. Allen WP, Taylor H. Mental retardation in South Carolina. VII. Inborn errors of metabolism. Proc Greenwood Genet Ctr 1996;15:76–79.
22. Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr Clin North Am 1992;39:929–943.
23. Levy SE, Hyman SL. Pediatric assessment of the child with developmental delay. Pediatr Clin North Am 1993;40:465–477.
24. First LR, Palfrey JS. The infant or young child with developmental delay. N Engl J Med 1994;330:478–483.
25. Curry CJ, Sandhu A, Fritos L, et al. Diagnostic yield of genetic evaluations in developmental delay/mental retardation. Clin Res 1996;44:130A.
26. Martin E, Boesch C, Zuerrer M, et al. MR imaging of brain maturation in normal and developmentally handicapped children. J Comput Assist Tomogr 1990;14:685–692.
27. Squires L, Krishnamoorthy KS, Natowitz MR. Delayed myelination in infants and young children: radiographic and clinical correlates. J Child Neurology 1995;10:100–104.
28. Moeschler J. The use of the CT scan in the medical evaluation of the mentally retarded child. J Pediatr 1981;98:63–65.
29. Lingham S, Kendall BE. Computed tomography in non-specific mental retardation and idiopathic epilepsy. Arch Dis Child 1983;58:628–643.
30. Root S, Carey JC. Brain dysmorphology and developmental disabilities. Proceedings of the Annual DW Smith Workshop on Malformation and Morphogenesis, 1996.
31. Kjos BO, Umansky R, Barkovich AJ. Brain MR imaging in children with developmental retardation of unknown cause: results in 76 cases. Am J Neuroradiol 1990;11:1035–1040.
32. O’Tuama LA, Dickstein DP, Neeper R, et al. Functional brain imaging in neuropsychiatric disorders of childhood. J Child Neurol 1999;14:207–221.
33. Filipek PA, Semrud-Clikeman M, Steingard RJ, et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589–601.
34. Prensky AL. An approach to the child with paroxysmal phenomena with emphasis on nonepileptic disorders. In: Dodson WE, Pellock JM, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos Publications, 1993.
35. Fedio P, Mirsky AF. Selective intellectual deficits in children with temporal lobe or centrencephalic epilepsy. Neuropsychologia 1969;7:287–300.
36. Stores G, Hart J, Piran N. Inattentiveness in school children with epilepsy. Epilepsia 1978;19:169–175.
37. Hernandez MT, Sauerwein HC, Jambaque I, et al. Deficits in executive functions and motor coordination in children with frontal lobe epilepsy. Neuropsychologia 2002;40:384–400.
38. Jambaque I, Lassonde M, Dulac O. The neuropsychology of childhood epilepsy. New York: Plenum, 1999.
40. Coplan J, Gleason JR. Quantifying language development from birth to 3 years using the Early Language Milestone scale. Pediatrics 1990;86:963–971.
41. Frankenburg WK, Dodds J, Archer P, et al. The Denver II: a major revision and restandardization of the Denver Developmental Screening test. Pediatrics 1992;89:91–97.
42. Newborg J, Stock JR, Wnek L. Batelle developmental inventory. Allen, TX: DLM Teaching Resources, 1984.
43. Bayley N. Bayley Scales of Infant Development II. New York: The Psychological Corporation, 1993.
44. Wechsler D. Wechsler preschool and primary scale of intelligence—revised. New York: Psychological Corporation, 1989.
45. Wechsler D. Wechsler intelligence scale for children—III. New York: Psychological Corporation, 1991.
46. Thorndike RL, Hagen EP, Samer JM. Guide for administering and scoring the Stanford-Binet Intelligence Scale, 4th ed. Chicago: Riverside Publishing, 1986.
47. Goodenough FL, Harris DB. Manual of the Goodenough-Harris drawing test. San Antonio: Psychological Corporation, 1963.
48. Kaufman AS, Kaufman NL. Kaufman assessment battery for children. Circle Paines, NM: American Guidance Services, 1983.
49. McCarthy D. Manual of the McCarthy scales of children’s disabilities. San Antonio: Psychological Corporation, 1972.
50. Leiter RG. The Leiter International Performance scale. California: Western Psychological Services, 1969.
P.1141

51. Achenbach TM. Manual for the Child Behavior Checklist/2–3 and 1992 profile. Burlington, VT: University of Vermont Department of Psychiatry, 1992.
52. Conners CK. Manual for Conners rating scales. North Tonawanda, NY: Multi-Health Systems, 1989.
53. Sparrow SS, Balla DA, Ciccheui DV. Vineland adaptive behavior scales. Circle Pines, MN: American Guidance Services, 1985.
54. Wilkinson GS. The wide range achievement test—revision 3, administration manual. Wilmington, DE: Wide Range, 1993.
55. Woodcock RW, Mather N. Woodcock-Johnson tests of achievement. Allen, TX: DLM Teaching Resources, 1989.
56. Dunn LM, Dunn LM. Peabody picture vocabulary test—revised. Circle Pines, MN: American Guidance Services, 1981.
57. Beery KE. The developmental test of visual-motor integration, 3rd rev. Cleveland: Modern Curriculum Press, 1989.
58. Lyon GR, Fletcher JM, Shaywitz SE. Rethinking learning disabilities. In: Finn CE Jr, Rotherham AJ, Hokanson CR Jr, eds. Rethinking special education for a new century. Washington, DC: Thomas B. Fordham Foundation and the Progressive Policy Institute, 2001:259–287.
59. McQuaid F, Alovisetti M. School psychological services for hearing-impaired children in New York and the New England area. Am Ann Deaf 1981;126:37–43.
60. Davis CJ. Perkins-Binet test of intelligence for the blind. Watertown, MA: Perkins School for the Blind, 1980.
61. Newland TE. The blind learning aptitude test. J Vis Impair Blind 1979;73:134–139.
62. Petersen MC, Kube DA, Palmer FB. Classification of developmental delays. Semin Pediatr Neurol 1998;5:2–14.
63. World Health Organization. The ICD-10: classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
64. American Association on Mental Retardation. Mental retardation: definition, classification, and systems of support, 9th ed. Washington, DC: American Association on Mental Retardation, 1992.
65. American Psychiatric Association. Diagnostic criteria from DSM-IV: diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994:63–66.
66. Hunt E. Will we be smart enough: cognitive changes in the coming workforce. New York: Russell Sage Foundation, 1995.
67. Hunter JE. Cognitive ability, cognitive aptitudes, job knowledge and job performance. J Vocatl Behav 1986;29:340–362.
68. Grossman H. Manual on terminology and classification in mental retardation. Washington, DC: American Association of Mental Retardation, 1973.
69. Reschly JD. Mental retardation: conceptual foundations, definitional criteria, and diagnostic operations. In: Hooper SR, Hynd GH, Mattison RE, eds. Developmental disorders: diagnostic criteria and clinical assessment. Hillsdale, NJ: Lawrence Erlbaum Associates, 1992:23–67.
70. Luckasson R, Borthwick-Duffy S. Mental retardation: definition, classification, and systems of support. Washington, DC: American Association on Mental Retardation, 1992.
71. Mattis S. Neuropsychological assessment of school-aged children. In: Rapin I, Segalowitz SJ, eds. Handbook of neuropsychology, Vol. 6. Child neuropsychology. Amsterdam: Elsevier, 1992:395–415.
72. Cattell RB, Cattell AKS. Handbook for the Culture-Fair Intelligence Test, Scale 2. Champaign, IL: Institute for Personality and Ability Testing, 1973.
73. Raven JC, Court JH, Raven J. Manual for Raven’s Progressive Matrices and Vocabulary Scales. Oxford, UK: Oxford Psychologists’ Press, 1996.
74. Bracken BA, McCallum RS. The Universal Nonverbal Intelligence Test. Chicago, IL, Riverside, 1997.
75. Carey JC, McMahon WM. Neurobehavioral disorders and medical genetics: an overview. In: Goldstein S, Reynolds CR, eds. Handbook of neurodevelopmental and genetic disorders in children. New York: Guilford, 1999:38–60.
76. Jones KL. Smith’s recognizable patterns of human malformation, 5th ed. Philadelphia: Saunders, 1997.
77. Turk J, Hill P. Behavioral phenotypes in dysmorphic syndromes. Clin Dysmorphol 1995;4:105–115.
78. Udwin O. A survey of adults with Williams syndrome and idiopathic infantile hypercalcemia. Dev Med Child Neurol 1990;32:129–136.
79. Gabel S, Tarter RE, Gavaler J, et al. Neuropsychological capacity of Prader-Willi children: general and specific aspects of impairment. Appl Res Ment Retard 1996;7:459–466.
80. Dykens EM, Hodapp RM, Evans DW. Profiles and development of adaptive behavior in children with Down syndrome. Am J Ment Retard 1994;98:580–587.
81. Carlesimo GB, Marotta L, Vicari S. Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down syndrome. Neuropsychologia 1997;35:71–79.
82. Spano M, Mercuri E, Rando T, et al. Motor and perceptual-motor competence in children with Down syndrome: variation in performance with age. Eur J Paediatr Neurol 1999;3:7–13.
83. Rasmussen P, Borjesson O, Wentz E, et al. Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol 2001;43:750–754.
84. Carr J. Down’s syndrome: children growing up. Cambridge: Cambridge University Press, 1995.
85. Dennis M, Jacennik B, Barnes MA. The content of narrative discourse in children and adolescents after early-onset hydrocephalus and in normally developing age peers. Brain Lang 1994;46:129–165.
85a. Hessl Y, Rivera S, Reiss AL. The neuroanatomy and neuroendocrinology of Fragile X Syndrome. Mental Retardation and Develop Disabilities Research Reviews 2004;10:17–24.
86. Wisniewski KE, French JH, Fernando S, et al. Fragile-X syndrome: associated neurological abnormality and developmental disabilities. Ann Neurol 1985;18:665–669.
87. Pennington B, Puck M, Robinson A. Language and cognitive development in 47 XXX females followed since birth. Behav Genet 1980;10:31–41.
88. Rovet JF. The psychoeducational characteristics of children with Turner’s syndrome. J Learn Disabil 1993;26:333–341.
89. Lawrence K, Kuntsi J, Coleman M, et al. Face and emotion recognition deficits in Turner syndrome: a possible role for X-linked genes in amygdala development. Neuropsychology 2003;17:39–49.
90. Rovet J, Netley C, Keenan M, et al. The psychoeducational profile of boys with Klinefelter Syndrome. J Learn Disabil 1996;29:180–196.
91. Stefanatos GA, Musikoff H. Specific neurocognitive deficits in Cornelia de Lange syndrome. J Dev Behav Pediatr 1994;15:39–43.
92. Antshel KM, Waisbren SE. Timing is everything: executive functions in children exposed to elevated levels of phenylalanine. Neuropsychology 2003;17:458–468.
93. Diamond A, Prevor M, Callender G, et al. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 1997;62:i–v, 1–208.
94. Channon S, German E, Cassina C, et al. Executive functioning, memory and learning in phenylketonuria. Neuropsychology 2004;18:613–620.
95. Rovet JF. Long-term neuropsychological sequelae of early-treated congenital hypothyroidism. Effects in adolescence. Acta Pediatrica 1999;88:88–95.
96. Antshel KM, Epstein IO, Waisbren SE. Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology 2004;18:658–664.
97. Dykens EM, Rosner BA. Refining behavioral phenotypes: personality-motivation in Williams and Prader-Willi syndromes. Am J Ment Retard 1999;104:158–169.
98. Stojanovik V, Perkins M, Howard S. Williams syndrome and specific language impairment do not support claims for developmental double dissociations and innate modularity. J Neuroling 2004;17:403–424.
99. Pinker S. Words and rules. London: Weidenfeld and Nicolson, 1999.
100. Rutter M, Graham P, Yule W. A neuropsychiatric study in childhood. Clin Dev Med 1970;35/36:1–272.
101. Borthwick-Duffy SA. Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol 1994;62:17–27.
102. Bregman JD. Current developments in the understanding of mental retardation: Part II. Psychopathology. J Am Acad Child Adolesc Psychiatry 1991;30:861–872.
P.1142

103. Crews WDJ, Bonaventura S, Rowe F. Dual diagnosis: prevalence of psychiatric disorders in a large state residential facility for individuals with mental retardation. Am J Ment Retard 1994;98:724–731.
104. Gillberg C, Persson E, Grufman M, et al. Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects. Br J Psychiatry 1986;149:68–74.
105. Matson JL, Barrett RP, Helsel WJ. Depression in mentally retarded children. Res Dev Disabil 1988;9:39–46.
106. Dawson JE, Matson JL, Cherry KE. An analysis of maladaptive behaviors in persons with autism, PDD-NOS, and mental retardation. Res Dev Disabil 1998;19:439–448.
107. Gath H, Gumley D. Behavior problems in retarded children with special reference to Down syndrome. Br J Psychiatry 1986;149:156–161.
108. Matson JL, Hamilton M, Duncan D, et al. Characteristics of stereotypic movement disorder and self-injurious behavior assessed with the Diagnostic Assessment for the Severely Handicapped (DASH-II). Res Dev Disabil 1997;18:457–469.
109. Buitelaar JK. Self-injurious behavior in retarded children: clinical phenomena and biological mechanisms. Acta Paedopsychiatrica 1993;56:105–111.
110. Carr KG, Smith CE. Biological setting events for self-injury. MRDD Research Reviews 1995;1.
111. Anderson LT, Ernst M. Self-injury in Lesch-Nyhan disease. J Autism Dev Disord 1994;24:67–81.
112. Matthews WS, Solan A, Barabas G. Cognitive functioning in Lesch-Nyhan syndrome. Dev Med Child Neurol 1995;37:715–722.
113. Whitman BY, Accardo P. Emotional symptoms in Prader-Willi syndrome adolescents. Am J Med Genet 1987;28:897–905.
114. Curfs LM, Fryos JP. Prader-Willi syndrome: a review with special attention to the cognitive and behavioral profile. Birth Defects: Original Article Series 1992;28:99–104.
115. Hagberg B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatrica 1995;84:971–976.
116. Papolos DF, Faedda GL, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardiofacial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996;153:1541–1547.
117. Motzkin B, Marion R, Goldberg R, et al. Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 1993;123:406–410.
118. Udwin O, Yule W. Expressive language of children with Williams syndrome. Am J Med Genet 1990;6:108–114.
119. Rossen ML, Samat HB. Why should neurologists be interested in Williams syndrome? [Editorial] Neurology 1998;5:8–9.
120. Marcus LC, Keens GT, Bautista BD, et al. Obstructive sleep apnea in children with Down Syndrome. Pediatrics 1991;88:132–139.
121. Andreou G, Galanopoulou C, Gourgoulianis K, et al. Cognitive status in Down syndrome individuals with sleep disordered breathing deficits (SDB). Brain Cogn 2002;50:145–149.
122. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry 2003;64:1195–1200.
123. Bassett AS, Hodgkinson K, Chow EWC, et al. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998;81:328–337.
124. Gothelf D, Gruber R, Pesburger G, et al. Methylphenidate treatment for attention-deficit/hyperactivity disorder of children and adults with velocardiofacial syndrome: an open label study. J Clin Psychiatry 2003;64:1163–1169.
125. McAuley E, Ross R, Kushner H, et al. Self-esteem and behavior in girls with Turner syndrome. J Dev Behav Ped 1995;16:82–88.
126. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996;334:1568–1572.
127. Down syndrome prevalence at birth: United States 1983–1990. MMWR Morb Mortal Wkly Rep 1994;43:617–622.
128. Steele J, Stratford B. The United Kingdom population with Down syndrome: present and future projections. Am J Ment Retard 1995;99:664–682.
129. Str⊘mme P, Valvatne K. Mental retardation in Norway: prevalence and sub-classification in a cohort of 30,037 children born between 1980 and 1985. Acta Paediatr 1998;87:291–296.
130. Hagberg B, Hagberg G, Lewerth A, et al. Mild mental retardation in Swedish school children. II. Etiologic and pathogenetic aspects. Acta Paediatr Scand 1981;70:445–452.
131. Murphy CC, Yeargin-Allsopp M, Decoufle P, et al. The administrative prevalence of mental retardation in 10-year-old children in Atlanta, 1985 through 1987. Am J Public Health 1995;85:319–323.
132. Brett EM, Goodman R. Mental retardation, infantile autism, and related disorders. In: Brett EM, ed. Paediatric neurology. London: Churchill Livingstone, 1997:406–423.
133. McLaren J, Bryson SE. Review of recent epidemiological studies of mental retardation: prevalence, associated disorders, and etiology. Am J Ment Retard 1987;92:243–254.
134. Eyman RK, Grossman HJ, Chaney RH, et al. Survival of profoundly disabled people with severe mental retardation. Am J Dis Child 1993;147:329–336.
135. Plioplys AV, Kasnocka I, Lewis S, et al. Survival rates among children with severe neurological disabilities. South Med J 1998;19:161–172.
136. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay. Neurology 2003;11:367–380.
137. Gustavson KH, Hagberg B, Hagberg G, et al. Severe mental retardation in a Swedish county. II. Etiologic and pathogenetic aspects of children born 1959–1970. Neuropaediatrie 1977;8:293–304.
138. Nelson KB. What proportion of cerebral palsy is related to birth asphyxia? J Pediatr 1988;112:572–573.
139. Gaffney G, Sellers S, Flavell V, et al. Case-control study of intrapartum care, cerebral palsy, and perinatal death. BMJ 1994;308:743–750.
140. Torfs CP, van den Berg B, Oechsli FW, et al. Prenatal and perinatal factors in the etiology of cerebral palsy. J Pediatr 1990;116:615–619.
141. Watemberg N, Silver S, Harel S, et al. Significance of microcephaly among children with developmental disabilities. J Child Neurol 2002;17:117–122.
142. McAnulty GB, Hicks RE, Kinsbourne M. Personal and familial sinistrality in relation to degree of mental retardation. Brain Cogn 1984;3:349–356.
143. Laxova R, Ridler MAC. An etiologic survey of the severely retarded Hertfordshire children who were born between January 1, 1965 and December 31, 1967. Am J Med Genet 1977;1:75–86.
144. Opitz JM, Kaveggia EG, Laxova R, et al. The diagnosis and prevention of severe mental retardation. Proceedings, lnternational Conference on Preventable Aspects of Genetic Morbidity, 1982, Cairo, ll.
145. Fryns JP, Kleczkowska A, Dereymaeker A, et al. A genetic diagnostic survey in an institutionalized population of 173 severely mentally retarded patients. Clin Genet 1986;30:315–323.
146. McQueen PC, Spence MW, Winsor EJ, et al. Causal origins of major mental handicap in the Canadian mountain provinces. Dev Med Child Neurol 1986;28:697–707.
147. Wellesley D, Hockey A, Stenely F. The aetiology of intellectual disability in westem Australia: a community-based study. Dev Med Child Neurol 1991;33:963–973.
148. Yeargin-Allsopp M, Murphy CC, Cordero JF, et al. Reported biomedical causes and associated medical conditions for mental retardation among 10-year-old children, metropolitan Atlanta, 1985 to 1987. Dev Med Child Neurol 1997;39:142–149.
149. Flint J, Wilkie AO. The genetics of mental retardation. Br Med Bull 1996;52:453–464.
150. Mirrett PL, Bailey DB, Roberts JE, et al. Developmental screening and detection of developmental delays in infants and toddlers with fragile X syndrome. J Dev Behav Ped 2004;25:21–27.
151. Mutch L, Leyland A, McGee A. Patterns of neuropsychological function in a low birth weight population. Dev Med Child Neurol 1993;35:943–956.
152. Breslau N, Paneth NS, Lucia VC. The lingering academic deficits of low birth weight children. Pediatrics 2004;114:1035–1040.
153. Vicari S, Caravale B, Carlesimo GA, et al. Spatial working memory in children at ages 3–4 who were low birth weight preterm infants. Neuropsychology 2004;18:673–678.
154. Hopkins-Golightly T, Raz S, Sander CJ. Influence of slight to moderate risk for birth anoxia on acquisition of cognitive and language function in the pretern infant: a cross-sectional comparison with preterm-birth controls. Neuropsychology 2003;17:3–13.
P.1143

155. Short EJ, Klein NK, Lewis BA, et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003;112:e359.
156. Casaer P, de Vries L, Marlow N. Prenatal and perinatal risk factors for psychological development. In: M Rutter, P Casaer, eds. Biological risk factors for psychosocial disorders. Cambridge: Cambridge University Press, 1991:139–174.
157. Johnston MV, Trescher WH, Taylor GA. Hypoxic and ischemic nervous system disorders in infants and children. Adv Pediatr 1995;42:1–45.
158. Foulder-Hughes LA, Cooke RW. Motor, cognitive and behavioural disorders in children born very preterm. Dev Med Child Neurol 2003;45:97–103.
159. Williams CE, Gunn AJ, Mallard C, et al. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann Neurol 1992;31:14–21.
160. Taylor HG, Minich N, Bangert B, et al. Long-term neuropsychological outcomes of very low birth weight: associations with early risks for periventricular brain insults. J Int Neuropsychol Soc 2004;10:987–1004.
161. Hunt CE, Corwin MJ, Baird T, et al. Cardiorespiratory events detected by home monitoring and one year neurodevelopmental outcome. J Pediatr 2004;145:465–471.
162. Gottlieb DL, Chase C, Vezina RM, et al. Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J Pediatr 2004;145:458–464.
163. Dowdeswell HJ, Slater AM, Broomhall J, et al. Visual deficits in children born at less than 32 weeks’ gestation with and without major ocular pathology and cerebral damage. Br J Ophthalmol 1995;79:447–452.
164. Isaacs EB, Lucas A, Chong WK, et al. Hippocampal volume and everyday memory in children of very low birth weight. Pediatr Res 2000;47:713–720.
165. Nosarti C, Al-Asady MH, Frangou S, et al. Adolescents who were born very preterm have decreased brain volumes. Brain 2002;125:1616–1623.
166. Peterson BS, Anderson AW, Ehrenkrantz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939–948.
167. Christ SE, White DA, Brunstrom JE, et al. Inhibitory control following perinatal brain injury. Neuropsychology 2003;17:171–178.
168. Vargha-Khadem F, Isaacs E, van der Werf S, et al. Development of intelligence and memory in children with hemiplegic cerebral palsy. The deleterious consequences of early seizures. Brain 1992;115:315–329.
169. Stiles J. Neural plasticity and cognitive development. Dev Neuropsychol 2000;18:237–272.
170. Breslau N, Chilcoat HD. Psychiatric sequelae of low birth weight at 11 years of age. Biol Psychiatry 2000;47:1005–1011.
171. Max JE, Mathews K, Manes FF, et al. Attention deficit hyperactivity disorder and neurocognitive correlates after childhood stroke. J Int Neuropsychol Soc 2003;9:815–829.
172. Gross-Tsur V, Shalev RS, Badihi N, et al. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD). J Child Neurol 2002;17:863–866.
173. Stratton K, Howe C, Bataglia F. Fetal alcohol syndrome: diagnosis, epidemiology and treatment. Washington, DC: National Academy Press, 1996.
174. Frank DA, Augustyn M, Knight WG, et al. Growth, development and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001;285:1613–1625.
175. Brown JV, Bakeman R, Coles CD, et al. Prenatal cocaine exposure: a comparison of 2-year-old children in parental and non-parental care. Child Dev 2004;1282–1295.
176. Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Devel Med Child Neurol 1994;36:361–369.
177. Bellinger DC. Lead. Pediatrics 2004;113:1016–1022.
178. Schroeder SR, Hawk B, Otto DA, et al. Separating the effects of lead and social factors on IQ. Environ Res 1985;38:144–154.
179. Pocock SJ, Smith M, Baghurst P. Environmental lead and children’s intelligence: a systematic review of the epidemiological literature. BMJ 1994;309:1189.
180. Kaufman AS. Do low levels of lead produce IQ loss in children? A careful examination of the literature. Arch Clin Neuropsychology 2001;6:403–431.
181. Needleman HL, Bellinger D. Studies of lead exposure and the developing central nervous system. A reply to Kaufman. Arch Clin Neuropsychology 2001;6:359–374.
182. Lanphear BP, Dietrich K, Auinger P, et al. Cognitive deficits associated with blood lead concentrations <10 ug/dl in US children and adolescents. Public Health Report 2000;115:521–529.
183. Canfield RL, Henderson CR, Cory–Slechta DA, et al. Intellectual impairment in children with blood lead concentrations below 10 ug per deciliter. N Engl J Med 2003;348:1517–1526.
184. Minder B, Das-Smaal EA, Orlebeke JF. Cognition in children does not suffer from very low lead exposure. J Learn Disabil 1998;31:494–502.
185. Stone BM, Reynolds CR. Can the National Health and Nutrition Examination Survey III (NHANES III) data help resolve the controversy over low lead levels and neuropsychological development in children? Arch Clinical Neuropsychology 2003;18:219–244.
186. O’Carroll RE, Masterton G, Dougall N, et al. The neuropsychiatric sequelae of mercury poisoning. The mad hatter’s disease revisited. Brit J Psychiatry 1995;167:95–98.
187. Warkany J, Hubbard DM. Acrodynia and mercury. J Pediatrics 1953;42:365–386.
188. National Research Council. Toxicological effects of methylmercury. Washington, DC: National Academy Press, 2000.
189. Takeuchi T, Eto K. The pathology of Minimata disease. Japan: Fukuoka Kyushi University Press, 1999.
190. Fukuda Y, Ushijima K, Kitano T, et al. An analysis of subjective complaints in a population living in a methylmercury-polluted area. Environ Res 1999;81:100–107.
191. Bakir F, Rustam H, Tikriti S, et al. Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J 1980;56:1–10.
192. Davis LE, Kornfeld M, Mooney HS, et al. Methylmercury poisoning: long-term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol 1994;35:680–688.
193. Myers GJ, Davidson PW. Prenatal methylmercury exposure and children: neurologic, developmental, and behavioral research. Environ Health Perspect 1998;3:841–847.
194. Grandjean P, Weihe P, White RF, et al. Cognitive performance of children prenatally exposed to “safe” levels of methylmercury. Environ Res A 1998;77:165–172.
195. Weiss B, Clarkson TW, Simon W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 2002;5:851–854.
196. Jacobson JL, Jacobson SW. Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 2003;143(6):780–788.
197. Vreugdenhil HJ, Lanting CI, Mulder PG, et al. Effects of prenatal PCB and dioxin background exposure on cognitive and motor abilities in Dutch children at school age. J Pediatr 2002;140:48–56.
198. Eskenazi B, Bradman A, Castorina R. Exposures of children to organophosphate pesticides and their potential adverse health effects. Environ Health Perspect 1999;107:409–419.
199. Miller RW. Delayed radiation effects in atomic bomb survivors. Science 1969;166:569–574.
200. Dekaban AS. Abnormalities in children exposed to x-radiation and during various stages of gestation: tentative timetable of radiation injury to the human fetus, Part I. J Nucl Med 1968;9:471–477.
201. Uchida IA, Holunga R, Lawler C. Maternal radiation and chromosomal aberrations. Lancet 1968;2:1045–1049.
202. Lozoff B. Nutrition and behavior. Am Psychol 1989;44:231–236.
203. Bronfenbrenner U, McClelland PD, Ceci S, et al. The state of Americans. New York: The Free Press, 1996.
204. Kiely M. The prevalence of mental retardation. Epidemiol Rev 1987;9:194–228.
205. Roeleveld N, Zielhuis GA, Gabreels F. The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol 1997;39:125–132.
206. Patterson CJ, Kupersmidt JB, Vaden NA. Income level, gender, ethnicity, and household composition as predictors of children’s school-based competence. Child Dev 1990;61:485–494.
P.1144

207. Aber JL, Bennett NG, Conley DC, et al. The effects of poverty on child health and development. Annu Rev Public Health 1997;18:463–483.
208. Ramer JC, Miller G. Overview of mental retardation. In: Miller G, Ramer JC, eds. Static encephalopathies of infancy and childhood. New York: Raven Press, 1992:1–10.
208a. National Institute of Child Health and Human Development Early Child Care Research Network. Duration and developmental timing of children’s cognitive and social development from birth through third grade. Child Develop 2005;76:795–810.
209. Kim-Cohen J, Moffitt TE, Caspi A, et al. Genetic and environmental processes in young children’s resilience and vulnerability to socioeconomic deprivation. Child Dev 2004;75:651–668.
210. Spitz RA. Hospitalism. Psychoanal Stud Child 1945;1:53–74.
211. Gunnar MR. Effects of early deprivation: findings from orphanage-reared infants and children. In: Nelson CA, Luciani M, eds. Handbook of developmental cognitive neuroscience. Cambridge, MA: MIT Press, 2001:617–630.
212. Zeanah CH, Nelson CA, Fox NA, et al. Designing research to study the effects of institutionalization on brain and behavior development: the Bucharest Early Intervention Program. Dev Psychopathol 2003;15:885–907.
213. Chisholm K. A three-year follow-up of attachment and indiscriminate friendliness in children adopted from Romanian orphanages. Child Dev 1998;69:1092–1106.
214. Chugani HT, Behen ME, Muzik O, et al. Local brain functional activity following early deprivation: a study of postinstitutionalized Romanian orphans. Neuroimage 2001;14:290–301.
215. Marshall PJ, Fox NA, BEIP Core Group. A comparison of the electroencephalogram between institutionalized and community children in Romania. J Cogn Neurosci 2004;16:1327–1338.
216. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549–555.
217. Kovacs M, Goldstone D, Iyengar S. Intellectual development and academic performance of children with insulin-dependent diabetes mellitus: a longitudinal study. Dev Psychol 1992;28:676–684.
218. Grantham-McGregor SM, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 2001;131:649S–668S.
219. Halterman JS, Kaczorowsky JM, Aligne CA, et al. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107:1381–1386.
220. Aman MG, Kern RA, McGhee DE, et al. Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects. J Am Acad Child Adolesc Psychiatry 1993;32:851–859.
221. Campbell M, Cueva JE. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years, Part I. J Am Acad Child Adolesc Psychiatry 1995;34:1124–1132.
222. Herman BH, Hammock MK, Arthur-Smith A, et al. Naltrexone decreases self-injurious behavior. Ann Neurol 1987;22:550–552.
223. Barnes TR. Tardive dyskinesia. BMJ 1988;296:150–151.
224. Swanson JM, Christian DL, Wigal T, et al. Tardive dyskinesia in a developmentally disabled population: manifestation during the initial stage of a minimal effective-dose program. Exp Clin Psychopharmacol 1996;4:1–6.
225. Ottenbacher K, Petersen P. The efficacy of early intervention programs for children with organic handicaps. Eval Prog Plan 1985;8:135.
226. Dodrill CB. Neuropsychology. In: Laidlaw J, Richens A, Chadwick D, eds. A textbook of epilepsy, 4th ed. New York: Churchill Livingstone, 1993:459–473.
227. Mayeux R, Brandt J, Rosen J, et al. Interictal and language impairment in temporal lobe epilepsy. Neurology 1980;30:120–125.
228. Caplan R, Siddarth P, Gurbani S, et al. Psychopathology and pediatric complex partial seizures: seizure-related, cognitive and linguistic variables. Epilepsia 2004;45:1273–1281.
229. Rapin I, Katzman R. Neurobiology of autism. Ann Neurol 1998;43:7–14.
230. Wing L. The autistic spectrum. Lancet 1997;350:1761–1766.
231. Pervasive developmental disorders. In: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994:65–78.
232. Folstein SE, Rutter ML. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977;18:297–321.
232a. Bolton PF, Murphy M, Macdonald H, et al. Obstetric complications in autism. Consequences or causes of the condition. J Aner Head Child Adoles Psychiat 1997;36:272–281.
233. Gillberg C, Gillberg IC. Infantile autism: a total population study of reduced optimality in the pre-, peri-, and neonatal period. J Autism Dev Disord 1983;13:153–166.
234. Tsai LY, Stewart MA. Etiological implication of maternal age and birth order in infantile autism. J Autism Dev Disord 1983;13:57–65.
235. Bryson SE, Smith IM, Eastwood D. Obstetrical suboptimality in autistic children. J Am Acad Child Adolesc Psychiatry 1988;27:418–422.
236. Mason-Brothers A, Ritvo ER, Pingree C, et al. The UCLA–University of Utah epidemiologic survey of autism: prenatal, perinatal, and postnatal factors. Pediatrics 1990;86:514–519.
237. Ritvo ER, Jorde LB, Mason-Brothers A, et al. The UCLA–University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 1989;146:1032–1036.
238. Wolff S, Narayan S, Moyes B. Personality characteristics of parents of autistic children: a controlled study. J Child Psychol Psychiatry 1988;29:143–153.
239. Steffenberg S, Gillberg C. Autism and autistic-like conditions in Swedish rural and urban areas: a population study. Br J Psychiatry 1986;149:81–87.
240. Bolton P, Macdonald H, Pickles A, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994;35:877–900.
241. Ritvo ER, Freeman BJ, Mason-Brothers A, et al. Concordance for the syndrome of autism in 40 pairs of afflicted twins. Am J Psychiatry 1985;142:74–77.
242. Steffenberg S, Gillberg C, Holmgren L. A twin study of autism in Denmark, Finland, Iceland, Norway, and Sweden. J Child Psychol Psychiatry 1989;30:405–416.
243. Piven J, Gayle J, Chase GA, et al. A family history study of neuropsychiatric disorders in the adult siblings of autistic individuals. J Am Acad Child Adolesc Psychiatry 1990;29:177–183.
244. Gillberg C, Gillberg IC, Steffenburg S. Siblings and parents of children with autism: a controlled population-based study. Dev Med Child Neurol 1992;34:389–398.
245. Philippe A, Martinez M, Guilloud-Bataille M, et al. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 1999;8:805–812.
246. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol 1996;38:191–202.
247. Ritvo ER, Mason-Brothers A, Freeman BJ, et al. The UCLA–University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry 1990;147:1614–1621.
248. Schroer RJ, Phelan MC, Michaelis RC, et al. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 1998;76:327–333.
249. Reiss AL, Feinstein C, Rosenbaum KN, et al. Autism associated with Williams syndrome. J Pediatrics 1985;106:247–249.
250. Gillberg C, Rasmussen P. Brief report: four case histories and a literature review of Williams syndrome and autistic behavior. J Autism Dev Disord 1994;24:381–393.
251. Bundey S, Hardy C, Vickers S, et al. Duplication of the 15q11-13 region in a patient with autism, epilepsy, and ataxia. Dev Med Child Neurol 1994;36:736–742.
252. Gurrieri F, Battaglia A, Torrisi L, et al. Pervasive developmental disorder and epilepsy due to maternally derived duplication of 15q11-q13. Neurology 1999;52:1694–1697.
253. Graf WD, Marin-Garcia J, Gao HG, et al. Autistic regression associated with a mutation in the mitochondrial tRNAlys gene (G8363A). Ann Neurol 1998;44:578.
254. Rogers SJ, Newhart-Larson S. Characteristics of infantile autism in five children with Leber’s congenital amaurosis. Dev Med Child Neurol 1989;31:598–608.
255. McKusick VA. Mendelian inheritance in man: catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes. Baltimore: The Johns Hopkins University Press, 1992:1893–1894.
256. Reiss AL, Freund L. The behavioral phenotype of fragile X syndrome: DSM-111-R autistic behavior in males. Am J Med Genet 1992;43:35–46.
P.1145

257. Singh VK, Fudenberg HH, Emerson D, et al. Immunodiagnosis and immunotherapy in autistic children. Ann NY Acad Sci 1988;540:602–604.
258. Zimmerman A, Frye V, Potter N. Immunological aspects of autism. Int Pediatr 1993;8:199–204.
259. Todd RD, Hickok JM, Anderson GM, et al. Antibrain antibodies in infantile autism. Biol Psychiatry 1988;23:644–647.
260. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637–641.
261. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971;1:33–47.
262. Ivarsson SA, Bjerre I, Vegfors P, et al. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990;21:102–103.
263. Lowe TL, Tanaka K, Seashore MR, et al. Detection of phenylketonuria in autistic and psychotic children. JAMA 1980;243:126–128.
264. Rutter M, Bartak L. Causes of infantile autism: some considerations from recent research. J Autism Child Schizophr 1971;1:20–32.
265. Kotsopoulos S, Kutty KM. Histidinemia and infantile autism. J Autism Dev Disord 1979;9:55–60.
266. Gillberg I, Gillberg C, Kopp S. Hypothyroidism and autism spectrum disorders. J Child Psychol Psychiatry 1992;33:531–542.
267. D’Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Pediatr 1996;85:1076–1079.
268. Rapin I. Autism in search of a home in the brain. Neurology 1999;52:902–904.
269. Courchesne E, Yeung-Courchesne R, Press GA, et al. Hypoplasia of cerebellar lobules Vl and Vll in infantile autism. N Engl J Med 1988;318:1349–1354.
270. Murakami JW, Courchesne E, Press GA, et al. Reduced cerebellar hemisphere size and its relationship to vermal hypoplasia in autism. Arch Neurol 1989;46:689–694.
271. Holttum JR, Minshew NJ, Sanders RS, et al. Magnetic resonance imaging of the posterior fossa in autism. Biol Psychiatry 1992;32:1091–1101.
272. Kleiman MD, Neff S, Rosman NP. The brain in infantile autism: are posterior fossa structures abnormal? Neurology 1992;42:753–760.
273. Garber HJ, Ritvo ER. Magnetic resonance imaging of the posterior fossa in autistic adults. Am J Psychiatry 1992;149:245–247.
274. Piven J, Saliba K, Bailey J, et al. An MRI study of autism: the cerebellum revisited. Neurology 1997;49:546–551.
275. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998;57:645–652.
276. Minshew NJ, Luna B, Sweeney JA. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Neurology 1999;52:917–922.
277. Bailey A, Luthert P, Dean A. A clinicopathological study of autism. Brain 1998;121:889–905.
278. Piven J, Berthier ML, Starkstein SE, et al. Magnetic resonance imaging evidence for a defect of cerebral cortical development in autism. Am J Psychiatry 1990;147:734–739.
279. Bauman M, Kemper T. Neuroanatomic observations of the brain in autism. In: Bauman M, Kemper T, eds. The neurobiology of autism. Baltimore: The Johns Hopkins University Press, 1994:119–145.
280. Horwitz B, Rumsey JM, Grady CL, et al. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Arch Neurol 1988;45:749–755.
281. Jacobson R, Le Couteur A, Howlin P, et al. Selective subcortical abnormalities in autism. Psychol Med 1988;18:39–48.
282. Prior MR, Tress B, Hoffman WL, et al. Computed tomographic study of children with classic autism. Arch Neurol 1984;41.
283. Creasey H, Rumsey JM, Schwartz M, et al. Brain morphometry in autistic men as measured by volumetric computed tomography. Arch Neurol 1986;43:669–672.
284. Fombonne E, Roge B, Claverie J, et al. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999;29:113–119.
285. Minshew NJ. Indices of neural function in autism: clinical and biologic implications. Pediatrics 1991;87:774–780.
286. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children. II. Epilepsy. Pediatrics 1991;88:1219–1225.
287. Bauman ML, Kemper TL. Abnormal cerebellar circuitry in autism? Neurology 1989;39:186.
288. Gaffney GR, Kuperman S, Tsai LY, et al. Morphological evidence of brain stem involvement in infantile autism. Biol Psychiatry 1988;24:578–586.
289. Hsu M, Yeung-Courchesne R, Courchesne E, et al. Absence of magnetic resonance imaging evidence of pontine abnormalities in infantile autism. Arch Neurol 1991;48:1160–1163.
290. Anderson GM, Freedman DX, Cohen DJ, et al. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885–900.
291. McDougle CJ, Naylor ST, Goodman WK, et al. Acute tryptophan depletion in autistic disorder: a controlled case study. Biol Psychiatry 1993;33:547–550.
292. Cook EH, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr 1996;8:348–354.
293. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666–669.
294. Gillberg C, Svennerholm L. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 1987;151:89–94.
295. Ross DL, Klykylo WM, Anderson GM. Cerebrospinal fluid indoleamine and monoamine effects in fenfluramine treatment of autism. Ann Neurol 1985;18:394.
296. Narayan M, Srinath S, Anderson GM, et al. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 1993;33:630–635.
297. Lake CR, Ziegler MG, Murphy DL. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry 1977;34:553–556.
298. Leventhal BL, Cook EH Jr, Morford M, et al. Relationships of whole blood serotonin and plasma norepinephrine within families of autistic children. J Autism Dev Disord 1990;20:499–511.
299. Minderaa RB, Anderson GM, Volkmar FR, et al. Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 1994;36:237–241.
300. Kalat JW. Speculation on similarities between autism and opiate addiction. J Autism Child Schizophr 1978;8:477–479.
301. Ross DL, Klykylo WM, Hitzemann R. Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autism. Pediatr Neurol 1987;3:83–86.
302. Coid J, Allolio B, Rees LH. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1983;2:545–546.
303. Herman B. A possible role of proopiomelanocortin peptides in self-injurious behavior. Prog Neuropsychopharmacol Biol Psychiatry 1990;14[Suppl]:S109–139.
304. Gillberg C. Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 1995;37:239–245.
305. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217–250.
306. Bishop DMV. Autism, Asperger’s syndrome and semantic-pragmatic disorder: where are the boundaries? Br J Disord Commun 1989;24:107–121.
307. Bolton P, Macdonald H, Pickels A, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994;35:877–900.
308. Bailey A, LeCouteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63–77.
309. Kurita H. Infantile autism with speech loss before the age of 30 months. J Amer Acad Child Psychiatry 1985;24:191–196.
310. Lord C, Shulman C, DiLavore P. Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry 2004;45:936–955.
311. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2003;25:377–382.
312. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform encephalogram correlates. Pediatrics 1997;99:560–566.
313. Rogers SJ. Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev 2004;10:139–143.
314. Rice D, Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000;108[Suppl 3]:511–533.
P.1146

315. Baron-Cohen S, Cox A, Baird G, et al. Psychological markers in the detection of autism in infancy in a large population. Br J Psychiatry 1996;168:158–163.
316. Osterling J, Dawson G. Early recognition of children with autism: a study of first birthday home video tapes. J Autism Dev Disord 1994;24:247–257.
317. Miles JH, Hillman RE. Value of a clinical morphology examination in autism. Am J Med Genet 2000;91:245–253.
318. Bauman ML. Motor dysfunction in autism. In: Joseph AB, Young RR, eds. Movement disorders in neurology and neuropsychiatry. Boston: Blackwell Science, 1992:658–661.
319. Lovaas O, Koegel R, Schreibman L. Stimulus overselectivity in autism: a review of research. Psychol Bull 1979;86:1236–1254.
320. Smith IM, Bryson SE. Imitation in autism. Cogn Neuropsychol 1998;15:747–771.
321. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children: clinical characteristics. Pediatrics 1991;88:1211–1218.
322. Rapin I, Dunn M. Language disorders in children with autism. Semin Pediatr Neurol 1997;4:86–92.
323. Tirosh E, Canby J. Autism with hyperlexia: a distinct syndrome? Am J Ment Retard 1993;98:84–92.
324. Grigorenko EL, Klin A, Pauls DL, et al. A descriptive study of hyperlexia in a clinically referred sample of children with developmental delays. J Autism Dev Disord 2003;32:3–12.
325. Liss C, Saulnier C, Fine D, et al. Sensory and attention abnormalities in autistic spectrum disorders. Autism, in press.
326. Kinsbourne M. Overfocusing: an apparent subtype of attention-deficit hyperactivity disorder. In: Amir N, Rapin I, Branski D, eds. Pediatric neurology: behavior and cognition of the child with brain dysfunction. Basel: Karger, 1991:18–35.
326a. Mann TA, Walker P. Autism and a deficit in broadening the spread of visual attention. J Child Psychol Psychiatry 2003;44:274–284.
326b. Frith U. Autism explaing the enigma. Oxford, Blackwell, 1989.
326c. Hermelin B, O’Connor N. Idiot savant calendrical calculators: rules and regularities. Psychol Med 1986;16:885–893.
326d. Happe FGE. Central coherence and theory of mind in autism: reading homographs in context. Brit J Develop Psychol 1997;15:1–12.
327. Boucher J, Lewis V. Unfamiliar face recognition in relatively able autistic children. J Child Psychol Psychiatry 1992;33:843–859.
328. Dawson G, Meltzoff AN, Osterling J, et al. Children with autism fail to orient to naturally occurring social stimuli. J Autism Dev Disord 1998;28:479–485.
329. Volkmar FR. The disintegrative disorders: childhood disintegrative disorder and Rett’s disorder. In: Volkmar FR, ed. Psychoses and pervasive developmental disorders in childhood and adolescence. Washington, DC: American Psychiatric Press, 1996:223–248.
330. Wing L. Asperger’s syndrome: a clinical account. Psych Rev 1981;11:115–129.
331. Baltaxe CAM, Simmons JQI. A comparison of language issues in high-functioning autism and related disorders with onset in childhood and adolescence. In: Schopler E, Mesibov GB, eds. High-functioning individuals with autism. New York: Plenum Publishing, 1991:201–225.
332. Rumsey JM, Hamburger SD. Neuropsychological findings in high-functioning men with infantile autism, residual state. J Clin Exp Neuropsychol 1988;10:201–222.
332a. Lord C, Rutter M, LeCouteur A. Interviw—Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659–685.
332b. Lord C, Risi S, Lambrecht L, et al. The Autism Diagnostic observation schedule—generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000;30:205–223.
333. Charman T, Baron-Cohen I, Baird G, et al. Commentary: the modified checklist for autism in toddlers. J Autism Dev Disord 2001;31:145–148.
334. Rogers SJ, DiLalla DL. Age of symptom onset in young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1990;29:863–872.
335. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63–77.
336. Wing L. The definition and prevalence of autism: a review. Eur Child Adol Psychiatry 1993;2:61–74.
337. Shapiro T, Hertzig ME. Social deviance in autism: a central integrative failure as a model for social nonengagement. Psychiatr Clin North Am 1991;14:19–32.
338. Ehlers S, Gillberg C. The epidemiology of Asperger’s syndrome: a total population study. J Child Psychol Psychiatry 1993;34:1327–1350.
339. Honda H, Shimizu Y, Misumi K, et al. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry 1996;169:228–235.
340. Webb EVJ, Lobo S, Hervas A, et al. The changing prevalence of autistic disorder in a Welsh health district. Dev Med Child Neurol 1997;39:150–152.
341. Bertrand J, Mars A, Boyle C, et al. Prevalence of autism in a United States population: the Brick township, New Jersey, investigation. Pediatrics 2001;108:1155–1161.
342. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285:3093–3099.
343. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev 2002;8:151–161.
344. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003;33:365–382.
345. Yeargin-Allsopp M, Rice C, Karapurkar T, et al. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49–55.
346. Croen LA, Grether JK, Selvin S. Descriptive epidemiology of autism in a California population: who is at risk? J Autism Dev Disord 2002;32:217–224.
347. Blaxill MF. What’s going on? The question of time trends in autism. Public Health Rep 2004;119:536–551.
348. Mandell DS, Thompson WW, Weintraub ES, et al. Trends in diagnosis rates for autism and ADHD at hospital discharge in the context of other psychiatric diagnoses. Psychiatr Serv 2005;56:56–62.
349. Bettelheim B. The empty fortress: infantile autism and the birth of the self. New York: Free Press, 1967.
350. Baird TD, Augus TGJ. Familial heterogeneity in infantile autism. J Autism Dev Disord 1985;15:315–321.
351. Ritvo ER, Jorde LB, Mason-Brothers A, et al. The UCLA–University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 1989;146:1032–1036.
352. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63–77.
353. Wassink TH, Piven J. The molecular genetics of autism. Curr Psychiatry Rep 2000;2:170–175.
354. Carper RA, Moses P, Tigue ZD, et al. Cerebral lobes in autism: early hyperplasia and abnormal age effects. NeuroImage 2002;1038–1051.
354a. Aylward EH, Minshew NJ, Field K, et al. Effects of age on brain volume and head circumference in autism. Neurol 2002;59:175–183.
355. Herbert MR, Ziegler DA, Makris N, et al. Localization of white matter volume increase in autism and developmental language disorder. Annals Neurol 2004;55:530–540.
356. Lainhart JE. Increased rate of head growth during infancy in autism. JAMA 2003;290:393–394.
357. Rapin I. Autism in search of a home in the brain. Neurology 1999;52:902–904.
358.
359. DeLong GR. Autism: new data suggest a new hypothesis. Neurology 1999;52:911–916.
360. Minshew NJ, Luna B, Sweeney JA. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Neurology 1999;52:917–922.
361. Courchesne E, Townsend J, Saitoh O. The brain in infantile autism: posterior fossa structures are abnormal. Neurology 1994;44:214–223.
362. Bailey A, Luthert P, Dean A. A clinicopathological study of autism. Brain 1998;121:889–905.
P.1147

363. Palmen SJMC, Engeland H van, Hop PR, et al. Neuropathological findings in autism. Brain 2004;127:2572–2583.
364. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2003;25:377–382.
365. Damasio AR, Maurer RG. A neurological model for childhood autism. Arch Neurol 1978;35:777–786.
366. Bishop DVM. Autism, executive functions and theory of mind: a neurological perspective. J Child Psychol Psychiatry 1993;34:279–293.
367. Bachevalier J. An animal model for childhood autism: memory loss and socioemotional disturbances following damage to the limbic system in monkeys. In: Tammiga CA, Schultz SC, eds. Advances in neuropsychiatry and psychopharmacology, Vol. 1. Schizophrenia Research. New York: Raven Press, 1991:129–140.
368. Kinsbourne M. Cerebral-brain stem relations in infantile autism. In: Schopler E, Mesibov GB, eds. Neurobiological issues in autism. New York: Plenum, 1987:107–125.
369. Casanova MF, Buxhoeveden DP, Switala AE, et al. Minicolumnar pathology in autism. Neurology 2002;58:428–432.
370. Belmonte MK, Yurgelun-Todd DA. Functional anatomy of impaired selective attention and compensatory processing in autism. Brain Res Cogn Brain Res 2003;17:651–664.
371. Just MA, Cherkassky VL, Keller TA, et al. Cortical activation and synchronization during sentence completion in high-functioning autism: evidence of underconnectivity. Brain 2004;127:1811–1821.
372. Hagberg B, Aicardi J, Dias K, et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett syndrome. Report of 35 cases. Ann Neurol 1983;14:471–479.
373. Bailey DB, Mesibov GB, Hatton DD, et al. Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord 1998;28:499–508.
374. Splawski, I, Timothy KW, Sharpe LM, et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004;119:19–31.
375. Stromland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Devel Med Child Neurol 1994;36:351–356.
376. Rodier SJ. The early origins of autism. Sci Amer 2000;282:56–63.
377. Volkmar FR, Douglas NS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 1990;29:127–129.
378. Wong V. Epilepsy in children with autistic spectrum disorder. J Child Neurol 1993;8:316–322.
379. Lord C, Mulloy C, Wendelboe M, et al. Pre- and perinatal factors in high-functioning females and males with autism. J Autism Dev Disord 1991;21:197–209.
380. Dunn HG, ed. Sequelae of low-birth-weight: the Vancouver Study. Clin Dev Med 1986;95/96:68–96.
381. DeLong GR, Bean SC, Brown FR. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 1981;38:191–194.
382. Gillberg IC. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism. Dev Med Child Neurol 1991;920–924.
383. Oades RD, Slusarek M, Velling S, et al. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity. World J Biol Psychiatry 2002;3:96–100.
384. Korvatska E, Van der Water J, Anders TF, et al. Genetic and immunological considerations in autism. Neurobiol Dis 2002;9:107–125.
385. Jyonouchi H, Sun SN, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorder and developmental regression. J Neuroimmunol 2001;120:170–179.
386. Warren RP, Margaretten NC, Pace NC, et al. Immune abnormalities in patients with autism. J Autism Dev Disorders 1986;16:189–197.
387. Zimmerman A, Frye V, Potter N. Immunological aspects of autism. Int Pediatr 1993;8:199–204.
388. Todd RD, Hickok JM, Anderson GM, et al. Antibrain antibodies in infantile autism. Biol Psychiatry 1988;23:644–647.
389. Sweeten TL, Bowyer SL, Posey DJ, et al. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003;112:e420.
390. Silva SC, Correia C, Fesel C, et al. Autoantibody repertoires to brain tissue in autism nuclear families. J Neuroimmunology 2004;152:176–182.
391. Vojdani A, O’Bryan T, Green JA, et al. Immune response to dietary proteins, gliadin, and cerebellar peptides in children with autism. Nutr Neurosci 2004;7:151–161.
392. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67–81.
393. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol 1996;38:191–202.
394. Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in neurobiological esearch. J Psychiatry Neurosci 1999;24:103–115.
395. Nanson JL. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res 1992;16:558–565.
396. Davis E, Fennoy I, Laraque D, et al. Autism and developmental disabilities in children with perinatal cocaine exposure. J Natl Med Assoc 1992;84:315–319.
397. Stromland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994;36:351–356.
398. Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev Med Child Neurol 1994;36:357–369.
399. Ward AJ. A comparison and analysis of the presence of family problems during pregnancy of mothers of “autistic” children and mothers of normal children. Child Psychiatry Hum Dev 1990;20:279–288.
400. Sweeten TL, Posey DJ, McDougle CJ. Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 2004;34:583–586.
401. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 2005;10:160–184.
402. Gillberg IC. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for chidhood autism. Dev Med Child Neurol 1991;33:912–929.
403. Ghaziuddin M, Al-Khouri I, Ghaziuddin N. Autistic syndrome following herpes encephalitis. Eur J Child Adolesc Psychiatry 2002;11:142–146.
404. Desmond MM, Wilson GS, Melnick JL, et al. Congenital rubella encephalitis. Course and early sequelae. J Pediatr 1967;71:311–331.
405. Hornig M, Lipkin WI. Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses and animal models. Ment Retard Devel Disabil Res Rev 2001;7:200–210.
405a. Barak Y, Kimhi R, Stein D, et al. Child Psychiatry Human Dev 1999;29:245–251.
406. Ciaranello AL, Ciaranello RD. The neurobiology of infantile autism. Ann Rev Neurosci 1995;18:101–128.
407. Fatemi Sh, Earle J, Kamodia R, et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002;22:25–33.
408. Shi L, Fatemi SH, Sidwell RW, et al. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003;23:297–302.
409. Pfeiffer ZRF, Quigley EMM. Neurogastroenterology. Semin Neurol 1996;16.
410. Horvath K, Papadimitriou JC, Rabsztyn A. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999;135:559–563.
411. Torrente F, Ashwood P, Day R, et al. Small intestine enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 2002;7:375–382,334.
412. Ashwood P, Anthony A, Torrente F, et al. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004;24:664–673.
P.1148

413. Montgomery SM, Morris DL, Pounder RE, et al. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999;116:796–803.
414. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998;351:611–612.
415. Lee JW, Melgaard B, Clements CJ, et al. Autism, inflammatory bowel disease, and MMR vaccine. Lancet 1998;351:905.
416. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026–2029.
417. Uhlmann V, Martin CM, Shiels O, et al. Potential viral; pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002;55:84–90.
418. Bradstreet JJ, El Dahr J, Anthony A, et al. Detection of measles virus genomic RNA in cerebrospinal fluid of children with regressive autism: a report of three cases. J Am Phys Surg 2004;9:38–45.
419. Prior M, Eisenmajer R, Leekam S, et al. Are there subgroups within the autistic spectrum? A cluster analysis of a group of children with autistic spectrum disorders. J Child Psychol Psychiatry 1998;39:893–902.
420. Heller T. Dementia infantilis. Zeitschrift für die Erforschung und Behandlung des Jugendlichen Schwachsinns 1908;2:141–165.
421. Fombonne E. Prevalence of childhood disintegrative disorder. Autism 2002;6:149–157.
422. Eggers C, Bunk D, Krause D. Schizophrenia with onset before age of eleven: clinical characteristics of onset and course. J Autism Dev Disord 2000;30:29–40.
423. Russell AT. The clinical presentation of childhood-onset schizophrenia. Schizophr Bull 1994;20:631–646.
424. McLellan JM, Werry J. Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;33:616–635.
425. Jones P, Rodgers B, Murray R, et al. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398–1402.
426. Walker E, Lewine RJ. Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am J Psychiatry 1990;147:1052–1056.
426a. Niemi L, Surisuari J, Tuulio-Henrikson A, et al. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophrenia Res 2003;60:239–258.
427. Walker E, Baum K, Diforio D. Developmental changes in the behavioral expression of vulnerability for schizophrenia. In: Lenzenweger M, Dworkin R, eds. Origins and development of schizophrenia. Washington, DC: American Psychological Association Press, 1998:469–492.
428. Kolvin I, Fundudis T. Elective mute children: psychological development and background factors. J Child Psychol Psychiatry 1981;22:219–232.
429. Bartak L, Rutter M, Cox A. A comparative study of infantile autism and specific developmental receptive language disorder. I. The children. Br J Psychiatry 1975;126:127–145.
430. Plioplys AV. Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med 1994;148:220–222.
431. Stefanatos GA, Grover W, Geller E. Case study: corticosteroid treatment of language regession in pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry 1995;34:1107–1111.
432. Lewine JD, Andrews R, Chez M, et al. Magnetoencephalographic patterns of epileptic form activity in children with regressive autism spectrum disorders. Pediatrics 1999;104:405–418.
433. Howlin P. Practitioner review: psychological and educational treatments for autism. J Child Psychol Psychiatry 1998;39:307–322.
434. Kjelgaard MM, Tager-Flusberg H. An investigation of language impairment in autism: implications for genetic subgroups. Lang Cogn Proc 2001;16:287–308.
435. Rapin I, Dunn M. Update on the language disorders of individuals on the autistic spectrum. Brain Dev 2003;25:166–172.
436. Herbert M, et al. MRI structural imaging of autism and developmental language disorder: a review and commentary. In: Sinha K, Chandra P, eds. Advances in clinical neuroscience, 2003.
437. Herbert MR, Ziegler DA, Deutsch C, et al. Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain 2005;128:213–226.
438. Folstein SE, Mankoski RE. Chromosome 7q: where autism meets language disorder? Am J Hum Genet 2000;67:278–281.
439. Warburton P, Baird G, Chen W, et al. Support for linkage of autism and specific language impairment to 7q3 from two chromosome rearrangements involving band 7q31. Am J Med Genet 2000;396:228–234.
440. Wassink TH, Piven J. The molecular genetics of autism. Curr Psychiatry Rep 2000;2:170–175.
441. Bradford Y, Haines J, Hutcheson H, et al. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 2001;105:539–547.
442. Alarcon M, Cantor RM, Liu J, et al. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 2002;70:60–71.
443. DeLong GR, Teague LA, McSwain-Kamran M. Effects of fluoxetine treatment in young children with idiopathic autism: a case series. Dev Med Child Neurol 1998;40:551–562.
444. Nicholson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry 1998;37:372–376.
445. Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004;114:e634–e641.
445a. Barnard L, Young AH, Pearson J, et al. A systematic review of the use of atypical antipsychotics in autism. J Psychopharm 2002;16:93–101.
446. Fankhauser MP, Karumanchi VC, German ML, et al. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1992;53:77–82.
447. Volkmar FR. Pharmacological interventions in autism: theoretical and practical issues. J Clin Child Psychol 2001;30:80–7.
448. Birmaher B, Quintana H, Greenhill L. Methylphenidate for the treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry 1988;27:248–251.
449. Raiten DJ, Massaro T. Perspectives on the nutritional ecology of autistic children. J Autism Dev Disord 1986;16:133–144.
450. Pfeiffer SI, Norton J, Nelson L, et al. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord 1995;25:481–494.
451. Reichelt PM, Scott H, Ekrem J. Gluten, milk proteins and autism: the result of dietary intervention on behaviour and peptide secretion. J Appl Nutr 1990;42:1–11.
452. Knivsberg AM, Reichelt KL, Nodland M. Reports on dietary intervention in autistic disorders. Nutr Neurosci 2001;4:25–37.
453. Lightdale JR, Hayer C, Duer A, et al. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded open label study. Pediatrics 2001;108:E90.
454. Sandler RH, Finegold SM, Bolte ER, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000;15:429–435.
455. Klin A, Jones W, Schultz R, et al. The enactive mind, or from actions to cognition: lessons from autism. Philos Trans R Soc Lond B Biol Sci 2003;358:345–360.
456. Ozonoff S, Miller NJ. Teaching theory of mind: a new approach to social skills training for individuals with autism. J Autism Dev Disord 1995;25:415–433.
457. McEachin J, Smith T, Lovaas O. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard 1993;4:359–372.
458. Schopler EA. Statewide program for the treatment and education of autistic and related communication handicapped children (TEACCH). In: Volkmar F, ed. Child and adolescent psychiatric clinics of North America: psychoses and pervasive developmental disorders. Philadelphia: WB Saunders, 1994:91–103.
459. Lord C. Facilitating social inclusion. In: Schopler E, Mesibov GB, eds. Learning and cognition in autism. New York: Plenum, 1995:221–239.
460. Mesibov GB. A comprehensive program for serving people with autism and their families: the TEACCH model. In: Matson JL, ed. Autism in children and adults: etiology, assessment and intervention. Belmont, CA: Brooks-Cole, 1995:85–97.
P.1149

461. Strain PS, Cordisco L. LEAP preschool. In: Harris S, Handelman J, eds. Preschool education programs for children with autism. Austin, TX: PRO-ED, 1994:225–252.
462. Harris SL. Educational strategies in autism. In: Schopler E, Mesibov GB, eds. Learning and cognition in autism. New York: Plenum, 1995:293–309.
463. Rogers S, Lewis H. An effective day treatment model for young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1989;28:207–214.
464. Gresham FM, Beebe-Frankenberger ME, MacMillan DL. A selective review of treatments for children with autism: description and methodological considerations. School Psycholog Rev 1999;28:559–575.
465. Howlin P. Children with autism and Asperger syndrome: a guide for practitioners and carers. Chichester: John Wiley & Sons, 1998.
466. Matson JL, Benavidez DA, Compton LS, et al. Behavioral treatment of autistic persons: a review of research from 1980 to the present. Res Dev Disabil 1996;17:433–465.
467. Quill K. Enhancing children’s social-communicative interactions. Teaching children with autism: strategies to enhance communication and socialization. New York: Delmar, 1995:163–192.
468. Rutter M. Infantile autism. In: Shaffer D, Ehrhardt AA, Greenhill LL, eds. The clinical guide to child psychiatry. New York: Free Press, 1985:48–78.
469. Cohen DJ, Volkmar FR. Autism and pervasive developmental disorders: a handbook. New York: John Wiley, 1997.
470. Gillberg C, Johansson M, Steffenberg S, et al. Auditory integration training in children with autism: brief report of an open pilot study. Autism 1997;1:97–100.
471. Bettison S. The long-term effects of auditory training in children with autism. J Autism Dev Disord 1996;26:361–374.
472. Bebko JM, Perry A, Bryson S. Multiple method validation study of facilitated communication. II. Individual differences and subgroup results. J Autism Dev Disord 1996;26:19–42.
473. Howlin P. Prognosis in autism: do specialist treatments affect outcome? Eur Child Adolesc Psychiatry 1997;6:55–72.
474. Horvath K, Stefanatos G, Sokolski KN, et al. Improved social skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998;9–15.
475. American Academy of Pediatrics. The Doman-Delacato treatment of neurologically handicapped children. Pediatrics 1982;70:810–812.
476. Mason SM, Iwata BA. Artifactual effects of sensory integrative therapy on self-injurious behaviour. J Appl Behav Anal 1990;26:361–370.
477. Hoehn TP, Baumeister M. A critique of the application of sensory integration therapy to children with learning disabilities. J Learn Disabil 1994;27:338–350.
478. Burden V, Stott CM, Forge J, et al. The Cambridge Language and Speech Project (CLASP). I. Detection of language difficulties at 36 to 39 months. Dev Med Child Neurol 1996;38:613–631.
479. Tomblin JB, Records NL, Buckwalter P, et al. Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res 1997;40:1245–1260.
480. Stem LM, Connell TM, Lee M, et al. Adelaide preschool language unit: results of follow-up. J Paediatr Child Health 1995;31:207–212.
481. Silva PA, Williams S, McGee R. A longitudinal study of children with developmental language delay at age three: later intelligence, reading, and behaviour problems. Dev Med Child Neurol 1987;29:630–640.
482. Werker JF. The effects of multilingualism on phonetic perceptual flexibility. Appl Psycholinguis 1986;7:141–156.
483. Lenneberg EH, Rebelsky FG, Nichols IA. The vocalization of infants born to deaf and to hearing parents. Vita Humana 1965;8:23–37.
484. Franco F, Butterworth G. Pointing and social awareness: declaring and requesting in the second year. J Child Lang 1996;307–336.
485. Bates E, Thal D, Janowsky JS. Early language development and its neural correlates. In: Segalowitz SJ, Rapin I, eds. Handbook of neuropsychology, Vol. 7. New York: Elsevier Science, 1992:69–110.
486. Capute AJ, Accardo PJ. Linguistic and auditory milestones during the first two years of life: a language inventory for the practitioner. Clin Pediatr 1978;17:847–853.
487. Thal D, Tobias S, Morrison D. Language and gestures in late talkers: a one-year follow-up. J Speech Hear Disord 1991;34:604–612.
488. Tallal P, Stark RE, Mellits ED. Identification of language-impaired children on the basis of rapid perception and production skills. Brain Lang 1985;25:314–322.
488a. Silva DA, Satz P. Pathological left-handedness: evaluation of a model. Brain & Lang 1979;7:8–16.
489. Nass R. Language development in children with congenital strokes. Semin Pediatr Neurol 1997;4:109–116.
489a. Vicari S, Chilosi AM, et al. Plasticity and reorganization during language development in children with early brain injury. Cortex 2000;36:31–46.
489b. Jonas R, Nguyen S, Hu B, et al. Cerebral hemispherectomy: hospital course, seizure, developmental language and motor outcome. Neurol 2004;62:1712–1721.
490. Woods BT, Teuber HL. Changing patterns of childhood aphasia. Ann Neurol 1978;3:273–280.
491. Vargha-Khadem F, Isaacs EB, Papleloudi H. Development of language in six hemispherectomized patients. Brain 1991;114:473–495.
492. Dall’Oglio AM, Bates E, Volterra V, et al. Early cognition, communication, and language in children with focal brain injury. Dev Med Child Neurol 1994;36:1076–1098.
493. Hiscock M, Kinsbourne M. Phylogeny and ontogeny of cerebral lateralization. In: Davidson R, Hugdahl K, eds. Brain asymmetry. Cambridge, MA: MIT Press, 535–578.
494. Duchowny M, Jayakar P, Harvey AS, et al. Language cortex representation: effects of developmental versus acquired pathology. Ann Neurol 1996;40:37–38.
495. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography of human brain functional development. Ann Neurol 1987;22:487–497.
496. Huttenlocher PR. Morphometric study of human cerebral cortex development. Neuropsychologia 1990;28:517–527.
497. Aram DM, Eisele JA. Intellectual stability in children with unilateral brain lesions. Neuropsychologia 1994;32:85–95.
498. Bates E, Thal D, Trauner D, et al. From first words to grammar in children with focal brain injury. Dev Neuropsych 1997;13:275–343.
499. Muter V, Taylor S, Vargha-Khadem F. A longitudinal study of early intellectual development in hemiplegic children. Neuropsychologia 1997;35:289–299.
500. Ramachandran VS. Behavioral and magnetoencephalographic correlates of plasticity in the adult human brain. Proc Nat Acad Sciences 1993;90:10413–10420.
501. Weiller C, Isenee C, Rijntjesz M, et al. Recovery from Wernicke’s aphasia: a positron emission tomography study. Ann Neurol 1995;37:723–732.
502. Wada J, Rasmussen T. Intracarotid injections of sodium amytal for clinical observations. J Neurosurg 1960;17:266–282.
503. Kinsbourne M. The minor cerebral hemisphere as a source of aphasic speech. Arch Neurol 1971;25:302–306.
504. Chiarello C. A house divided? Cognitive functioning with callosal agenesis. Brain Lang 1980;11:128–158.
505. Nass R, Koch D. Differential effects of early unilateral brain damage on temperament. Dev Neuropsychol 1987;3:93–99.
506. Schmahmann JD, Sherman JC. The cerebellar cognitive-emotional syndrome. Brain 1998;121:561–579.
507. Riva D, Giorgi C. The cerebellum contributes to higher functions during development. Brain 2000;123:1051–1061.
508. Gottwald B, Wilde B, Mihajlovic Z, et al. Evidence for distinct cognitive deficits after focal cerebellar lesions. J Neurol Neurosurg Psychiatry 2004;75:1524–1531.
509. Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuropsychological consequences of cerebellar tumour resection in children. Brain 2000;123:1041–1050.
510. Guzzetta F, Mercuri E, Bonanno S, et al. Autosomal recessive congential cerebellar atrophy: a clinical and neuropsychological study. Brain Dev 1993;15:439–445.
511. Travis LS. Handbook of speech pathology and audiology. New York: Appleton-Century-Crofts, 1971.
512. Kools JA, Williams AF, Vickers MJ, et al. Oral and limb apraxia in mentally retarded children with deviant articulation. Cortex 1971;7:387–400.
P.1150

513. Braun AR, Varga M, Stager S, et al. Altered patterns of cerebral activity during speech and language production in developmental stuttering. An H2(15)O positron emission tomography study. Brain 1997;120:761–784.
514. Fox PT, Ingham RJ, Ingham JC, et al. A PET study of the neural systems of stuttering. Nature 1996;382:158–161.
515. Bishop DVM. Handedness and developmental disorder: clinics in developmental medicine. Oxford: Blackwell Science, 1990:110.
516. Hancock K, Craig A, McCready C, et al. Two- to six-year controlled-trial stuttering outcomes for children and adolescents. J Speech Lang Hear Res 1998;41:1242–1252.
517. DeFusio EN, Menken M. Symptomatic cluttering in adults. Brain Lang 1979;8:25–33.
518. Mathinos DA. Communication competence of children with learning disabilities. J Learn Disabil 1988;21:437–443.
519. Kinsbourne M. The neuropsychology of bilingualism. Ann NY Acad Sci 1981;379:50–58.
520. Singh JA, Zingg RM. Wolf children and feral man. New York: Harper & Row, 1942.
521. Davis K. Final note on a case of extreme isolation. Am J Sociol 1947;52:432.
522. Curtis S. Genie: a psycholinguistic study of a modern day “Wild Child.” New York: Academic Press, 1977.
523. Johnson J, Newport E. Critical period effects in second language learning: the influence of maturational state on the acquisition of English as a second language. Cogn Psychol 1989;21:60–99.
524. Stein DG, Brailovsky S, Will B. Brain repair. New York: Oxford University Press, 1995.
525. Mogford K. Oral language acquisition in the prelinguistically deaf. In: Bishop D, Mogford K, eds. Language development in exceptional circumstances. Edinburgh: Churchill Livingstone, 1988:110–131.
526. Mayberry RI, Eichen EB. The long-lasting advantage of learning sign language in childhood: another look at the critical period for language acquisition. J Mem Lang 1991;30:486–512.
527. Poizner J, Klima ES, Bellugi U. What the hands reveal about the brain. Cambridge, MA: MIT Press, 1987.
528. Mayer P, Lowenbraun S. Total communication use among elementary teachers of hearing-impaired children. Am Ann Deaf 1990;135:257–263.
529. Kaplan P. Pathways for exceptional children. Minneapolis, MN: West, 1996.
530. Gascon GG, Johnson R, Burd L. Central auditory processing and attention deficit disorders. J Child Neurol 1986;1:27–33.
531. Klein SK, Rapin I. Intermittent conductive hearing loss and language development. In: Bishop D, Mogford K, eds. Language development in exceptional circumstances. London: Churchill Livingstone, 1988:96–109.
532. Spencer LJ, Gantz BJ, Knutson JF. Outcomes and achievements of students who grew up with access to cochlear implants. Laryngoscope 2004;114:1576–1581.
532a. Tomblin JB, Records N, Buck water P, et al. Prevalence of specific language impairment in children. J Speech and Hearing Research 1997;39:1284–1294.
533. Leonard LB. Children with specific language impairment. Cambridge, MA: MIT Press, 1998.
534. Silva PA, McGee R, Williams S. Developmental language delay from three to seven years and its signficance for low intelligence and reading difficulties at age seven. Dev Med Child Neurol 1983;25:783–793.
535. Rapin I, Allen DA. Developmental language disorders: nosological considerations. In: Kirk U, ed. Neuropsychology of language, reading, and spelling. New York: Academic Press, 1983:155–184.
536. Tallal P, Stark RE, Mellits D. The relationship between auditory temporal analysis and receptive language development: evidence from studies of developmental language disorder. Neuropsychologia 1985;23:527–534.
537. Bishop DMV. The underlying nature of specific language impairment. J Child Psychol Psychiat 1992;23:3–66.
538. Cohen M, Campbell R, Yaghmai F. Neuropathological abnormalities in developmental dysphasia. Ann Neurol 1989;25:567–570.
539. Shields J, Varley R. Broks P, et al. Social cognition in developmental language disorders and high-level autism. Dev Med Child Neurol 1996;38:487–495.
540. Shields J, Varley R, Broks P, et al. Hemispheric function in developmental language disorders and autism. Dev Med Child Neurol 1996;38:473–486.
541. Hurst JA, Baraitser M, Auger E, et al. An extended family with an inherited speech disorder. Dev Med Child Neurol 1990;32:347–355.
542. Stromswold K. The heritability of language: a review and meta-analysis of twin, adoption and linkage studies. Language 2001;77:647–723.
543. Bishop DV. Motor immaturity and specific speech and language impairment: evidence for a common genetic basis. Am J Med Genet 2002;8:56–63.
543a. Marcus GF, Fisher SE. FOXP2 in focus: what can genes tell us about speech and language? Trends in Cognitive Sciences 2003;7:257–262.
544. Beichtman JH, Nair R, Clegg M, et al. Prevalence of psychiatric disorders in children with speech and language disorders. J Am Acad Child Adolesc Psychiatry 1993;32:595:603.
545. Willinger U, Brunner E, Diendorfer-Radner G, et al. Behaviour in children with language developmental disorders. Can J Psychiatry 2003;48:607–614.
546. Van Hout A. Acquired aphasia in children. Semin Pediatr Neurol 1997;4:102–108.
547. Cranberg LD, Filley CM, Hart EJ, et al. Acquired aphasia in childhood: clinical and CT investigations. Neurology 1987;37:1165–1172.
548. Stiles J. The effect of early brain injury on lateralization of cognitive function. Curr Direct Psychol Science 1998;7:21–26.
549. Liegeois F, Connelly A, Cross JH, et al. Language reorganization in children with early-onset lesions of the left hemisphere: an fMRI study. Brain 2004;127:1229–1236.
550. Van Dongen HR, Loonen MCB. Factors related to prognosis of acquired aphasia in children. Cortex 1977;13:131–136.
551. Cooper JA, Flowers CR. Children with a history of acquired aphasia: residual language and academic impairment. J Speech Hear Disord 1987;52:251–262.
552. Stefanatos GA, Kinsbourne M, Wasserstein J. Acquired epileptiform aphasia: a dimensional view of Landau-Kleffner syndrome and the relation to regressive autistic spectrum disorder. Child Neuropsychology 2002;8:195–228.
553. da Silva EA, Chugani DC, Muzik O, et al. Landau-Kleffner syndrome: metabolic abnormalities in temporal lobe are a common feature. J Child Neurol 1997;12:489–495.
554. Appleton RE. The Landau-Kleffner syndrome. Arch Dis Child 1995;72:386–387.
555. Lahey M. Who shall be called language disordered? Some reflections and one perspective. J Speech Hear Disord 1990;55:612–620.
556. Binnie CD, Kasteleijn-Nolst Trenite DG, Smit AM, et al. Interactions of epileptiform EEG discharges and cognition. Epilepsy Res 1987;1:239–245.
557. Kim KHS, Relkin NR, Lee KM, et al. Distinct cortical areas associated with native and second languages. Nature 1997;388:171–174.
558. Friedrich U, Dalby M, Staehelin-Jensen T, et al. Chromosomal studies of children and developmental language retardation. Dev Med Child Neurol 1982;24:645–652.
559. Ratcliffe SG. Speech and learning disorders in children with sex chromosome abnormalities. Dev Med Child Neurol 1982;24:80–84.
560. Mazzocco MM, Myers GF, Hamner JL, et al. The prevalence of the FMR1 and FMR2 mutations among preschool children with language delay. J Pediatr 1998;132:795–801.
561. Cantwell DP, Baker C. Association between attention-deficit hyperactivity disorder and learning disorders. J Learn Disabil 1991;24:88–95.
562. Allen DA, Mendelson L, Rapin I. Syndrome-specific remediation in preschool developmental dysphasia. In: French JH, Havel S, Casser P, eds. Child neurology and developmental disabilities. Baltimore: Brooks, 1989:233–243.
563. Tallal P. Developmental language disorders. In: Kavanagh JF, Truss TJ, eds. Learning disorders. Parkton, MD: York Press, 1988:181–272.
564. Law J, Garrett Z, Nye C. The efficacy of treatment for children with developmental speech and language delay/disorder: a meta-analysis. J Speech Lang Hear Res 2004;47:924–943.
565. Owens RE, House LI. Decision-making process in augmentative communication. J Speech Hearing Disord 1984;47:18–25.
P.1151

566. Amir N, Seligman-Wine J, Gross-Tsur V. The role of augmentative communication in impaired language acquisition. In: Amir N, Rapin I, Bianski D, eds. Pediatric neurology: behavior and cognition of the child with brain dysfunction, Vol 1. Basel: Karger, 1991:129–145.
567. Bilken D. Communication unbound. Harv Educ Rev 1990;60:291–314.
568. Cummus RA, Prior MP. Autism and assisted communication: a response to Bilken. Harv Educ Rev 1992;62:228–241.
569. Kavanagh JF, Truss TJ. Learning disabilities. Parkton, MD: York Press, 1988.
570. Lyon GR. Toward a definition of dyslexia. Ann Dyslexia 1995;45:3–27.
570a. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva, World Health Organization.
571. Siegel L. IQ is irrelevant to the definition of learning disabilities. J Learn Disabil 1989;22:469–478.
572. Meyer MS. The ability-achievement discrepancy: does it contribute to an understanding of learning disabilities? Edu Psychol Rev 2000;12:315–337.
573. Flowers L, Meyer M, Lovato J, et al. Does third grade discrepancy status predict the course of reading development? AnnDyslexia 2001;50:1–23.
574. Lyon GR, Fletcher JM, Shaywitz SE, et al. Rethinking learning disabilities. In: Finn CE Jr, Rotherham AJ, Hokanson CR Jr, eds. Rethinking special education for a new century. Washington, DC: Thomas B. Fordham Foundation and the Progressive Policy Institute, 2001:259–287.
575. Willcutt EG, Pennington BF. Psychiatric comorbidity in children and adolescents with reading disability. J Child Psychol Psychiatry, 2000;41:1039–1048.
576. Wood FB, Felton RF. Separate linguistic and attentional factors in the development of reading. Top Lang Disord 1994;14(4):42–57.
577. Knopik VS, De Fries JC. Etiology of covariation between reading and mathematics performance: a twin study. Twin Res (Engl), 1999;2:226–34.
578. Moores DF. Educating the deaf: psychology, principles, and practices, 3rd ed. Boston: Houghton-Mifflin, 1987.
579. Ross M. Hard-of-hearing children in regular schools. Englewood Cliffs, NJ: Prentice-Hall, 1982.
580. Stein PA, Hoover JH. Manifest anxiety in children with learning disabilities. J Learn Disabil 1989;22:66–71.
581. Smith SL. Succeeding against the odds: how the learning disabled can realize their promise. New York, NY: G. P. Putnum’s Sons, 1991.
582. Casey R, Levy SE, Brown K, et al. Impaired emotional health in children with mild reading disability. J Dev Behav Pediatr 1992;13:256–260.
583. Prior M, Smart D, Sanson A, et al. Relationships between learning difficulties and psychological problems in preadolescent children from a longitudinal sample. J Am Acad Child Adolesc Psychiatry 1999;38:429–436.
584. Maughan B, Rowe R, Loeber, R, et al. Reading problems and depressed mood. J Abnorm Child Psychol 2003;31:219–229.
585. Fristad MA, Topolosky S, Weller EB, et al. Depression and learning disabilities in children. J Affect Disord 1992;26:53–58.
586. Handwerk ML, Marshall RM. Behavioral and emotional problems of students with learning disabilities, serious emotional disturbance, or both conditions. J Learn Disabil 1998;31:327–338.
587. Maag JW, Behrens JT. Depression and cognitive self statements of learning disabled and seriously emotionally disturbed adolescents. J Spec Ed 1989;23:17–27.
588. Svetaz MV, Ireland M, Blum R. Adolescents with learning disabilities: risk and protective factors associated with emotional well being: findings from the National Longitudinal Study of Adolescent Health. J Adolesc Health 2000;27:340–348.
589. Wood F, Goldston D. Learning disabilities: a hidden source of suicidal thought and behaviour. In: Schlebusch L, Bosch BA, eds. Suicidal behavior 4. Proceedings of the Southern African conference on suicidology, Durban, South Africa.
590. Willcutt EG, Pennington BF. Psychiatric comorbidity in children and adolescents with reading disability. J Child Psychol Psychiat 2000;41:1039–1048.
591. Wright-Strawderman C, Watson BL. The prevalence of depressive symptoms in children with learning disabilities. J Learn Disabil 1992;25:258–264.
592. U. S. Department of Education. 17th annual report to Congress on the implementation of IDEA.
593. Shaywitz SE, Shaywitz BA, Fletcher JM, et al. Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. JAMA 1990;264:998–1002.
595. Nichols PL, Chen TC. Minimal brain dysfunction: a prospective study. Hillsdale, NJ: Erlbaum, 1981.
596. Liberman IY, Shankweiler D, Liberman AM. The alphabetic principle and learning to read. In: Shankweiler D, Liberman IY, eds. Phonology and reading disability: solving the reading puzzle. Ann Arbor, MI: University of MI Press, 1989:1–33.
597. Stanovitch K. Explaining the variance in reading ability in terms of psychological processes: what have we learned? Ann Dyslexia 1986;35:67–96.
598. Stevenson H. Orthography and reading disabilities. J Learn Disabil 1984;18:132–135.
599. Rutter M, Yule W. The concept of specific reading retardation. J Child Psychol Psychiatry 1975;16:181–197.
600. Nelson HE, Warrington EK. Developmental spelling retardation. In: Knights RM, Bakker DJ, eds. The neuropsychology of learning disorders: theoretical approaches. Baltimore: University Park Press, 1976:325–332.
601. Lyon GR. Research initiatives in learning disabilities: contributions from scientists supported by the National Institute of Child Health and Human Development. J Child Neurol 1995;10:120–S126.
602. Gleitman LR, Rozin P. The structure and acquisition of reading. I. Relations between orthographies and the structure of language. In: Reber AJ, Scarborough DL, eds. Toward a psychology of reading. Hillsdale, NJ: Erlbaum, 1977.
603. Bradley L, Bryant P. Categorizing sounds and learning to read—a causal connection. Nature 1983;301:419–421.
604. Tallal P. Auditory temporal perception, phonics, and reading disabilities in children. Brain Lang 1980;9:182–198.
605. Eden GF, Stein JF, Wood HM, et al. Temporal and spatial processing in reading disabled and normal children. Cortex 1995;31:451–468.
606. Reynolds AM, Elkonin N, Brown FRI. Specific reading disabilities: early identification and long-term outcome. MRDD Res Rev 1996;2:21–27.
607. Denckla M. Motor coordination in dyslexic children. In: Duffy F, Geschwind N, eds. Dyslexia. Boston: Little, Brown and Company, 1987.
608. Duffy FH, Denckla MB, Bartels PH, et al. Dyslexia: automated diagnosis by computerized classification of brain electrical activity. Ann Neurol 1980;7:421–428.
609. Lou HC, Hendrikson L, Bruhn P. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 1984;41:825–829.
610. Galaburda AM, Sherman GF, Rosen GD, et al. Developmental dyslexia: four consecutive patients with cortical anomalies. Ann Neurol 1985;18:222–233.
611. Denckla MB, LeMay M, Chapman CT. No CT scan abnormalities found even in neurologically impaired learning disabled children. J Learn Disabil 1985;18:132–135.
611a. EcKert M. Neuroanatomical markers for dyslexia: A review of dyslexia structural imaging studies. The Neuroscientist 2004;10:362–371.
612. Johnson D, Balock J. Adults with learning disabilities. Orlando: Grune & Stratton, 1987.
613. Kinsbourne M, Rufo DT, Gamzu E, et al. Neuropsychological deficits in adults with dyslexia. Dev Med Child Neurol 1991;33:763–775.
614. Felton R, Naylor C, Wood F. Neuropsychological profile of adult dyslexics. Brain Lang 1990;39:485–497.
615. Wood FB, Flowers Dl, Grigorenko E. The functional neuroanatomy of fluency or why walking is just as important to reading as talking is. In: Wolf M, ed. Dyslexia, fluency, and the brain. Baltimore, MD: York Press, 2001:235–244.
616. Pugh KR, Mencl WE, Jenner AR, et al. Neurobiological studies of reading and reading disability. J Commun Disord (USA), Nov–Dec 2001;34:479–492).
P.1152

617. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Functional disruption in the organization of the brain for reading in dyslexia. Proc Nat Acad Sci USA 1998;95:2636–2641.
618. Flowers DL, Wood FB, Naylor CE. Regional cerebral blood flow correlates of language processes in reading disability. Arch Neurol 1991;48:637–643.
619. Gross-Glenn K, Duara R, Barker WW, et al. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults. J Clin Exp Neuropsychol 1991;13:531–544.
620. Rumsey JM, Andreason P, Zametkin AJ, et al. Right frontotemporal activation by tonal memory in dyslexia, an O15 PET study. Biol Psychiatry 1994;36:171–180.
621. Rumsey JM, Zametkin AJ, Andreason P, et al. Normal activation of frontotemporal language cortex in dyslexia as measured with oxygen 15 positron emission tomography. Arch Neurol 1994;51:27–38.
622. Rumsey JM, Nace K, Donohue B, et al. A positron emission tomographic study of impaired word recognition and phonological processing in dyslexic men. Arch Neurol 1997;54:562–573.
623. Eden GF, Jones KM, Cappell K, et al. Neural changes following remediation in adult developmental dyslexia [in process citation] Neuron (USA), 2004;44:411–422.
624. Torgeson J. Catch them before they fall. The American educator. Spring/Summer, 1998.
625. Maughan B. Annotation: long-term outcomes of developmental reading problems. J Psychol Psychiatry 1995;36:357–371.
626. Thomas CJ. Congenital “word blindness” and its treatment. Ophthalmoscope 1905;3:380–385.
627. Hallgren B. Specific dyslexia (congenital word-blindness); a clinical and genetic study. Acta Neurol Scand Suppl 1950;65:1–287.
628. Yule W, Rutter M. Reading and intelligence. In: Knights R, Bakker J, eds. Neuropsychology of language disorders: theoretical approaches. Baltimore: University Park Press, 1976.
629. Finucci JM, Whitehouse CC, Isaacs SD, et al. Derivation and validation of a quantitative definition of specific reading disability for adults. Dev Med Child Neurol 1984;26:143–153.
630. Pennington BF. Using genetics to understand dyslexia. Ann Dyslexia 1989;39:81–93.
631. Tzenova J, Kaplan BJ, Petryshen TL, et al. Confirmation of a dyslexia susceptibility locus on chromosome 1p34-p36 in a set of 100 Canadian families. Am J Med Genet 2004;127B:117–124.
632. Fagerheim T, Raeymaekers P, Tonnessen FE, et al. A new gene (DYX3) for dyslexia is located on chromosome 2. J Med Genet 1999;36:664–669.
633. Fisher SE, Francks C, Marlow AJ, et al. Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nat Genet 2002;30:86–91.
634. Deffenbacher KE, Kenyon JB, Hoover DM, et al. Refinement of the 6p21.3 quantitative trait locus influencing dyslexia: linkage and association analyses. Hum Genet 2004;115:128–138.
635. Morris DW, Robinson L, Turic D, et al. Family-based association mapping provides evidence for a gene for reading disability on chromosome 15q. Hum Mol Genet 2000;9:843–848.
636. Finucci J, Childs B. Are there really more dyslexic boys than girls? In: Ansarer A, Geschwind N, Galaburda A, eds. Sex differences in dyslexia. Baltimore, MD: The Orton Society, 1981.
637. Grigorenko EL, Wood FB, Meyer MS, et al. Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15. Am J Hum Genet 1997;60:27–39.
638. Fagerheim T, Raeymaekers P, Tonnessen FE, et al. A new gene (DYX3) for dyslexia is located on chromosome 2. J Med Genet 1999;36:664–669.
638a. Bishop DVM, Snowling MJ. Developmental dyslexia and specific language impairment: Same or different? Psychol Bull 2004;130:858–886.
639. Harnadek MC, Rourke BP. Principal identifying features of the syndrome of nonverbal learning disabilities in children. J Learn Disabil 1994;27:144–154.
640. Geary DC. Mathematics and learning disabilities. J Learn Disabil 2004;37:4–15.
641. Satz P, Morris R. Learning disability subtypes: a review. In: Pirozzolo FJ, Wittrock MC, eds. Neuropsychologic and cognitive processes in reading. New York: Academic Press, 1981.
642. Geiger G, Lettvin JY. Peripheral vision in persons with dyslexia. N Engl J Med 1987;316:1238–1243.
643. Slaghuis WL, Lovegrove WJ. Spatial-frequency-dependent visible persistence and specific reading disability. Brain Cogn 1985;4:219–240.
644. Livingstone MS, Rosen GD, Drislane FW, et al. Physiological and anatomical evidence for a magnocellular defect in developmental dyslexia. Proc Nat Acad Sci USA 1991;88:7943–7947.
645. Lehmkuhle S, Garzia RP, Turner L, et al. A defective visual pathway in children with reading disability. N Engl J Med 1993;328:989–996.
645a. Greatrex JC, Drasdo N. The magnocellular deficit hypothesis in dyslexia: A review of reported evidence. Opthal and Physiol Optics 1995;15:501–506.
645b. Skottum BC. The magnocellular deficit theory of dyslexia: The evidence from contrast sensitivity. Vision Res 40:111–127.
646. Wolf M, Bowers PG. Naming-speed processes and developmental reading disabilities: an introduction to the special issue on the double-deficit hypothesis. J Learn Disabil 2000;33:322–324.
647. Huff E, Sorenson J, Dancer J. Relation of reading rate and rapid automatic naming in third graders. Percept Mot Skills 2002;95:925–926.
648. Meyer MS, Wood FB, Hart LA, et al. Selective predictive value of rapid automatized naming in poor readers. J Learn Disabil 1998;31:106–117.
649. Kinsbourne M, Warrington EK. Developmental factors in reading and writing backwardness. Br J Psychol 1963;54:145–156.
650. Kinsbourne M, Warrington EK. The development of finger differentiation. Quarterly J Exper Psychol 1964;15:132–137.
651. Hicks RE, Kinsbourne M. On the genesis of human handedness: a review. J Mot Behav 1976;8:257–266.
652. Geschwind N, Behan P. Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci USA 1982;79:5097–5100.
653. Crawford SG, Kaplan BJ, Kinsbourne M. The effects of parental immunoreactivity on pregnancy, birth, and cognitive development: maternal immune attack on the fetus? Cortex 1992;28:483–491.
654. Gilger JW, Pennington BF, Harbeck RJ, et al. A twin and family study of the association between immune system dysfunction and dyslexia using blood serum immunoassay and survey data. Brain Cogn 1998;36:310–333.
655. Porac C, Cohen S. Lateral preferences and human behavior. New York: Springer-Verlag, 1981.
656. Hiscock M, Kinsbourne M. Progress in the measurement of laterality and implications for dyslexia research. Ann Dyslexia 1995;45:249–268.
657. Schultz RT, Cho NK, Staib LH, et al. Brain morphology in normal and dyslexic children: the influences of sex and age. Ann Neurol 1994;35:732–742.
658. Leonard CM, Voeller KK, Lombardino LJ, et al. Anomalous cerebral structure in dyslexia revealed with magnetic resonance imaging. Arch Neurol 1993;50:461–469.
659. Geschwind DH, Dykens E. Neurobehavioral and psychosocial issues in Klinefelter syndrome. Learn Disabil Res Prac 2004;19:166–173.
660. Hinton VJ, DeVivo DC, Fee R, et al. Investigation of poor academic achievement in children with Duchenne muscular dystrophy. Learn Disabil Res Prac 2004;19:146–154.
661. Stein JF, Riddell PM, Fowler S. Disordered vergence control in dyslexic children. Br J Ophthalmol 1988;72:162–166.
662. Comelissen P, Bradley L, Fowler S, et al. Covering one eye affects how some children read. Dev Med Child Neurol 1992;34:296–304.
663. Polatajko HJ. A critical look at vestibular dysfunction in learning disabled children. Dev Med Child Neurol 1985;27:283–292.
664. Ball EW, Blachman BA. Does phoneme awareness training in kindergarten make a difference in early word recognition and development of spelling? Read Res Quart 1991;26:49–66.
665. Meyer MS, Felton RH. Repeated reading to enhance fluency: old approaches and new directions. Ann Dyslexia 1999;49:284–306.
666. The 1986/87 Future of Visual Development/Performance Task Force Special Report. The efficacy of optometric vision therapy. J Am Optom Assoc 1988;59:95–105.
667. Carte E, Morrison D, Sublett J, et al. Sensory integration therapy: a trial of a specific neurodevelopmental therapy for the remediation of learning disabilities. J Dev Behav Pediatr 1984;5:189–194.
668. Cummins RA. Sensory integration and learning disabilities: Ayers’ factor analyses reappraised. J Learn Disabil 1991;24:160–168.
P.1153

669. Tomatis A. Education and dyslexia. France, Quebec: Les Editions, 1978.
670. Aman MG, Werry JS. Methylphenidate and diazepam in severe mental retardation. J Am Acad Child Adolesc Psychiatry 1982;21:31–37.
671. Levinson HN. A solution to the riddle dyslexia. New York: Springer-Verlag, 1980.
672. Fagan JE, Kaplan BJ, Raymond JE, et al. The failure of antimotion sickness medication to improve reading in developmental dyslexia: results of a randomized trial. J Dev Behav Pediatr 1988;9:359–366.
673. McMahon JR, Gross RT. Physical and psychological effects of aerobic exercise in boys with learning disabilities. J Dev Behav Pediatr 1987;8:274–277.
674. Kohen-Raz RL. Learning disabilities and postural control. London: Freund, 1986.
675. American Academy of Ophthalmology. Learning disabilities and children: what parents need to know. San Francisco: American Academy of Ophthalmology, 1984.
676. Delacato CH. The diagnosis and treatment of speech and reading problems. Springfield, IL: Charles C Thomas, 1963.
677. Felton RH. Effects of instruction on the decoding skills of children with phonological-processing problems. J Learn Disabil (USA) 1993;26:583–589.
678. Foorman BR, Francis DJ, Fletcher JM, et al. The role of instruction in learning to read: preventing reading failure in at-risk children. J Edu Psychol 1998;90:37–55.
679. Juel C. What makes literacy tutoring effective? Read Res Quart 1996;31:268–289.
680. Fayol M, Barrouillet P, Mrinthe C. Predicting arithmetical achievement from neuropsychological performance: a longitudinal study. Cognition 1998;68:63–70.
681. Rourke B, Finlayson M. Neuropsychological significance of variations in patterns of academic performance: verbal and visuospatial abilities. J Abnorm Child Psychol 1978;6:121–133.
682. Shalev RS, Wurtmann R, Amir N. Developmental dyscalculia. Cortex 1988;24:555–561.
683. Ackerman P, Anhalt J, Dykman R. Arithmetic automatization failure in children with attention and reading disorders: associations and sequela. J Learn Disabil 1986;19:222–232.
684. Shalev RS, Manor O, Auerbach J, et al. Persistence of developmental dyscalculia: what counts? Results from a 3-year prospective follow-up study. J Pediatr 1998;133:320–321.
685. Shalev RS. Developmental dyscalculia. J Child Neurol 2004;19:756–771.
686. Chandler HN. Confusion confounded: a teacher tries to use research results to teach maths. J Learn Disabil 1987;11:361–369.
687. Semrud-Clikeman M, Hynd GW. Right hemisphere dysfunction in nonverbal learning disabilities: social, academic, and adaptive functioning in adults and children. Psychol Bull 1990;107:196–209.
688. Levin HS, Scheller J, Rickard T, et al. Dyscalculia and dyslexia after right hemisphere injury in infants. Arch Neurol 1996;53:88–96.
689. Cleaver RL, Whitman RD. Right hemisphere, white matter learning disabilities associated with depression in an adolescent amd young adult psychiatric population. J Nerv Ment Dis 1998;186:561–565.
690. Mattson AJ, Sheer DE, Fletcher JM. Electrophysiological evidence of lateralized disturbances in children with learning disabilities. J Clin Exp Neuropsychol 1992;14:707–716.
691. Pennington BF, van Doorninck WJ. Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Def 1985;89:467–474.
692. Rovet J. Turner syndrome: genetic and hormonal factors contributing to a specific learning disability profile. Learn Disabil Res Prac 2004;19:133–145.
693. Swillen A, Devriendt K, Legius E, et al. The behavioural phenotype in velo-cardio-facial syndrome in adolescence. Genet Couns 1999;10:79–88.
694. Pennington BF. Genetics of learning disabilities. Semin Neurol 1991;11:28–34.
695. Aldenkamp HP, Alpherts WC, Dekker MJ, et al. Neuropsychological aspects of learning disabilities in epilepsy. Epilepsia 1990;31 [Suppl 4]:9–20.
696. Eliason MJ. Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders. Neurofibromatosis 1987;6:17–25.
697. Cutting LE, Clements AM, Lightman AD, et al. Cognitive profile of neurofibromatosis type 1: rethinking nonverbal learning disabilities. Learn Disabil Res Prac 2004;19:155–165.
698. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999;89:45–52.
699. North K, Joy P, Yuille D, et al. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 1994;44:878–883.
700. Sevick RJ, Barkovich AJ, Edwards MS, et al. Evolution of white-matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 1992;159:171–175.
701. Denckla MB. Neurofibromatosis type 1: a model for the pathogenesis of reading disability. MRDD Res Rev 1996;2:48–53.
702. Gresham FM, Reschly DJ. Social skills, deficits and low peer acceptance of mainstreamed learning disabled children. Learn Disabil Quart 1986;9:23–32.
703. Dudley-Marling C, Edmiaster R. Social status of learning disabled children and adolescents: a review. Learn Disabil Quart 1985;8:189.
704. Hazel JS, Schumaker JB. Social skills and learning disabilities: current issues and recommendations for future research. In: Kavanagh F, Truss TJ, eds. Learning disabilities: proceedings of the national conference. Parkton, MD: York Press, 1988:293–344.
705. Cratty BJ. Clumsy child syndromes: descriptions, evaluation and remediation. USA: Harwood Academic Publishers, 1994.
706. Smyth TR. Clumsiness: kinaesthetic perception and translation. Child Care Health Dev 1996;22:1–9.
707. Wilson PH, MacKenzie BE. Information processing deficits associated with developmental coordination disorder: a meta-analysis of research findings. J Child Psychol Psychiatry 1998;39:829–240.
708. Mandich A, Buckolz E, Polatajko H. On the ability of children with developmental coordination disorder (DCD) to inhibit response initiation: the Simon effect. Brain Cogn 2002;50:1501–1512.
709. Rasmussen P, Gilberg C. Natural outcomes of ADHD with developmental coordination disorder at age 22 years. A controlled longitudinal community-based study. J Acad Child Adolesc Psychiatry 2000;39:1424–1431.
710. Pitcher TM, Piek JP, Hay DA. Fine and gross motor ability in males with ADHD. Dev Med Child Neurol 2003;45:525–535.
711. Deuel RK. Developmental dysgraphia and motor skill disorder. J Child Neurol 1994;10:6–8.
712. Schoemaker MM, Hijlkema MGJ, Kalverboer AF. Physiotherapy for clumsy children: an evaluation study. Dev Med Child Neurol 1994;36:143–155.
713. Willcutt EG, Pennington BF, DeFries JC. Etiology of inattention and hyperactivity/impulsivity in a community sample of twins with learning disabilities. J Abnorm Child Psychol 2000;28:149–159.
714. DeQuiros GB, Kinsbourne M, Palmer RL, et al. Attention deficit disorder in children: three clinical variants. J Devel Behav Pediatrics 1994;15:311–319.
715. Rappley MD. Attention deficit-hyperactivity disorder. N Engl J Med 2005;352:165–173.
716. Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997;36:1211–1221.
717. Kaplan BJ, McNicol J, Conte RA, et al. Sleep disturbances in preschool-aged hyperactive and nonhyperactive children. Pediatrics 1987;80:839–844.
718. Chervin RD, Dillon JE, Bassetti C, et al. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 1997;20:1185–1192.
719. Palfrey JS, Levine MD, Walker DK, et al. The emergence of attention deficits in early childhood: a prospective study. J Dev Behav Pediatr 1985;6:339–348.
720. Stewart MA, Thach BT, Freidin MR. Accidental poisoning and the hyperactive child. Dis Nerv Syst 1970;31:403–407.
721. Gerring JP, Brady KD, Chen A, et al. Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Acad Child Adolesc Psychiatry 1998;37:647–654.
722. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997;36:1036–1045.
P.1154

723. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159:36–42.
724. Porrino LJ, Rapoport JL, Behar D, et al. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 1983;40:681–687.
725. Pelham W, Bender NE. Peer relationships in hyperactive children: description and treatment. Adv Behav Disabil 1982;1:365–435.
726. Levine MD, Oberklaid F, Meltzer L. Development output failure: a study of low productivity in school-age children. Pediatrics 1981;67:18–25.
727. Cantwell DP, Satterfield JH. The prevalence of academic underachievement in hyperactive children. J Pediatr Psychol 1978;3:168–197.
728. Lambert NM, Sandoval J. The prevalence of learning disabilities in a sample of children considered hyperactive. J Abnorm Child Psychol 1980;8:33–50.
729. Ackerman PT, Dykman RA, Gardner MY. ADD students with and without dyslexia differ in sensitivity to rhyme and alliteration. J Learn Disabil 1990;23:279–283.
730. Nigg JT, Hinshaw SP, Carte ET, et al. Neuropsychological correlates of childhood attention-deficit/hyperactivity disorder: explainable by comorbid disruptive behavior or reading problems? J Abnorm Psychol 1998;107:468–480.
731. Barkley RA. Behavioral inhibition, sustained attention and executive function: constructing a unified theory of ADHD. Psychol Bull 1997;121:65–94.
732. Nigg JT. Is ADHD a disinhibitory disorder? Psychol Bull 2001;127:571–598.
733. Scheres A, Oosterlaan J, Geurts H, et al. Executive functioning in boys with ADHD: primarily an inhibition deficit? Arch Clin Neuropsychology 2004;19:569–594.
734. Kinsbourne M. Testing models for attention deficit hyperactivity disorder in the behavioral laboratory. In: Conners C, Kinsbourne M, eds. ADHD: attention deficit-hyperactivity disorder. Munich: MMV Medizin Verlag, 1990:51–70.
735. Teicher MH, Ito Y, Glod CA, et al. Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry 1996;35:334–342.
736. Kinsbourne M. Toward a model for the attention deficit disorder. In: Perlmutter M, ed. Minnesota symposia in child development. Hillsdale, NJ: Erlbaum, 1983:137–166.
737. Conners CK. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Amer 1999;46:857–870.
738. Zametkin A, Rapoport JL. The neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 1987;26:676–686.
739. Bhatia MS, Nigam VR, Bohra N, et al. Attention deficit disorder with hyperactivity among paediatric outpatients. J Child Psychol Psychiatry 1991;32:297–306.
740. Wolraich ML, Hannah JN, Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996;35:319–324.
741. Szatmari P. The epidemiology of attention-deficit hyperactivity disorders. Child Adolesc Psychiatry Clin North Am 1992;1:361–371.
742. Wasserman RC, Kelleher KJ, Bocian A, et al. Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics 1999;103:E38.
743. Robinson LM, Skaer JL, Sclar DA, et al. Is attention deficit hyperactivity disorder increasing among girls in the U.S? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 2000;16:129–137.
744. Lambert MC, Knight F, Taylor R, et al. Epidemiology of behavioral and emotional problems among children of Jamaica and the United States: parent reports for ages 6 to 11. J Abnorm Child Psychol 1994;22:113–128.
745. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization, 1992.
746. Prendergast M, Taylor E, Rapoport JL, et al. The diagnosis of childhood hyperactivity: a US-UK cross-national study of DSM-III and ICD-9. J Child Psychol Psychiatry 1988;29:289–300.
747. Hinshaw SP. On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in childhood psychopathology. Psychol Bull 1987;101:443–463.
748. Stewart MA, Cummings C, Singer S, et al. The overlap between hyperactive and unsocialized aggressive children. J Child Psychol Psychiatry 1981;22:35–45.
749. Biederman J, Fararone SV, Laysey K. Comorbidity of diagnosis in attention-deficit hyperactivity disorder. Child Adolesc Psychiatry Clin North Am 1992;1:335–358.
750. NICHD early child care research network. Trajectories of physical aggression from toddlerhood to middle childhood. Monographs Soc Res Child Dev 2004;69:1–129.
751. Dennis M, Wilkinson M, Koski L, et al. Attention deficits in the long term after childhood head injury. In: Broman S, Michel ME, eds. Traumatic brain injury in children. New York: Oxford University Press, 1994.
752. Olson HC, Streissguth AP, Sampson PD, et al. Association of prenatal alcohol exposure with behavioral and learning problems in early adolescence. J Am Acad Child Adolesc Psychiatry 1997;36:1187–1194.
753. Astbury J, Orgill A, Bajuk B. Relationship between two-year behavior and neurodevelopmental outcome at five years of very low-birth-weight survivors. Dev Med Child Neurol 1987;29:370–379.
754. Klebanov PK, Brooks-Gunn J, McCormick MD. Classroom behavior of very-low-birth-weight elementary school children. Pediatrics 1994;94:700–708.
755. Krouse JP, Kaufman JM. Morphological anomalies in exceptional children: a review and critique of research. J Abnorm Child Psychol 1972;10:247–264.
756. Wasserman J, Wolf LE, LeFever F, eds. Adult Attention Deficit Disorder, Brain Mechanisms and Life Outcomes. Ann Ny Acad Sci 2001.
757. Lahey BB, Piacentini JC, McBurnett K, et al. Psychopathology in the parents of children with conduct disorder and hyperactivity. J Am Acad Child Adolesc Psychiatry 1988;27:163–170.
758. Hechtman L. Families of children with attention deficit hyperactivity disorder: a review. Can J Psychiatry 1996;41:350–360.
759. Biederman J, Faraone SJV, Keenan K, et al. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Amer Acad Child Adolesc Psychiatry 1990;29:526–533.
760. Epstein JN, Conners CK, Erhardt D, et al. Familial aggregation of ADHD characteristics. J Abnorm Child Psychol 2000;28:595–599.
761. Faraone SV, Biederman J, Milberger S. An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry 1994;35:398–402.
762. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;1:121–124.
763. Cook EHJ, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993–998.
764. Gill M, Daly G, Heron S, et al. Confirmation of association between attention-deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997;2:311–313.
765. Doughety DD, Bonab AA, Spencer TJ, et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999;354:2132–2133.
766. Zentall SS, Meyer MJ. Self-regulation of stimulation for ADD-H children during reading and vigilance task performance. J Abnorm Child Psychol 1987;15:519–536.
767. Filipek PA, Semrud-Clikeman M, Steingard RJ, et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589–601.
768. Castellanos FX, Giedd JN, Eckburg P, et al. Quantitative morphology of the caudate nucleus in attention-deficit hyperactivity disorder. Am J Psychiatry 1994;151:1791–1796.
769. Hynd GW, Hern KL, Novey ES, et al. Attention-deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339–347.
770. Aylward EH, Reiss AL, Reader MJ, et al. Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996;11:112–115.
P.1155

771. Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002;288:1740–1748.
772. Baumgardner TL, Singer HS, Denckla MB, et al. Corpus callosum morphology in children with Tourette’s syndrome and attention-deficit hyperactivity disorder. Neurology 1996;47:1–5.
773. Semrud-Clikeman M, Filipek PA, Biederman J, et al. Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 1994;33:875–881.
773a. Mostofsky SH, Reiss AL, Lockhart P, et al. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 1998;13:434–439.
774. Lou HC, Henriksen L, Bruhn P, et al. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1990;46:48–52.
775. Matochik JA, Liebenauer LL, King AC, et al. Cerebral glucose metabolism in adults with attention-deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994;151:658–664.
776. Satterfield JH, Schell AM, Nicholas T, et al. Topographic study of auditory-event related potentials in normal boys and boys with attention deficit disorder with hyperactivity. Psychophysiology 1988;25:591–606.
777. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50:333–340.
778. Lazzaro I, Gordon E, Whitmont S, et al. Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clin Electroencephalogr 1998;29:37–42.
779. Harter MR, Annelo-Vento L, Wood FB, et al. Separate brain potential characteristics in children with reading disability and attention deficit disorder. Brain Cogn 1988;7:115–140.
780. Robaey P, Breton F, Dugas M, et al. An event-related potential study of controlled and automatic processes in 6- to 8-year-old boys with ADHD. Electroencephalogr Clin Neurophysiol 1992;6:330–340.
781. Conners CK, March JS, Erhardt D, et al. Assessment of attention deficit disorders (ADHD): conceptual issues and future trends. J Psychoeduc Assess 1995;14:186–205.
782. Aylward EH, Whitehouse D. Learning disability with and without attention deficit disorders. In: Ceci SJ, ed. Handbook of cognitive, social, and neuropsychological aspects of learning disabilities. Hillsdale, NJ: Erlbaum Associates, 1986–1987:321–342.
783. March JS, Swanson JM, Arnold LE, et al. Anxiety as a predictor and outcome variable in the multimodel treatment study of children with ADHD (MTA). J Abnorm Child Psychol 2000;28:527–541.
784. Swanson J, Kinsbourne M, Roberts W, et al. A time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 1978;61:21–29.
785. Epstein JN, Erkanli A, Conners CK, et al. Relations between continuous performance test performance measures and ADHD behaviors. J Abnorm Child Psychol 2003;31:543–554.
786. Greenberg LM, Waldman I. Developmental normative data on the test of variables of attention. J Child Psychol Psychiatry 1993;6:1019–1030.
787. Epstein JN, Erkanli A, Conners CK, et al. Relations between continuous performance test measures and ADHD behaviors. J Abnorm Child Psychol 2003;31:543–554.
787a. Liss IN, Saulnier C, Fein D, Kinsbourne M. Sensory and attention abnormalities in autistic spectrum disorders. Autism, in press.
788. Kagan J, Reznick JS, Snidman N. Biological bases of childhood shyness. Science 1988;40:167–171.
789. Nuechterlein KM. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and hyperactive children. J Abnorm Psychol 1983;92:4–28.
790. Tillman R, Geller B, Craney JL, et al. Relationship of parent and child informants to prevalent mania symptoms in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004;161:1278–1284.
791. Akiskal HS, Downs J, Jordan P, et al. Affective disorders in referred children and younger siblings of manic depressives. Arch Gen Psychiatry 1985;42:996–1003.
792. Leibenluft E, Charney DS, Towbin KE, et al. Defining clinical phenotypes of juvenile mania. Amer J Psychiatry 2003;160:430–437.
793. Geller B, Zimerman B, Williams M, et al. J Child Adolesc Psychopharmacology 2002;12:11–25.
794. Rickler KC. Episodic dyscontrol. In: Benson F, Blumer A, eds. Psychiatric aspects of neurologic disease, Vol II. New York: Grune & Stratton, 1982.
795. Swedo SE, Leonard HL, Kiessling L. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994;93:323–326.
796. Yeates KO, Bornstein RA. Attention deficit disorder and neuropsychological functioning in children with Tourette’s disorder. Neuropsychology 1994;8:65–74.
797. Channon S, Pratt P, Robertson MM. Executive function, memory and learning in Tourette’s syndrome. Neuropsychology 2003;17:247–254.
798. American Academy of Pediatrics Committee on Children with Disabilities and Committee on Drugs. Medication for children with attentional disorders. Pediatrics 1996;98:301–304.
799. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24 months outcomes of treatment strategies for attention-deficit hyperactivity disorder. Pediatrics 2004;113:754–761.
800. McDaniel KD. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents, Part 1. Clin Pediatr (Phila) 1986;25:65–71.
801. Barkley RA. Hyperactive boys and girls: stimulant drug effects on mother-child interactions. J Child Psychol Psychiatry 1989;30:379–390.
802. Schachar R, Taylor E, Wieselberg M, et al. Changes in family function and relationships in children who respond to methylphenidate. J Am Acad Child Adolesc Psychiatry 1987;26:728–732.
803. Swanson JM, McBurnett K, Wigal T, et al. Effect of stimulant medication on children with attention deficit disorder: a “review of reviews.” Except Child 1993;60:154–162.
804. Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 2004;161:1173–1180.
805. Lipkin PH, Goldstein IJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 1994;148:859–861.
806. Rapport MD, duPaul GJ, Kelly KL. Attention-deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharm Bull 1989;25:285–290.
807. Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996;35:1–10.
808. Comings DE, Comings BG. Tourette’s syndrome and attention deficit disorder with hyperactivity. Arch Gen Psychiatry 1987;44:1023–1026.
809. Price RA, Leckman JF, Pauls DL, et al. Gilles de la Tourette’s syndrome. Tics and central nervous system stimulants in twins and non-twins. Neurology 1986;36:232–237.
810. Cohen AJ, Leckman JF. Sensory phenomena associated with Gilles de la Tourette. J Clin Psychiatry 1992;53:519–523.
811. Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995;95:74–81.
812. Kilgore BS, Dickinson LC, Burnett CR, et al. Alterations in cartilage metabolism by neurostimulant drugs. J Pediatr 1979;94:542–545.
813. Croche AF, Lipman RS, Overall JE, et al. The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics 1979;63:847–850.
814. Gittelman-Klein R, Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988;45:1131–1134.
815. Kalachnik JE, Sprague RL, Sleator EK. Effect of methylphenidate hydrochloride on stature of hyperactive children. Dev Med Child Neurol 1982;24:586–595.
816. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up. Changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762–769.
817. Faraone SV, Wilens T. Does stimulant treatment lead to substance abuse disorder? J Clin Psychiatry 2003;64[Suppl]11:9–13.
P.1156

818. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupanciees in the human brain induced by therapeutic doses of oral methylphenidate. Amer J Psychiatry 1999;155:1325–1331.
819. Greenhill L, Beyer DH, Finkelstein J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention deficit/hyperactivity disorder. J Attention Disord 2000;6:S89–S100.
820. Greenhill LL, Swanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Amer Acad Child Adolesc Psychiatry 2001;40:180–187.
821. Funk JB, Chessare JB, Weaver MT, et al. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate. Pediatrics 1993;91:816–819.
822. Feldman H, Crumrine P, Handen BL, et al. Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 1989;143:1081–1086.
823. Gross-Tsur V, Manor O, vander Meere J, et al. Epilepsy and attention deficit disorder: is methylphenidate safe and effective? J Pediatr 1997;130:40–44.
824. Wroblewski BA, Leary JM, Phelan AM, et al. Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry 1992;53:86–89.
825. Spencer T, Biedermark J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention deficit hyperactivity disorder. Arch Gen Psychiatry 2001;58:775–782.
826. Pelham WE, Swanson JM, Furman MB, et al. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiatry 1995;34:1504–1513.
827. Shevell M, Schreiber R. Pemoline-associated hepatic failure: a critical analysis of the literature. Pediatr Neurol 1997;16:141–146.
828. Marotta PJ, Roberts EA. Pemoline hepatotoxicity in children. J Pediatr 1998;132:894–897.
829. Greenhill LL. Pharmacotherapy: stimulants. Child Adolesc Psychiatry Clin North Am 1992;1:411–447.
830. Chappell PB, Riddle MA, Scahill L, et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995;34:1140–1146.
831. Swanson JM, Flockhart D, Udrea D, et al. Clonidine in the treatment of ADHD: questions about safety and efficacy. J Child Adolesc Psychopharmacol 1995;5:301–304.
832. Balldin J, Berggren U, Erikson E, et al. Guanfacine as an alpha-2-agonist inducer of growth hormone secretion: a comparison with clonidine. Psychoneuroendocrinology 1993;18:45–55.
833. Michelson D, Farris D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder a randomized, placebo-controlled dose-response study. Pediatrics 2001;108:E83.
834. Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder including an assessment of evening and morning behavior: a double-blind placebo-controlled trial. Pediatrics 2004;63:114. e1-e8.
835. Kratochvil CJ, Heiligenstein JH, Dittmann R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolescent Psychiatry 2002;41:776–784.
836. Biederman J, Gastfriend DR, Jellinek MS. Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 1986;6:359–363.
837. Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 1993;3:1–10.
838. Popper CW. Antidepressants in the treatment of attention-deficit hyperactivity disorder. J Clin Psychiatry 1997;58:14–29.
839. Wolf SM, Forsythe A. Behavior disturbance, phenobarbital, and febrile seizures. Pediatrics 1978;61:728–731.
840. Stein MA, Krasowski M, Leventhal BL, et al. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Arch Pediatr Adolesc Med 1996;150:284–288.
841. Christakis DA, Zimmerman FJ, DiGiuseppe DL, et al. Early television exposure and subsequent attentional problems in children. Pediatrics 2004;113:708–713.
842. Feingold BF. Why your child is hyperactive. New York: Random House, 1975.
843. Swanson JM, Kinsbourne M. Food dyes impair performance of hyperactive children on a laboratory learning test. Science 1980;207:1485–1487.
844. Egger J, Carter CM, Graham PJ, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1985;1:540–545.
845. Kaplan BJ, McNicol J, Conte RA, et al. Dietary replacement in preschool-aged hyperactive boys. Pediatrics 1989;83:7–17.
846. Egger J, Stolla A, McEwen LM. Controlled trial of hyposensitization in children with foot induced hyperkinetic syndrome. Lancet 1993;341:114–115.
847. Kinsbourne M. Sugar and the hyperactive child. N Engl J Med 1994;330:355–356.
848. Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995;274:1617–1621.
849. Conners CK, Blouin AG. Nutritional effects on behavior of children. J Psychiatr Res 1982;17:193–201.
850. Shaywitz BA, Sullivan CM, Anderson GM, et al. Aspartame, behavior, and cognitive function in children with attention deficit disorder. Pediatrics 1994;93:70–75.
851. Satterfield JM, Satterfield BT, Schell AM. Therapeutic interventions to prevent delinquency in hyperactive boys. J Am Acad Child Adolesc Psychiatry 1987;26:56–64.
852. Abikoff H, Hechtman L, Klein RG, et al. Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 2004;43:820–829.
853. Klein RG, Abikoff H, Hechtman L, et al. Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 2004;43:792–801.
854. Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatmen, 2nd ed. New York: Guilford Press, 1996.
855. Pelham WEJ, Carlson C, Sams SE, et al. Separate and combined effects of methylphenidate and behavior modification on boys with attention-deficit hyperactivity disorder in the classroom. J Consult Clin Psychol 1993;61:506–515.
856. Abikoff H. Cognitive training in ADHD children: less to it than meets the eye. J Learn Disabil 1991;24:204–209.
857. Wilens TE, McDermott SP, Biederman J, et al. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J Cogn Psychotherapy 1999;13:215–226.
858. Braswell L, Bloomquist ML. Cognitive-behavioral therapy with ADHD children: child, family and school interventions. New York: Guilford, 1991.
859. Swanson JM. School-based assessments and interventions for ADD students. Irvine, CA: KC Publications, 1992.
860. Latham P, Latham P. Who has a disability under the ADA? Attention 1999;6:40–42.
861. Roy-Byrne P, Scheele L, Brinkley J, et al. Adult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinic. Compr Psychiatry 1997;38:133–140.
862. Loney J, Kramer J, Milich R. The hyperactive child grows up: predictors of symptoms, delinquency, and achievement at follow-up. In: Gadow J, Loney J, eds. Psychosocial aspects of drug treatment for hyperactivity. Boulder, CO: Westview, 1981:381–415.
863. Tarter RE, Alterman Al, Edwards KL. Vulnerability to alcoholism in men: a behavior-genetic perspective. J Stud Alcohol 1985;46:329–356.
864. Linnoila VI, Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry 1992;53[Suppl]:46–51.
865. Marcus J, Hans SL, Nagler S, et al. Review of the NIMH Israeli Kibbutz-City Study and the Jerusalem Infant Development Study. Schizophr Bull 1987;13:425–438.
866. Schweitzer JB, Lee DO, Handford RB, et al. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatr 2004;56:597–606.